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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these recommen­
dations along with other considerations such as feasibility and means of 
implementation in developing regulatory standards.
It is intended to present successive reports as research and epide­
miologic studies are completed and as sampling and analytical methods are 
developed. Criteria and standards will be reviewed periodically to ensure 
continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on
1,1,1-trichloroethane by members of my staff and the valuable, constructive 
comments by the Review Consultants on 1,1,1-Trichloroethane, by the ad hoc 
committees of the American Industrial Hygiene Association and the American 
Academy of Occupational Medicine, and by Robert B. O'Connor, M.D., NIOSH 
consultant in occupational medicine. The NIOSH recommendations for 
standards are not necessarily a consensus of all the consultants and
professional societies that reviewed this criteria document on 1,1,1- 
trichloroethane. Lists of the NIOSH Review Committee members and of the 
External Reviewers appear on the following pages.
John F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
The Division of Criteria Documentation and Standards 
Development, National Institute for Occupational 
Safety and Health, had primary responsibility for 
development of the criteria and recommended standard 
for 1.,1,1-trichloroethane. The Division Review 
staff for this document consisted of Keith H. 
Jacobson, Ph.D., Chairman; Richard A. Rhoden, Ph.D.; 
Paul E. Caplan; and special reviewers Hervey B. 
Elkins, Ph.D. and Charles C. Hassett, Ph.D.
Agatha Corporation developed the basic information 
for consideration by NIOSH staff and consultants 
under contract HSM-99-73-20. Robert W. Mason, 
Ph.D., had NIOSH program responsibility and John A. 
Wass, Ph.D., served as criteria manager.
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I. RECOMMENDATIONS FOR A 1,1,1-TRICHLOROETHANE STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that worker exposure to 1,1,1-trichloroethane (CH3 CC1 3), also 
known as methyl chloroform, in the workplace be controlled by adherence to 
the following sections. The standard is designed to protect the health and 
safety of workers for up to a 10-hour workday, 40-hour workweek over a 
working lifetime; compliance with the standard should therefore prevent 
adverse effects of 1,1,1-trichloroethane on the health and safety of 
workers. The standard is measurable by techniques that are valid, 
reproducible, and available to industry and governmental agencies. 
Sufficient technology exists to permit compliance with the recommended 
standard. The standard will be subject to review and revision as 
necessary.
"Occupational exposure to 1,1,1-trichloroethane" is defined as 
exposure above 200 ppm measured as a time-weighted average (TWA) for up to 
a 10-hour workday, 40-hour workweek.
Occupational exposure to 1,1,1-trichloroethane requires adherence to 
all the following sections. Exposure at lower environmental concentrations 
will not require adherence to Sections 1, 2, 7(b), and 4(a) except 4(a)(5).
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure shall be controlled so that workers are not 
exposed to 1,1,1-trichloroethane at greater than a ceiling concentration of
1
350 ppm (1,910 mg/cu m) as determined by a 15-minute sample.
(b) Sampling and Analysis
Procedures for sampling and analysis of workroom air shall be as 
provided in Appendices 1 and II or by any method shown to be at least 
equivalent.
Section 2 - Medical
(a) Preplacement initial or interim medical and work history.
(b) Preplacement physical examinations giving attention to at 
least the neurological, cardiovascular, and liver functions, and skin 
condition.
(c) A judgment should be made of the worker's ability to use 
positive or negative pressure respirators.
(d) Periodic examinations shall be made available on an annual 
basis or at some other frequency to be determined by the responsible 
physician.
(e) Proper medical management shall be made available to workers 
suffering from adverse effects of 1,1,1-trichloroethane.
(f) Initial medical examinations shall be made available to all 
workers within 60 days of the promulgation of the standard.
(g) Workers shall be advised that available scientific information 
from one experimental animal study has shown that the offspring of mice and 
rats exposed at high levels of 1,1,1-trichloroethane were observed to have 
congenital abnormalities. The relevance of this study to male or female 
workers or their offspring has not yet been determined. It does, however,
suggest that employers and workers attempt to minimize exposure to 1,1,1- 
trichloroethane whenever possible. If the physician becomes aware of any 
adverse reproductive effects including repeated spontaneous abortions in
1,1,1-trichloroethane exposed workers or congenital abormalities in their 
children, this information should be forwarded to the Director, National 
Institute for Occupational Safety and Health.
(h) Medical records shall be maintained for all persons employed
in work involving exposure to 1,1,1-trichloroethane. All pertinent medical 
records with supporting documents shall be maintained for 20 years after 
the individual's employment is terminated. These records shall be made 
available to the designated medical representatives of the Secretary of 
Health, Education, and Welfare, of the Secretary of Labor, of the employer, 
and of the employee or former employee.
Section 3 - Labeling and Posting
(a) The following warning sign shall be affixed in a readily
visible location on processing or other equipment and on 1,1,1- 
trichloroethane storage tanks or containers:
1,1,1-TRICHLOROETHANE
BREATHING VAPOR MAY BE 
HAZARDOUS TO HEALTH.
May generate toxic gases on contact 
with open flame, hot surfaces, or 
other heat-producing conditions.
Keep containers closed when not in use.
Use only with adequate ventilation.
Avoid breathing of vapor.
Avoid contact with skin.
Notice to physician: Sympathomimetic
amines are contraindicated.
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This sign shall also be printed in the predominant language of non- 
English-speaking workers. All employees shall be trained and informed of 
the hazardous areas, with special instructions given to illiterate workers.
(b) This sign shall also be posted at or near entrances to areas 
in which there is occupational exposure to 1,1,1-trichloroethane.
Section 4 - Personal Protective Equipment and Clothing
(a) Respiratory Protection
(1) Engineering controls shall be used wherever necessary 
to maintain 1,1,1-trichloroethane concentrations at or below the 
recommended environmental exposure standard. Compliance with the 
permissible exposure limits may be achieved by the use of respirators only:
(A) During the time necessary to Install or test the 
required engineering controls.
(B) For nonroutine operations such as brief exposure 
at concentrations in excess of the environmental limits for maintenance or 
repair activities.
(C) During emergencies when air concentrations of
1,1,1-trichloroethane may exceed the recommended limits.
(2) When respirators are permitted, a respirator program
meeting the requirements of 29 CFR 1910.134 and 30 CFR 11.2-1 shall be
established and enforced by the employer.
(3) Only appropriate respirators as described in Table 1-1 
shall be used pursuant to the following requirements:
(A) To determine the class of respirator to be used,
the employer shall measure the atmospheric concentration of 1,1,1-
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trichloroethane in the workplace initially and thereafter whenever process, 
worksite, climate, or control changes occur which are likely to increase 
the 1,1,1-trichloroethane concentration. This requirement shall not apply 
when only self-contained or combination supplied-air and self-contained 
positive pressure respirators are used.
(B) The employer shall ensure that no worker is 
being exposed to 1,1,1-trichloroethane in excess of the exposure limit 
because of improper respirator selection, fit, use, or maintenance.
(C) When respirators are required, the employer 
shall provide respirators in accordance with Table 1-1 and shall ensure 
that the employee uses the respirator provided.
(D) Respiratory protective devices described in 
Table 1-1 shall be those approved under the provisions of 30 CFR 11.
(E) Respirators specified for use in higher 
concentrations of 1,1,1-trichloroethane are permitted in atmospheres of 
lower concentrations.
(F) The employer shall ensure that respirators are 
adequately cleaned, maintained, and stored, and that employees are 
instructed on the use of respirators and on testing for leakage.
(4) Chemical cartridges and canisters shall not be used for 
periods of time in excess of those indicated in Table 1-1. In any case 
chemical cartridges and canisters should be replaced after each day of use.
(5) Where an emergency may develop that could result in 
employee injury from overexposure to 1,1,1-trichloroethane, the employer 
shall provide respiratory protection as listed in Table 1-1.
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(b) Protective Clothing
In any operation where the worker may come into direct contact with 
liquid 1,1,1-trichloroethane, protective clothing shall be worn. The 
clothing should be resistant to 1,1,1-trichloroethane. Gloves, boots, 
overshoes, and bib-type aprons that cover boot tops shall be provided when 
necessary. Impervious supplied-alr hoods or suits shall be worn when 
entering confined spaces such as pits or tanks unless known to be safe. In 
situations where heat stress is likely to occur, air-supplied suits shall 
be used. All protective clothing shall be well-aired and inspected for 
defects prior to reuse. Hands placed in liquid 1,1,1-trichloroethane shall 
be protected by Impervious gloves. Any liquid 1,1,1-trichloroethane that 








500 ppm or less
1000 ppm or less
A chemical cartridge respirator with organic 
vapor cartridge(s), maximum service life of 
5 hours; chemical cartridges should be 
changed after each day of use.
A self-contained breathing apparatus
A chemical cartridge respirator with a full 
facepiece and organic vapor cartridge(s), 
Maximum service life of 2 hours
Greater than 
1000 ppm or entry 




A gas mask with a chin-style or a front- 
or back-mounted organic vapor canister
A supplied-air respirator with a full 
facepiece, helmet or hood
A self-contained breathing apparatus 
with a full facepiece
Self-contained breathing apparatus with 
a full facepiece operated in pressure- 
demand or other positive pressure mode
A combination respirator which includes a 
Type C supplied-alr respirator with a 
full facepiece operated in pressure-demand 
or other positive pressure or continuous- 
flow mode and an auxiliary self-contained 
breathing apparatus operated In pressure- 
demand or other positive pressure mode
Self-contained breathing apparatus with a 
full facepiece operated in pressure-demand 
or other positive pressure mode
A gas mask providing protection 
against organic vapors




Eye protection shall be provided for, and worn by, any employee 
engaged in an operation where 1,1,1-trichloroethane liquid or spray may 
enter the eye. Chemical-type goggles or safety glasses with splash shields 
made completely of l,i,l-trichloroethane-resi8tant materials shall be used. 
Suitable eye protection shall be in accordance with 29 CFR 1910.133.
Section 5 - Informing Employees of Hazards from 1,1.1-Trichloroethane
(a) All new and present employees in any 1,1,1-trichloroethane 
area shall be kept informed of the hazards, relevant symptoms, effects of 
overexposure, and proper conditions and precautions concerning safe use and 
handling of 1,1,1-trichloroethane.
(b) A continuing educational program shall be Instituted to ensure 
that all workers have current knowledge of job hazards, proper maintenance 
procedures, and cleanup methods, and that they know how to correctly use 
respiratory protective equipment and protective clothing. It shall include 
a description of the general nature of the mechanical surveillance 
procedures and why it is advantageous to the worker to undergo these 
examinations.
The Information explaining the hazards of working with 1,1,1- 
trichloroethane shall be kept on file and readily accessible to the worker 
at all places of employment where 1,1,1-trichloroethane is manufactured, 
used, transported, or stored.
(c) Information as required shall be recorded on US Department of 
Labor Form 0SHA-20, "Material Safety Data Sheet,” or similar form approved 
by the Occupational Safety and Health Administration, US Department of 
Labor.
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Section 6 - Work Practices
(a) Handling and Storage
(1) Containers delivered by closed truck or rail shall not 
be unloaded until the vehicle in which they arrived has been ventilated. 
The absence of any odor of 1,1,1-trichloroethane should not be used as a 
criterion of adequate ventilation.
(2) Storage containers piping, and valves shall be 
inspected periodically for leakage
(3) Storage facilities shall be designed to contain spills 
and prevent contamination of workroom air.
(4) Processes and storage facilities shall not be located
near open flames or high-temperature operations, unless precautions are
taken to prevent fire and explosion hazards.
(b) Contaminant Controls
(1) Suitable engineering controls designed to limit 
exposure to 1,1,1-trichloroethane shall be utilized if needed. Ventilation 
systems, if used, shall be designed to prevent the accumulation or 
recirculation of 1,1,1-trichloroethane in the workroom and to effectively 
remove 1,1,1-trichloroethane from the breathing zones of workers. 
Adequate, uncontaminated make-up air shall be provided. Ventilation 
systems shall be subjected to regular preventive maintenance and cleaning 
to ensure maximum effectiveness, which shall be verified by periodic 
airflow measurements.
(2) Portable exhaust ventilation or suitable general
ventilation shall be provided, if necessary, to limit environmental
concentrations for nonroutine operations that require the application of
1,1,1-trichloroethane.
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(c) Equipment Maintenance and Emergency Procedures
(1) 1,1,1-Trichloroethane hazard areas
A hazard area that workers may enter (any space with physical 
characteristics and sources of 1,1,1-trichloroethane that could result in 
concentrations of 1,1,1-trichloroethane in excess of the environmental 
limits) shall have exits that are plainly marked. Emergency exit doors 
shall be conveniently located and shall open into areas which will remain 
free of contamination in an emergency. At least two separate means of exit 
shall be provided from each room or building in which 1,1,1-trichloroethane 
is stored or handled in quantities that could create a hazard.
(2) Confined spaces
(A) Entry into confined spaces or into other areas 
where there may be limited egress shall be controlled by a permit system. 
Permits shall be signed by an authorized representative of the employer 
certifying that preparation of the confined space, precautionary measures, 
personal protective equipment, and procedures to be used are all adequate.
(B) Tanks, pits, tank cars, process vessels, 
tunnels, sewers, grain storage bins, or other confined spaces which have 
contained 1,1,1-trichloroethane shall be thoroughly ventilated to assure an 
adequate supply of oxygen and a safe concentration of 1,1,1- 
trichloroethane, tested for 1,1,1-trichloroethane and inspected prior to 
each entry. Ventilation shall be maintained while workers are in the 
space.
(C) Inadvertent infiltration of 1,1,1-
trichloroethane into the confined space while work is in progress Inside 
shall be prevented by disconnecting and blanking off 1,1,1-trichloroethane
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(D) Personnel entering confined spaces shall be 
furnished with appropriate personal protective equipment and protected by a 
lifeline tended by another worker outside the space, who shall also be 
equipped for entry with approved respiratory, eye and skin protection, 
lifeline, and have contact with a third party.
(E) Written operating instructions and emergency 
medical procedures shall be formulated and posted in conspicuous locations 
where accidental exposure to concentrations of 1,1,1-trichloroethane in 
excess of the environmental limit may occur. These instructions and 
procedures shall be printed both in English and in the predominant language 
of non-English-speaking workers, if any. Special instructions shall be 
given to illiterate workers.
(d) Showers and Eye Wash Fountains
Showers and eye wash facilities shall be provided and so located as 
to be readily accessible to workers in all areas where skin or eye splash 
with 1,1,1-trichloroethane is likely. If 1,1,1-trichloroethane is splashed 
on the worker, contaminated clothing shall be promptly removed and the skin 
washed with soap and water. If liquid 1,1,1-trichloroethane contacts the 
eyes, they shall be thoroughly irrigated with clean water, promptly 
followed by medical assistance. Such incidents shall be reported to the 
immediate supervisor by the affected employee or by a fellow worker.
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Section 7 - Monitoring and Recordkeeping
(a) General
Workers are not considered to be occupationally exposed to 1,1,1- 
trichloroethane if environmental concentrations, as determined on the basis 
of an industrial hygiene survey, do not exceed the action level, or if 
there is no operation, storage, or handling of 1,1,1-trichloroethane in any 
form, or contamination of workplace air by 1,1,1-trichloroethane from other 
sources. These industrial hygiene surveys shall begin within 6 months 
after this standard is promulgated, and be repeated at least every 3 years 
and within 30 days after any process or operating change likely to result 
in increases of airborne concentrations of 1,1,1-trichloroethane. Records 
of these surveys, including the basis for concluding that airborne 
concentrations of 1,1,1-trichloroethane are at or below the action level, 
shall be maintained until the next survey has been completed.
The following requirements apply to occupational exposure to 1,1,1- 
trichloroethane, ie, to workplaces where the action level is exceeded.
(b) Personal Monitoring
A program of breathing zone or personal monitoring shall be
instituted to identify and measure the exposure of all employees
occupationally exposed to 1,1,1-trichloroethane. This sampling and 
analysis shall be conducted every 3 months on at least 25% of the workers 
so that each worker's exposure is measured at least every year; this
frequency and percentage of employees sampled may be different if so
directed by a professional industrial hygienist. Sufficient samples shall 
be taken and analyzed to permit construction of valid estimates of the TWA 
and ceiling concentration exposures. If monitoring of any worker shows
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exposure in excess of the recommended environmental limit, additional 
monitoring shall be promptly initiated. If confirmed, control procedures 
shall be instituted as soon as possible; these may precede and obviate 
confirmatory monitoring if the employer desires. Affected employees shall 
be advised that exposures have been excessive and be notified of the 
control procedures being implemented. Monitoring of these employees shall 
be conducted at least as often as every 30 days and shall continue until 2 
successive samplings at least a week apart confirm that exposure no longer 
exceeds recommended limits. Normal monitoring may then be resumed.
For each TWA concentration determination, a sufficient number of 
samples to characterize each worker’s exposure during each workshift shall 
be taken and analyzed. The number of TWA and ceiling concentration 
determinations for an operation shall be based on such factors as the 
variations in location and job functions of workers in that operation.
(c) Recordkeeping
Environmental monitoring records shall be maintained for at least 20 
years. These records shall include methods of sampling and analysis used, 
types of respiratory protection used, and TWA and ceiling concentrations 
found. Each employee shall be able to obtain information on his own 
envi ronmen t al exp o s ur es.
Pertinent medical records shall be retained for 20 years after the 
last occupational exposure to 1,1,1-trichloroethane. Records of 
environmental exposures applicable to an employee should be included in 
that employee's medical records. These medical records shall be made 
available to the designated medical representatives of the Secretary of 
Labor, of the Secretary of Health, Education, and Welfare, of the employer, 
and of the employee or former employee.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to 1,1,1-trichloroethane. The criteria 
document fulfills the responsibility of the Secretary of Health, Education, 
and Welfare, under Section 20(a)(3) of the Occupational Safety and Health 
Act of 1970, to "...develop criteria dealing with toxic materials and 
harmful physical agents and substances which will describe...exposure 
levels at which no employee will suffer impaired health or functional 
capacities or diminished life expectancy as a result of his work
experience."
The National Institute for Occupational Safety and Health, (NIOSH) 
after a review of data and consultations with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health of workers from exposure to hazardous chemical and
physical agents. The criteria and recommended standard should enable 
management and labor to develop better engineering controls resulting in
more healthful work environments. Simply complying with the recommended 
standard should not be the final goal.
These criteria for a standard for 1,1,1-trichloroethane are part of a 
continuing series of criteria developed by NIOSH. The proposed standard 
applies only to the processing, manufacture, and use of 1,1,1- 
trichloroethane as applicable under the Occupational Safety and Health Act 
of 1970. The standard was not designed for the population-at-large, and 
any extrapolation beyond occupational exposures is not warranted. It is
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intended to (1) protect workers against development of systemic effects, 
especially central nervous system (CNS) and hepatic insult, (2) be 
measurable by techniques that are valid, reproducible, and available to 
industry and governmental agencies, and (3) be attainable with existing 
technology.
Further research is needed to more completely characterize the 
effects of certain levels of 1,1,1-trichloroethane on workers, especially 
epidemiological, chronic and teratological studies. Animal studies are 
underway at the National Cancer Institute to determine if 1,1,1- 
trichloroethane is carcinogenic. Similar studies are being performed by 
the Dow Chemical Company.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
1.1.1-Trichloroethane (CH3 CC1 3) is also known as methyl chloroform 
and alpha-trichloroethane. [1,2]
There are two isomers of trichloroethane. The 1,1,2 isomer is also 
known as ethane trichloride, vinyl trichloride, beta-trichloroethane and 
monochloroethylenechloride. [1-3] Some reports do not clearly distinguish 
between the isomers, and some confusion exists in the literature because of 
Indiscriminate use of the term trichloroethane. [4-7]
The odor threshold of 1,1,1-trichloroethane was reported by the 
American National Standards Institute to be around 100 ppm. [8] Stewart 
found a sex difference in odor "acceptance" at 350 ppm. [9] May [10] 
reported that the odor threshold for 1,1,1-trichloroethane of his subjects 
was 400 ppm, and that they perceived the odor more clearly at 700 ppm. 
Arthur D. Little Inc. [11] reported the odor recognition threshold, 
detected by four expert panel members when 1,1,1-trichloroethane was in 
room air, to be 16 ppm. These data reflect the variability in odor 
threshold values and highlight the danger of using odor as a criterion for 
detection of harmful levels of 1,1,1-trichloroethane. Some physical data 
for 1,1,1-trichloroethane are presented in Table XII-1. [1,8,12-15]
1.1.1-Trichloroethane was first marketed as an Industrial cold clean­
ing solvent in 1951. [16] United States production of 1,1,1- 
trichloroethane in 1961 was 20,000,000 lbs. [17] In 1966, when the US 
Tariff Commission began tabulating production data separately for 1,1,1- 
trichloroethane, production of 242,943,000 lbs by four manufacturers was
16
Production has increased steadily and in 1973, production of 548,394,000 
lbs was reported. [19-24]
There are many uses of 1,1,1-trichloroethane as a solvent and clean­
ing agent. [16,25,26] In 1969, Gleason et al [27] tabulated over 40 pro­
ducts, marketed by 30 companies, which contained it. Among the products 
were type cleaners, color film cleaners, insecticides, spot removers, 
cements and adhesives, and fabric cleaning solutions. [27] One of the most 
common industrial uses is as a degreasing agent.
Workers involved in the manufacture of 1,1,1-trichloroethane, in its 
formulation into the many products containing it, and in their final uses, 
are potentially exposed to 1,1,1-trichloroethane. In addition to job 
related exposures, workers may be exposed to 1,1,1-trichloroethane by home 
use of the many products which contain it.
Commercial 1,1,1-trichloroethane contains small amounts of 
stabilizing substances. Among the materials which may be used for this 
purpose are glycol diesters, ketones, nitriles, dialkyl sulfoxides, dialkyl 
sulfides, dialkyl sulfites, tetraethyl lead, nitroaliphatic hydrocarbons, 
2-methyl-3-butyn-2-ol, tertiary butyl alcohol, 1,4-dioxane, dioxolane, sec- 
butyl alcohol, and monohydric acetylenic alcohols. [12,14] 1,1,1-Tri-
chloroethane preparations containing these additives are called inhibited
1.1.1-trichloroethane.
NIOSH estimates that 100,000 US workers are potentially exposed to
1.1.1-trichloroethane in their places of employment.
Historical Reports
Tauber, [2] in 1880, used 1,1,1-trichloroethane as an anesthetic
17
agent in humans to produce unconsciousness without excitation or notable 
effects on respiratory or heart rates. Vomiting and fatigue were 
experienced, however, during recovery from anesthesia. Tauber's 
experiments with frogs, rabbits and dogs also showed that 1,1,1- 
trichloroethane did not materially affect respiratory or pulse rates during 
anesthesia. [2]
Blondeau [28] anesthetized frogs and guinea pigs with 1,1,1- 
trichloroethane saturated air and reported his experiments in 1883. He 
found that it took longer to produce anesthesia with 1,1,1-trichloroethane 
than with chloroform, and he considered that 1,1,1-trichloroethane would be 
more offensive as an anesthetic. [29]
Experimental studies of 1,1,1-trichlorethane as an inhalation 
anesthetic, with dogs as the experimental animal, were reported in 1887 by 
Dubois and Roux. [30] They prepared purified 1,1,1-trichloroethane and 
found it to have a pleasant odor which was not as penetrating and 
suffocating as that of chloroform. They found that dogs became completely 
anesthetized in 7 to 8 minutes when inhaling air saturated with 1,1,1- 
trichloroethane. There was a slight acceleration of respiration initially, 
but, with muscular relaxation, the respiration soon became calm and 
regular. Within 1 to 2 minutes after cessation of 1,1,1-trichloroethane 
inhalation, the animals were completely awake. There was no excessive 
salivation as with chloroform and the authors considered that, at least 
with dogs, 1,1,1-trichloroethane was superior to chloroform as an 
anesthetic agent. [30]
Exposures of an unspecified number of mice to 1,1,1-trichloroethane 
to determine the minimum concentrations required to produce prostration,
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loss of reflexes, and death within 2 hours of exposure, were reported by 
Lazarew in 1929. [31] 1,1,1-Trichloroethane was 1 of 12 chlorinated
hydrocarbons studied. To attain each of the end points, higher 
concentrations of the 1,1,1- than of the 1,1,2-isomer were required as 
shown in Table III-l.
TABLE III-l
EFFECTS OF TRICHLOROETHANE ISOMERS ON MICE
Isomer Minimum Concentration For Response 
Within 2 Hours of Exposure (mg/1)
proneness loss of reflexes death
1,1,1-
1,1,2-
40 45 65 
10 15 60
Adapted from Lazarew [31]
Lazarew assigned toxicity ratings to the 12 compounds based on the
concentrations required to cause prostration. [31] Higher indices meant 
greater toxicity. The index for 1,1,1-trichloroethane was 3.5 compared to 
14 for 1,1,2-trichloroethane, meaning that the 1,1,2- isomer was 4 times as 
toxic as the 1,1,1- isomer. This index was misinterpreted by Lehmann and 
Flury [3] who gave toxicity in the reverse order.
Effects on Humans
(a) Experimental Central Nervous System Effects
The most harmful effects of 1,1,1-trichloroethane seem to be 
manifested as CNS disorders. These include impairment of perceptual speed,
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reaction time, manual dexterity, and equilibrium.
Anesthesia was induced smoothly by 1,1,1-trichloroethane and main­
tained uneventfully for 30 minutes in a 30-year-old volunteer in an ex­
periment reported in 1959 by Krantz et al. [32] Recovery was slow but 
uneventful. The subject complained of being tired for several hours after 
the anesthesia.
In 1958 and 1959, Dornette and Jones found the concentration of
1,1,1-trichloroethane to vary from 10,000 to 26,000 ppm for induction of 
anesthesia, and to vary from 6,000 to 22,500 ppm for maintenance of light 
anesthesia in surgical patients. [33] The patients were given 0.43 mg of 
atropine and 11 mg of morphine by intramuscular injection 1 hour before 
induction of anesthesia. Nitrous oxide-oxygen (4:1) was used as the 
vehicle for 1,1,1-trichloroethane and as a supplemental anesthetic agent.
The investigators [33] found that, because of the lack of an 
irritating odor, the 1,1,1-trichloroethane could be administered
concurrently with the start of the nitrous oxide and that light plane 1 
anesthesia (analgesia and progressive loss of consciousness) usually
occurred within 2 minutes after the onset of administration. They [33] did 
not attempt to assess the effect of 1,1,1-trichloroethane alone, but
considered that at least one-quarter of the total narcosis could be
attributed to the nitrous oxide. Recovery from light plane 1 anesthesia 
and recovery of reflexes usually occurred within 3-5 minutes after 
discontinuation of the anesthetic agent.
Electroencephalographic patterns during 1,1,1-trichloroethane 
anesthesia were reported by Siebecker et al [34] to show little change 
before circulatory depression, and the changes were similar to those during
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2-bromo-2-chloro-l,1,1-trifluoroethane (halothane) anesthesia. The
investigators [34] found 1,1,1-trichloroethane to be clinically less potent 
than either chloroform or 2-bromo-2-chloro-l,1,1-trifluoroethane, and even 
less potent than trichloroethylene in supplementing nitrous oxide-oxygen 
for anesthesia.
In an experiment reported in 1961 by Stewart et al, [35] the exposure 
chamber concentration was increased continuously from 0 to 2,650 ppm for 15 
minutes (total exposure). One of seven exposed subjects became very 
lightheaded when the concentration reached 2,600 ppm, and at 2,650 ppm, two 
could not stand, and three others became very lightheaded. Two of the 
seven subjects did not become lightheaded. One subject maintained the 
ability to perform a normal Romberg test (loss of proprioceptive control 
evidenced by unsteadiness of standing patient when eyes are closed) 
throughout the exposure. The other six subjects regained their equilibrium 
within 5 minutes after cessation of exposure. The five subjects who became 
lightheaded reported a feeling of malaise for 5 hours after the exposure. 
The inhibited 1,1,1-trichloroethane used in this experiment contained 94- 
97% 1,1,1-trichloroethane, 2.4-3.0% dioxane, 0.12-0.3% butanol, and small 
amounts of 1,2-dichloroethane, water and other materials. [35]
Equilibrium was disturbed and the Romberg test was positive in 
subjects exposed at 1,740-2,180 ppm of uninhibited 1,1,1-trichloroethane in 
experiments reported by Torkelson et al in 1958. [36] Groups of two to 
four individuals were exposed at each concentration. Other concentrations 
studied by these investigators were about 500 ppm or 1,000 ppm. Light­
headedness was experienced by three of four subjects exposed at 1,000 ppm 
for 70-75 minutes. Coordination and equilibrium as measured by Flanagan
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tests (aptitude classification test of coordination) during exposure, and 
Romberg tests following exposure, were impaired. [36] Equilibrium was not 
disturbed by exposures at 1,000 ppm for 30 minutes and neither reflexes nor
equilibrium was disturbed by exposures at 500 ppm for up to 450 minutes.
Stewart et al [35] reported responses of their subjects to three
different exposures at about 900 ppm of the same inhibited 1,1,1-
trichloroethane. The results are presented in Table III-2.
TABLE III-2
RESPONSE OF HUMAN SUBJECTS EXPOSED
AT 900 ppm 1,1,1-TRICHLOROETHANE
Exposure Data Response
900 ppm Positive Romberg in 1 subject; greater effort
(3 subjects) required to perform normal Romberg in 2 subjects;
20 minutes normal heel-to-toe walking; lightheadedness in
2 subjects
910 ppm Increased mental effort required to perform
(2 subjects) normal Romberg test; heel-to-toe walking per­
35 minutes formed well; persistent lightheadedness in
1 subject
951 ppm Increased mental effort required to perform
(3 subjects) normal Romberg test after 10 minutes of exposure;
73 minutes consistently positive Romberg tests in 1 subject
after 15 minutes of exposure; heel-to-toe walking
performed well by all; no lightheadedness
Adapted from Stewart et al [35]
There were no symptoms of central nervous system response at 500 ppm 
of this inhibited 1,1,1-trichloroethane observed by Stewart et al [35] in 
two experiments in each of which six subjects were exposed for up to 3
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hours. Neither balance nor coordination was affected.
Psychophysiologic performance in six students, 20-23 years of age, 
was studied by Salvini et al [37] during exposures to inhibited 1,1,1-
trichloroethane at 350 and 450 ppm. [26] The psychophysiologic tests, 
including a perception test, the Wechsler memory scale, complex reaction
time test, an aspiration test, and a manual dexterity test by the O'Connor 
method were performed during the first and last hours of 8 exposure hours. 
The subjects were exposed individually in a 4 x 3 x 4 meter room at 20 C
and 45% relative humidity from 8:30 AM to 12:30 PM and from 2 to 6 PM.
During exposure the subjects alternated their activity with a 1-hour study 
period followed by 20 minutes of physical exercise (3 k cal/minute). [37]
The only factor that was reported to be statistically significant 
with regard to 1,1,1-trichloroethane was the interaction between perception 
of mental strain and 1,1,1-trichloroethane exposure at 450 ppm. Under 
stress conditions, exposure to 1,1,1-trichloroethane at 450 ppm decreased 
perceptive capabilities. [37] Because of the choice of subjects (healthy 
students) as well as the lack of controls on intervening variables (food 
and drinking habits), it would seem that further work is needed to justify 
a dose-response relationship.
Twelve subjects were exposed at 250, 350, 450 and 550 ppm of 1,1,1- 
trichloroethane in inspiratory air during four continuous 30-minute periods 
in an experiment reported by Gamborale and Hultengren [38] in 1970. The 
air-gas mixture was supplied via a breathing valve and a mouthpiece with 
very low resistance. The effects of the introduction of the breathing tube 
were not assessed. In the final 20 minutes of each exposure period, five 
performance tests were made. Two of them were tests of perceptual speed
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and the others were tests of simple reaction time, choice reaction time and 
manual dexterity.
The same subjects were also studied in control conditions in which 
inspiratory air contained no 1,1,1-trichloroethane but in which all 
operations and measurements were the same as during exposure to the 
solvent. The presence or absence of 1,1,1-trichloroethane was completely 
disguised for the subjects by menthol crystals in a canister, introduced 
through the tube to the mouthpiece. To balance the training effects 
between conditions, the order of conditions was reversed for half the 
subjects. [38]
The change in mean performance level during exposure to the 
increasing concentrations of 1,1,1-trichloroethane differed systematically 
from the change under control conditions. The level of performance in the 
manual dexterity test and two perceptual tests was affected by training, 
but the training effect was less pronounced during exposure to 1,1,1- 
trichloroethane. The tests of reaction time were less sensitive to 
training and with these there was an absolute decline in performance 
capability as the exposure concentration increased. [38] This study 
suffers from several deficiencies, as the substance used to disguise the
1,1,1-trichloroethane odor may itself have had a toxic effect and the 
introduction of a breathing tube may have induced stress in the subjects.
Statistically significant performance differences between 
experimental and control conditions were obtained for all tests with 
exposures at 350 ppm or more. 1,1,1-Trichloroethane had an adverse effect 
on subject performance capability at 350 ppm. [38]
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An experiment designed to simulate occupational exposures was 
reported by Stewart et al [39] in 1969. Mild sleepiness occurred 
repeatedly in four of five subjects exposed 6.5 to 7 hours daily for 5 
consecutive days at 500 ppm of a commercial 1,1,1-trichloroethane 
preparation. Other subjective symptoms of central nervous system response 
that were occasionally experienced by the subjects were lightheadedness and 
mild headache. The ability of two subjects to perform a modified Romberg 
test was impaired during the last 5-6 hours of each daily exposure. Their 
ability to perform the test normally was regained 5-10 minutes after 
removal from exposure. [39]
The 1,1,1-trichloroethane [26] used in this experiment contained (in 
liquid form) 4 vol% of 1,4-dioxane, 0.5 vol% butylene oxide, and 0.5 vol% 
of nitromethane as inhibitors. The liquid also contained traces of 1,2- 
dichloroethane (1,755 ppm), 1,1-dichloroethane (803 ppm), chloroform (385 
ppm), carbon tetrachloride (370 ppm), trichloroethylene (245 ppm), 1,1,2- 
trichloroethane (147 ppm), and vinylidene chloride (176 ppm). [39]
(b) Effects on the Cardiovascular System
Depression of the circulatory system was found with 1,1,1- 
trichloroethane, evidenced by a drop in blood pressure and bradycardia.
Blood pressure dropped to 70% of the preanesthetic level, but no 
significant electrocardiographic changes were found during the anesthesia 
reported by Krantz et al [32] in 1959.
A drop in systolic blood pressure of 5-10 mm of mercury in about 50% 
of their patients during 1,1,1-trichloroethane anesthesia was reported by 
Dornette and Jones. [33] In three patients, there was a greater drop in 
systolic blood pressure, and in one of these, a drop of 60 mm of mercury
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was observed. In all three, blood pressure returned to preoperative levels 
when the 1,1,1-trlchloroethane concentration was reduced to maintenance 
levels. Electrocardiograms of 32 of the patients showed 6 cases of changes 
in nodal rhythm, 3 cases with occasional premature ventricular 
contractions, 2 cases with frequent premature ventricular contractions, and 
2 cases with depressed S-T segments. One case of cardiac arrest during 
light anesthesia with 1,1,1-trichloroethane was reported, but the authors 
[33] considered there was no definite evidence to either incriminate or 
absolve 1,1,1-trichloroethane.
Depression of the circulatory system, evidenced by hypotension and 
bradycardia, was reported by Slebecker et al [34] to be an effect of 1,1,1- 
trichloroethane during anesthesia.
Stewart et al [35] did not find blood pressure changes in their sub­
jects exposed to inhibited 1,1,1-trichloroethane when its concentration 
rose from 0 to 2,650 ppm for 15 minutes, or at 900-955 ppm for up to 75 
minutes.
Electrocardiograms of four individuals were normal throughout 
exposures of 70-75 minutes duration at 900-1,000 ppm of uninhibited 1,1,1- 
trichloroethane in the experiment reported by Torkelson et al. [36] They 
found no significant changes in pulse rate or blood pressure during 450 
minutes of exposure at 415-590 ppm of uninhibited 1,1,1-trichloroethane. 
[36]
Trochimowicz et al [40] did not find cardiac sensitization in a study 
of 41 dogs given 0.5% (v/v) 1,1,1-trichloroethane. An experimental group 
was subjected to myocardial infarction by placement of a copper wire within 
selected sites of the descending left coronary artery. Results
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demonstrated greater potential for sensitization, evidenced by changes in 
the ECG and serum glutamic-oxaloacetic transaminase (SGOT) levels, in the 
group that recovered from infarction as compared to the normal, healthy 
group.
(c) Effects on other Organ Systems
Serum transaminase (unspecified) was studied by Dornette and Jones 
[33] in five patients before anesthesia and 2, 4, and 6 days after anesthe­
sia. Although there were slight increases noted in two patients, the 
authors [33] concluded that anesthesia with 1,1,1-trichloroethane of up to 
2 hours duration would not be hepatotoxic.
Positive urinary urobilinogen was found 7 hours after exposure in two 
of seven male subjects exposed for 15 minutes to inhibited 1,1,1-trichloro­
ethane in a concentration increased continuously from 0-2,650 ppm during 
the 15-minute exposure. [35] On examination of centrifuged urine, five 
subjects were found to have 1-2 red blood cells per high-power field, com­
pared to none before exposure.
Elevated urinary urobilinogen was reported by Stewart et al [35] in 
one of three male subjects 20 hours after removal from a 20-minute exposure 
at 900 ppm of inhibited 1,1,1-trichloroethane. In one experimental 
exposure of six male subjects at 500 ppm of inhibited 1,1,1-trichloroethane 
for 78 minutes, 3-6 red blood cells per high power field and a trace of 
albumin were found in the urine of one subject 20 hours after the exposure. 
Serum glutamic-oxaloacetic transaminase was not affected by any of the 
exposures reported by Stewart et al. [35]
In a subsequent experiment reported in 1969 by Stewart et al, [39] 
there were no clinical findings indicative of liver or kidney injury in
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subjects exposed about 7 hours/day on 5 consecutive days at 440-560 ppm of 
a different inhibited 1,1,1-trichloroethane preparation. Torkelson et al 
[36] did not find evidence of liver or kidney injury in subjects 
experimentally exposed at 450-590 ppm of uninhibited 1,1,1-trichloroethane 
for up to 450 minutes or at 900-1,190 ppm for up to 75 minutes. McNutt et 
al, [41] found significant changes in the livers of mice exposed at 1,000 
ppm 1,1,1-trichloroethane continuously for 14 weeks and minor changes in 
mice exposed at 250 ppm. Changes in the 1000 ppm group included 
triglyceride accumulation, necrosis of hepatocytes, and cytoplasmic 
alterations of centrilobular hepatocytes. Cytoplasmic alterations were 
described as "mild to minimal" in the 250 ppm group.
(d) Intentional, Accidental, or Suicidal Exposures
Nausea, vomiting, diarrhea, and fatigue were the overt signs of 
poisoning reported by Stewart and Andrews [42] in 1966 in a 47-year-old 
worker who drank 1 oz of inhibited 1,1,1-trichloroethane. The onset of 
nausea began about 30 minutes after the ingestion, gastric lavage was 
performed on hospitalization 2 hours later, and the vomiting and diarrhea 
subsided 6 hours after ingestion. During this time the patient remained 
oriented, coordinated and alert, and there were no abnormal findings in a 
detailed neurologic examination. His blood pressure was 120/80 and his 
heart rate was 84 beats/minute.
At the time of admission to the hospital the hematocrit was 53% and 
hemoglobin concentration was 18 g/100 ml. Proteinuria was 1+ and there 
were 8-10 red blood cells in a high-power field examination of concentrated 
urine. A slight elevation in serum bilirubin concentration was found 48 
hours after hospitalization. Other findings, including urinalysis, SGOT,
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serum glutamic-pyruvic transaminase (SGPT), blood urea nitrogen (BUN), and 
ECG, remained normal. [42]z
Serum bilirubin concentrations of 2-11 mg/100 ml (normal < 1.5 mg/100 
ml), SGOT of 340-1,110 Karmen units (normal = 5-40), alkaline phosphatase 
of 7-30 Bessey-Lowry units (normal = 0.8-2.5), prothrombin time of 17/12— 
20/12 seconds (normal = 70-100%), and thymol turbidity of 8-15 units
(normal = 0-6 units) were reported in 1969 by Litt and Cohen [43] in five
teenage boys who had sniffed a spot remover containing 1,1,1- 
trichloroethane and trichloroethylene. These data are probably indicative 
of liver damage. All five were nauseated immediately after inhalation. 
Two of them reported nervous system symptoms including paresthesia, 
tinnitus, ataxia, and headache. In addition to the complications imposed 
on the interpretation of this report by the mixed composition of the 
inhalant, three of the patients had also sniffed glue, and one had 
"snorted" heroin. Among five other patients in whom findings of impaired 
liver or kidney function were not found, only one became nauseated after 
sniffing the spot remover. [43]
Two fatal cases in which the subjects intentionally inhaled cleaning 
fluids containing 1,1,1-trichloroethane were reported by Hall and Hine [44] 
in 1966. A 19-year-old woman was observed sniffing cleaning fluid over 
several days and acting irrationally. She was found dead on her bed. 
Pathologic findings on autopsy were confined to the respiratory system, 
stomach and brain. The vessels of the bronchi were congested, and the 
bronchi contained thick, yellowish-brown secretions. There was passive 
congestion throughout the lungs and the parenchyma showed considerable 
amounts of thick, dark red blood and thin frothy fluid in the congested
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areas. The mucosa of the stomach was hyperemic. The leptomeninges were 
thin, glistening, transparent and markedly congested. The ventricles 
(brain) contained clear cerebrospinal fluid. The vascular markings were 
prominent, and there was acute passive congestion throughout the brain. 
[44]
There were Indications of chronic, intentional inhalation of a 
cleaning fluid containing 1,1,1-trichloroethane in the other fatal case 
studied by Hall and Hine. [44] In this case, a 29-year-old man was found 
dead in bed with a washcloth over his mouth. There were several empty 
cleaning fluid cans in the room. On autopsy, pathologic findings were 
confined to the respiratory system and the kidneys. The lungs were 
congested and edematous, the vessels were dilated, and small hemorrhagic 
areas were present. The kidneys showed marked vascular congestion around 
the pyramids, especially on the periphery. [44]
In neither of the cases reported by Hall and Hine [44] were drugs or 
solvents detected in the stomach contents, and no barbiturates were found 
in the blood.
Twenty-nine cases of sudden death in the United States from sniffing
1,1,1-trichloroethane during 1964-69 were reported by Bass. [45] These 29 
deaths were among 110 cases of sudden death from sniffing volatile 
hydrocarbons and halocarbons studied by the author. [45] Suffocation in 
plastic bags was not a factor in any of these 110 cases, and death was 
quick ir . In 18 of the 110 cases, death followed sniffing and some 
sort of exercise. No anatomical abnormalities were found from gross or 
microscopic post mortem examinations which would explain the sudden deaths. 
The author [45] discussed the possibility that the deaths resulted from
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cardiac sensitization to endogenous catecholamines.
Serum enzyme studies of a patient who was hospitalized after inhaling 
a mixture of 1,1,1-trichloroethane and trichloroethylene were reported by 
Griffiths et al [46] in 1972. The man's respiration was arrested by the 
time that he entered the hospital, probably due to the effects of the 
mixture inhaled. Prothrombin activity was 60-91% of normal on days 1-4 and 
100% on day 5. The SGOT measurements by the Reitman-Frankel method were 
85, 160, 270, and 176 on days 1-4, respectively, (normal = 8-40 units).
Lactic dehydrogenase (LDH) measurements by the Wroblewski-LaDue method were 
450, 1,690 and 1,020 on days 1, 3, and 5, respectively, (normal = 200-500
units). Fractionation of LDH on day 5 showed that its major source was the 
heart. The patient died on day 5 without regaining consciousness. Some
heart cell necrosis and early fatty metamorphosis in the liver were found 
on autopsy.
Twenty-one deaths from abuse or gross misuse of decongestant aerosol 
sprays containing 1,1,1-trichloroethane in the solvent resulted in removal 
of several such products from the market (Federal Register 38:21935-36, 
1973).
(e) Effects of Occupational Exposures to 1,1,1-Trichloroethane
Industrial experiences with 1,1,1-trichloroethane exposed workers 
were discussed by Torkelson et al [36] in 1958. They reported that when it 
was used in confined spaces, varying degrees of anesthesia had occurred, 
and that two individuals had died from exposures in unventilated tanks. 
The authors did not give any additional information about these incidents. 
However, Irish [14] considered that the concentrations may have been near 
saturation, approximately 167,000 ppm. He gave the exposure time of one
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worker as 30 minutes, and stated that the exposure time was not known in 
the other case.
Another death from occupational exposure to 1,1,1-trichloroethane in 
an open tank was reported by Stewart [47] in 1963. The vapor 
concentrations were reported to have "exceeded several thousand ppm." No 
other details were reported.
A more detailed account of a fatal occupational exposure to 1,1,1- 
trichloroethane was given by Kleinfeld and Feiner [48] in 1966. A man was 
working in a 14 x 7 x 7 foot vault cleaning grease from conduits with rags 
dipped into 1,1,1-trichloroethane. He left the vault, reentered to connect 
a circulating fan, but left before connecting the fan. He collapsed 
shortly after emerging, and stopped breathing. Mouth-to-mouth 
resuscitation and oxygen failed to revive the worker. It was estimated he 
spent 10 minutes in the vault and that the 1,1,1-trichloroethane 
concentration was "in excess of 5,000 ppm." [48]
Six fatal occupational exposures to 1,1,1-trichloroethane were 
reported by Stahl et al [49] in 1969. The 1,1,1-trichloroethane had been 
used for paint removal in one, for cleaning an air vent in another case, 
and for cleaning electrical equipment in the other four cases. In five 
cases, the work was performed in closed spaces. The circumstances of 
exposure in the sixth case were not as well defined. All of the workers 
were found dead in their exposure areas. The skin of two of these workers 
was reported to be cyanotic. Congestion and edema of the lungs were found 
in all the workers at autopsy. Varying amounts of congestion were also 
found in other organs. [49]
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An extensive report of gross and microscopic autopsy observations of 
a worker who died while working with 1,1,1-trichloroethane in a confined
space was given by Hatfield and Maykoski [50] in 1970. A 27-year-old
worker was found in a 450-gallon aircraft tip tank which he had been 
cleaning with a pad saturated with 1,1,1-trichloroethane. When found by
fellow workmen he was unresponsive, cyanotic and apneic. Articifical
respiration was unsuccessful and the worker died. Significant autopsy 
findings included considerable congestion of some myocardial vessels, 
moderate edema and marked congestion of the lung parenchyma with focal 
extravasations of red blood cells into the alveoli, and acute passive 
congestion of the spleen, kidneys, and brain. Eighty minutes after the 
accident, 500 ppm of 1,1,1-trichloroethane were found in the tank. The work 
conditions were simulated later and concentrations of 36,000-62,000 ppm 
were generated. [50]
In their 1958 discussion of occupational experience with 1,1,1-tri­
chloroethane , Torkelson et al [36] reported that they knew of four cases of 
illness or unconciousness from work in confined areas. In these four cases 
the individuals had recovered quickly after removal from exposure and 
aftereffects were not observed. No details of these incidents were 
reported.
Giddiness and lightheadedness were experienced by three coworkers of 
the fatal case reported by Kleinfeld and Feiner [48] in 1966. These men 
worked in a 14 x 7 x 7 foot underground vault removing grease from conduits 
with rags dipped into 1,1,1-trichloroethane. When they noticed their 
symptoms, they emerged from the vault into fresh air, and apparently had an 
uneventful recovery.
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Four men experienced "minor effects," particularly giddiness, from 
exposure to 1,1,1-trichloroethane, but continued to work with it. [49] 
They were cleaning electrical equipment in two closed compartments of a 
ship with a spray apparatus. Neither the duration of exposure nor the 
exposure concentrations were reported. One man, who apparently had been 
unconcious, awoke and found his three coworkers dead. These three deaths 
were discussed previously. Aftereffects of the survivor were not reported 
by Stahl et al. [49]
Dizziness to the point of being unable to stand was experienced by a 
worker while cleaning a floor with 1,1,1-trichloroethane. [51] This case 
was one of four acute exposures reported by Stewart [51] in 1971. The 
worker poured large quantities of 1,1,1-trichloroethane on the floor and 
mopped up the excess with rags while on his hands and knees. The room, 15 
x 15 x 8 feet, was ventilated by one door. The worker was exposed for 
about 1 hour with intermittent exits to fresh air for 1-2 minutes to 
relieve his dizziness. Fifteen minutes after exposure he was still dizzy 
but he was lucid and well-oriented. An abnormal Romberg's sign was found 
in a detailed neurologic examination. One hour later, results of a 
repeated detailed neurologic examination were normal. The worker felt 
marked fatigue for 24 hours. Other findings at the time of the incident, 
and for 6 days thereafter, were normal. The tests included 
electrocardiograms and those for liver and kidney function. [51]
Another case reported by Stewart [51] in 1971 was that of a 55-year- 
old man who used 1,1,1-trichloroethane to remove celllng-tlle adhesive. He 
worked for 1 hour in a poorly ventilated room, became dizzy, and fell from 
a ladder, suffering a scalp injury. Fifteen minutes later, the results of
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a detailed neurologic examination with the patient supine were normal. 
Other tests, including those for liver and kidney injury and an ECG, were 
normal. Sixteen hours following exposure the patient was asymptomatic. 
However, on the fourth day after exposure, this worker's urinary 
urobilinogen rose to 9 units/24 hours and remained elevated for 4 days. 
Reticulocyte counts were between 0.3 and 0.45%. Results of other clinical 
tests, repeated over 10 days, remained normal.
The subject of a third case reported by Stewart [51] in 1971 was a 
47-year-old man with coronary artery disease. The man became dizzy and 
nauseated when he spent 2 hours cleaning a crane with a sponge, which he 
continually soaked in 1,1,1-trichloroethane (contained in an open 5-gallon 
pail). Thirty minutes after removal from exposure he was anxious and per­
spiring. Results of a detailed neurologic examination, ECG, and tests for 
liver and kidney injury were normal.
A worker who experienced a sudden onset of nausea, vomiting, 
"explosive diarrhea" and dizziness 2 hours after leaving work was the 
subject of a fourth case reported by Stewart. [51] The previous day the 
man had worked in the vicinity of an engine cleaning operation where 1,1,1- 
trichloroethane had been used and he had been aware of its odor throughout 
the day. His illness, however, was not attributed by the author to the 
effects of 1,1,1-trichloroethane. The illness lasted for 6 hours. Results 
of a physical examination by the plant physician the following morning were 
"completely normal."
(f) Absorption and Excretion
Absorption of inhaled 1,1,1-trichloroethane from alveolar air was 
studied with Cl-38 labeled 1,1,1-trichloroethane by Morgan et al [52] and
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reported in 1970. Approximately 5 mg of pure, labeled 1,1,1-trichloro- 
ethane diluted with air was inhaled in a single breath. The breath was held 
for 20 seconds to ensure maximum absorption and the subject exhaled through 
a trap containing 50 grams of 18/52 mesh granulated charcoal. The subject 
then inhaled one breath of room air and exhaled again through the same 
charcoal. The amount asorbed on the charcoal was subtracted from the 
amount inhaled to give the absorbed dose. After the admistration, the 
subject continued to inhale room air and to exhale through a charcoal trap. 
The traps were changed Initially every 2 minutes and later every 10 
minutes for 1 hour. In that time, 44% of the total dose of inhaled 1,1,1- 
trichloroethane was excreted in the exhaled breath. The Cl-38 labeled
1.1.1-trichloroethane activity was measured by gamma-ray scintillation
spectrometry. [52]
Stewart et al [9] studied breath analysis in subjects exposed at 0, 
100, 350 and 500 ppm 1,1,1-trichloroethane to develop a method for biologic 
monitoring. A total of twenty men and women were exposed at those 
concentrations for periods of 1, 3, and 7.5 hours in a controlled
environment chamber. Chamber air was measured by a Wilks MIRAN-I 
monitoring device, with a gas chromatograph as a backup system. Breath 
samples were analyzed for 1,1,1-trichloroethane by gas chromatography. 
Exposures were repeated for up to 4 weeks. Breath samples were taken from 
1 minute to 71 hours after exposure at each exposure level. The authors 
found that the rate of 1,1,1-trlchloroethane excretion was a function of
exposure duration. The data generated a family of postexposure breath 
decay curves that could be used to estimate the magnitude of exposure.
1.1.1-Trichloroethane was readily detectable 16 hours after exposure at 100
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ppm for 7.5 hours. Some data are presented in Table III-3.
TABLE III-3
1,1,1-TRICHL0R0ETHANE BREATH CONCENTRATIONS 
OF MEN AND WOMEN EXPOSED AT 350 ppm
Time
Men Women
No. Mean Range No. Mean Range
Isolated 1-Hour Exposure
2 Minutes preexit exposure 3 150 144 - 157 3 183 173 - 193
1 Minute post exposure 3 76.4 48.6 - 108 2 120 116 - 123
23 Hours post exposure 3 1.11 0.75 -1.63 2 0.8 0.57 - 1.03
Isolated 7.5--Hour Exposure
2 Minutes preexit exposure 4 234 222 - 252 3 254 247 - 262
1 Minute post exposure 4 149 444 - 153 4 181 156 - 205
16 Hours post exposure 4 7.07 6.62 - 7.73 4 6.93 4.83 - 8.74
Adapted from Stewart et al [9]
Absorption of liquid 1,1,1-trichloroethane through the skin was 
studied by Stewart and Dodd [53] and reported in 1964. Six subjects each 
immersed one thumb in a beaker of 1,1,1-trichloroethane for 30 minutes. 
The experiment was designed to prevent contamination of the inhaled air 
with 1,1,1-trichloroethane. Alveolar air samples were collected when their 
thumbs had been submerged for 10, 20, and 30 minutes. 1,1,1-
Trichloroethane concentrations in alveolar air were measured by a gas 
chromatograph equipped with both an electron capture detector and a 
hydrogen flame detector. The ranges of concentrations of 1,1,1- 




FOUND IN ALVEOLAR AIR OF 
EXPERIMENTAL SUBJECTS
Duration of Immersion Alveolar Air Concentrations, ppm
10 minutes 0.10 - 0.10
20 minutes 0.14 - 0.37
30 minutes 0.19 - 1.02
Adapted from Stewart and Dodd [53]
On another occasion, one of the subjects immersed one hand in 1,1,1- 
trichloroethane for 30 minutes. The maximum concentration of 1,1,1- 
trichloroethane found in this subject's alveolar air (21.5 ppm) occurred 10 
minutes after his hand was removed from the liquid. [53]
Further information on absorption of 1,1,1-trichloroethane was not 
found in a search of the literature. However, concentrations of 1,1,1- 
trichloroethane have been studied in the blood [35,54] and breath [54] cf 
subjects during exposure and several investigators have studied 
concentrations of 1,1,1-trichloroethane in alveolar air of subjects after 
removal from experimental exposures. [35,39,52,54-57]
1,1,1-Trichloroethane in the blood was determined during and after 
exposure in the experiments reported by Stewart et al. [35] The 












500 ppm 30 1.5
78 minutes 7.5 6.5




955 ppm 15 1
73 minutes 30 2 - 4
65 7 - 1 0
30 post exposure Not detected
0 - 2,650 ppm 9 post exposure 5 + 1
15 minutes 20 post exposure 0.5 + 1
total exposure time
Adapted from Stewart et al [35]
A comprehensive study of blood concentrations of 1,1,1-
trichloroethane during exposure was reported by Astrand et al. [54] The 
data show effects of exercise, exposure time, and exposure concentration on 
blood levels. Some of the data are presented in Table XII-2. The 
simultaneous concentrations of 1,1,1-trichloroethane in the alveolar air, 
arterial blood, and venous blood were studied. Twelve healthy, young male
subjects were exposed at 250 and 350 ppm of 1,1,1-trichloroethane during
rest and during periods of exercise. A linear correlation was found
between alveolar air and blood concentrations of 1,1,1-trichloroethane 
(within the alveolar air, a concentration range of 100-300 ppm, and in the 
arterial blood, a concentration range of 2-8 ppm). The concentrations in
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alveolar air and the arterial blood with exposure at 350 ppm during rest 
were the same as with exposure at 250 ppm during light exercise. [54]
Table III-6 lists the reported concentrations of 1,1,1- 
trichloroethane in the blood of victims of fatal intoxication.
TABLE III-6
REPORTS OF 1,1,1-TRICHL0R0ETHANE 
CONCENTRATIONS IN THE BLOOD OF 
VICTIMS OF FATAL INTOXICATION
Authors Concentrations, ppm
Hatfield and Maykoski [50] 1 case 60 ppm
Stahl et al [49] 3 cases 1*5*, 60, 62, and 120 ppm
Hall and Hine [44] 2 cases 130 and 720 ppm
* This death was attributed to suffocation
The concentration of 1,1,1-trichloroethane in the alveolar air during 
and after removal from exposure were found to depend on the exposure 
concentration, [35,54,55] the duration of exposure, [35] the time since the 
last exposure, [35,39,52,54-58] the breathing capacity of the subject, 
[54,55] previous exposure history, [39] exercise during exposure, [54] and 
individual factors. [55]
After exposure of six subjects at 600 ppm of 1,1,1-trichloroethane 
for 3 hours, Gazzaniga et al [56] found the concentrations in alveolar air 
shown in Table III-7.
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TABLE III-7
CONCENTRATIONS OF 1,1,I-TRICHLOROETHANE 
IN THE ALVEOLAR AIR OF SUBJECTS 
EXPOSED AT 600 ppm FOR 3 HOURS




1 minute 77 65-90
4 hours 46 40-50
12 hours 21 15-25
24 hours 10 7-13
48 hours 2 1-3.5
96 hours 1 0.5-1
Adapted from Gazzaniga et al [56] 
In a similar experiment reported by Stewart et al, [35] the con-
centrations in the exhaled air decreased at a faster rate than was reported 
by Gazzaniga et al. [56] After subjects were removed from 3 hours of 
exposure at 496 ppm of inhibited 1,1,1-trichloroethane, Stewart et al [35] 
reported the alveolar air concentrations in Table III-8.
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TABLE III-8
CONCENTRATIONS OF 1,1,l-TRICHLOROETHANE 
IN THE ALVEOLAR AIR OF SUBJECTS 
EXPOSED AT 496 ppm FOR 3 HOURS
Time After Removal Concentrations (ppm)
From Exposure
Average Range
30 minutes 65 35-90
1 hour 38 30-40
4 hours 20 19-21
20 hours 2.6 1.5-4
Adapted from Stewart et al [35]
With exposures of 2 hours duration at 460 and 632 ppm of 1,1,1- 
trichloroethane, Fukabori [55] reported average alveolar air concentrations 
in four subjects after removal from exposure, as shown in Table III-9.
TABLE III-9
CONCENTRATIONS OF 1,1,l-TRICHLOROETHANE 
IN THE ALVEOLAR AIR OF SUBJECTS 
EXPOSED AT 460 AND 632 ppm FOR 2 HOURS










Immediately 134 127-140 222 187-279
30 minutes 34 36-36 69 60-77
1 hour 23 22-25 41 34-53
4 hours 4.6 2.1-8.9 9.7 6.5-15
Adapted from Fukabori [55]
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When subjects were exposed by Stewart et al [39] to inhibited 1,1,1- 
triehloroethane 6.5 to 7 hours/day on 5 consecutive days at an average 
concentration of 507 ppm (420-612 ppm), the concentrations in the alveolar 
air 16 hours after removal from each daily exposure increased on successive 
days. They [39] did not present the data, but reported that 1,1,1- 
trichloroethane was found in alveolar air for 1 month after the last 
exposure.
1,1,1-Trichloroethane and tetrachloroethylene were both still present 
in the breath of one individual at 0.1 ppm 1 month after removal from an 
exposure to the vapors of these two compounds. [57] The individual was 
exposed 7 hours/day for 5 days to a vapor mixture containing 370 ppm of
1,1,1-trichloroethane and 130 ppm of tetrachloroethylene. [57,58]
Application of breath analysis to evaluate occupational exposure was 
reported in 1972 by Prost et al. [59] They found that collection of 
expired air samples in bags was acceptable to the workers. They took 
breath samples 1 hour before the end of the workday and immediately after 
the workday. The study involved only 12 workers and the investigators [59] 
considered that it was inadequate for making formal conclusions. However, 
from results of analysis of the breath samples the investigators were able 
to differentiate the workers exposed at greater concentrations of 1,1,1- 
trichloroethane from those exposed at lesser concentrations. The expired 
air of degreasers working in a confined environment without ventilation 
contained 25 ppm of 1,1,1-trichloroethane compared to 3-5 ppm found in the 
expired air of subjects doing similar work in a larger room with 
ventilation. [59]
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Stewart et al [35] reported that only trace amounts of 1,1,1-tri- 
chloroethane were excreted In the urine. Morgan et al, [52] using Cl-38 
labeled 1,1,1-trichloroethane, found that the urinary excretion rate of 
labeled compounds during the first hour after inhalation was less than 
0.01% of the total dose/minute.
(g) Metabolism
The metabolites of 1,1,1-trichloroethane which have been found in man 
are carbon dioxide, trichloroethanol (TCE), and trichloroacetic acid (TCA). 
[39,55,59-61] The major metabolite would seem to be TCE with smaller 
amounts of TCA and C02 present. [39]
In the study reported by Stewart et al [39] in 1969, the 24-hour 
urinary excretion of TCA and TCE by the subjects repeatedly exposed at 500 
ppm of 1,1,1-trichloroethane, 7 hours/day for 5 days, was as detailed in 
Table III-10.
The analytical method used by Stewart et al [39] for determining TCA 
and TCE was not mentioned in the report.
Trichloroacetic acid in the urine of two subjects exposed to 1,1,1- 
trichloroethane was studied by Tada [60] and reported in 1969. The 
subjects were first exposed at average concentrations of 210 ppm during six 
2-hour sessions; one on the first day, two on the second, two on the third, 
and one on the fourth day. Urine samples were collected periodically to 
determine the TCA concentration, adjusted to a specific gravity of 1.024, 
as well as the total amount excreted per day. TCA was determined by the 
alkali-pyridine-benzidine method. The concentration of TCA in the urine 
and the total amount excreted per day increased each day of exposure, then 
slowly decreased over the next 4 days. The maximum amount excreted per day 









Preexposure 14.2 (8.0-11.8) 1.0 or less
First exposure day 7.5 (2.6-10.5) 20.1 (7.9-49.0)
Second exposure day 10.9 (8.2-19.3) 30.1 (14.8-66.5)
Third exposure day 12.3 (5.6-27.0) 29.3 (19.1-51.0)
Fourth exposure day 14.1 (7.8-19.2) 46.6 (23.4-93.6)
5 days after last exposure 18.0 (13.0-26.0) 7.0 (1.0-14.9)
12 days after last exposure 17.0 (8.0-22.0) lessi than 1.0
* Exposure at 500 ppm 1,1,1-trichloroethane 
Adapted from Stewart et al [39]
In a second experiment reported by Tada, [60] the same two subjects 
were exposed at an average of 420 ppm 1,1,1-trichloroethane, 2 hours/day
for three days. With this exposure, both the TCA concentration in the 
urine and the total amount excreted per day continued to increase on the 2 
days following the last exposure, before beginning to decline on the third 
and fourth days after exposure. The maximum amount excreted per day was 
7.2 mg, averaged for the two subjects.
Excretion of TCA in the urine of two subjects was studied for 8 days 
and reported by Fukabori [55] in 1970. These subjects were exposed 2 
hours/day to 1,1,1-trichloroethane at average concentrations of 195 ppm on 
the first day, 376 ppm on the second, 558 ppm on the third, and 832 ppm on
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the fourth day. The maximum amount of TCA (7.5 mg/day) was excreted on the 
day following the last exposure. Four days after the last exposure, an 
average of 2.5 mg TCA/liter of urine was found, compared to a normal value 
in Japanese men of 0-0.9 mg/liter. TCA was measured by Fukabori [55] by 
the alkali-pyridine-benzidine method.
Trichloroacetic acid has been studied in the urine of workers 
occupationally exposed to 1,1,1-trichloroethane. [59-61]
A field survey of 15 workers in a printing plant who were exposed to
1,1,1-trichloroethane every workday was reported by Tada [60] in 1969. 
Urine was collected for 8 hours on workdays 3 through 5. Atmospheric 
concentrations of 1,1,1-trichloroethane determined every day by the alkali- 
pyridine two-phase method at various parts of the room averaged 37 ppm for 
7-hour workdays. The TCA concentrations in the urine averaged 3.4 mg/liter
(3.0-3.7 mg/liter for the daily averages).
Seven of the women studied by Weitbrecht [61] had TCA concentrations 
of 20-60 mg/liter of urine. The atmospheric exposures of these women were
reported to be 40 ppm or less as determined by methyl bromide indicator
tubes. The author himself was dubious about the meaning of his air 
measurements.
Prost et al [59] also studied TCA excretion by workers occupationally 
exposed to 1,1,1-trichloroethane and concluded that it was not as reliable 
for evaluation of exposure as analysis of breath for 1,1,1-trichloroethane.
(h) Effects on Mucous Membranes and Skin
Passive congestion and edema were found in the lungs of workers who 
were found dead from over exposure to 1,1,1-trichloroethane at their places 
of work in reports by Stahl [49] and by Hatfield and Maykoski. [50]
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Chemical analyses or other information about the inhibitors or impurities 
in the 1,1,1-trichloroethane to which these workers were exposed were not 
reported.
Marked accumulation of white, frothy, slightly bloody edema fluid was 
found in the lungs and a small amount of mucoid material was found in the 
bronchi of one of the fatalities reported by Hall and Hine. [44] The man 
had inhaled (and possibly aspirated) a 1,1,1-trichloroethane cleaning fluid 
containing dioxane. [26,39] The other fatality reported by Hall and Hine 
[44] had habitually inhaled another cleaning fluid containing 1,1,1- 
trichloroethane. In this case of chronic exposure, passive congestion was 
found throughout the lungs and there were considerable amounts of thick, 
dark red blood and thin, frothy fluid in the dependent areas. Thick, 
yellowish-brown secretions were found in the bronchi. Microscopic findings 
included some atelectasis in the lung parenchyma, edema and congestion in 
the lungs and desquamated epithelium in the bronchi. [44]
Slight eye irritation was experienced by one of four subjects during 
the experimental 30-minute exposure to uninhibited 1,1,1-trichloroethane at 
900-1,000 ppm reported by Torkelson et al. [36]
Eye, nose and throat irritation have been experienced during 
experimental exposures to inhibited 1,1,1-trichloroethane at 400-500 ppm 
[37] and 420-612 ppm. [39]
Torkelson et al stated that the Dow Chemical Company had received no 
reports of eye irritation from industrial use of inhibited 1,1,1- 
trichloroethane at that time (1958) , but a few cases of skin irritation 
associated with its use had occurred. [36]
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A slight prickling and mild burning sensation on the dorsal surface 
of thumbs immersed for 10 minutes in 99% pure 1,1,1-trichloroethane was 
reported by Stewart and Dodd. [53] A mild, temporary erythema and fine 
scaling was observed after 30 minutes of immersion.
The subject who immersed his hand in the liquid for 30 minutes 
experienced a burning sensation at 4 minutes which became uncomfortable 
after 10 minutes of immersion. [53] At 20 minutes, his hand felt cold md 
the sensation persisted for 10 minutes after his hand was removed from the 
30-minute immersion. A mild erythema persisted for 1 hour and a fine, 
chalky scale was observed. Repeated dipping of his hand into 1,1,1- 
trichloroethane caused an Intense cold sensation, a mild erythema and a 
fine scale. The sensation persisted for 45 minutes after exposure and the 
scaliness was still observable 18 hours later. [53]
Transient irritation of the conjunctiva or the upper respiratory
tract and a burning sensation of the tongue were experienced by women using
pure 1,1,1-trichloroethane to clean brass frames. [61] There was no
burning sensation on intact skin and an initial swelling was not observed
by Weitbrecht [61] when the women wet their hands in the washing process. 
They did experience ice-cold fingers, however, and paleness of the skin of 
the hands was observed.
Epidemiologic Studies
Chronic exposures to 1,1,1-trichloroethane have not been extensively 
reported. Torkelson et al [36] reported in 1958 that when 500 ppm of
1,1,1-trichloroethane was used with adequate ventilation, no injuries had 
occurred. Stewart [47] reported in 1963 that no injury to man following
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repeated occupational exposures to vapor concentrations of less than 500 
ppm had been observed, and in 1966 he reiterated this. [62] These authors 
[36,47,62] presented no data to support their statements. Hatfield and 
Maykoski [50] stated in their 1970 report that 1,1,1-trichloroethane had 
been used to clean airplane tip tanks for several years without incident. 
The manner in which the tanks were customarily cleaned resulted in 
breathing zone concentrations of 100 to 200 ppm, with peaks inside the 
tanks of 800 ppm. [36] While significant details are missing from these 
reports, [36,47,50,62] they indicate that overt signs of adverse responses 
to chronic exposure to 1,1,1-trichloroethane were not apparent to the
investigators.
Workers in a shop in central Italy had symptoms which apparently were 
attributable to substances used in the work cycle, according to a report by 
Binaschi et al in 1969. [63] The symptoms appeared when an inhibited
1,1,1-trichloroethane preparation began to be used in addition to the
solvents already used in the shop. The concentration of 1,1,1- 
trichloroethane found in the work room air was 250 ppm. Additional details
such as the number of workers involved, the nature of the symptoms, and the
other solvents involved were not reported. [63]
Nine women washing brass frames in open containers of pure 1,1,1- 
trichloroethane were studied from the onset of their exposure and were the 
subject of a report in 1965 by Weitbrecht. [61] Air measurements were made 
during the summer with methyl bromide indicator tubes, the validity of 
which for measuring 1,1,1-trichloroethane was considered problematic. An 
average of 10 ppm of 1,1,1-trichloroethane was found in the general room 
air and 20 ppm in the worksite air. In addition to vapor exposures, the
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women had their hands immersed in liquid 1,1,1-trlchloroethane for varying 
periods of time. Breathing zone samples were not collected. It seems 
likely that breathing zone concentrations would have been considerably 
higher if the women were working directly over the solvent containers.
The women experienced transient irritation of the conjunctiva or 
upper respiratory passages and a characteristic burning sensation of the 
tongue. They also reported that their teeth felt dull (rhubarb effect). 
They did not experience a burning sensation or initial swelling when their 
hands were placed in liquid 1,1,1-trlchloroethane. They did have a feeling 
of ice cold fingers. A sustained paleness of the fingers occurred only at 
the beginning of the work, otherwise it appeared only when the manipulation 
was carried out continuously. [61]
After the windows were closed in the fall, the women complained of 
loss of appetite, pressure in the stomach, vomiting, tiredness, headache, 
and insomnia. The author [61] considered that these complaints were 
neurotic chain reactions influenced in part by safety signs in the shop. 
He did not differentiate the effects of the 1,1,1-trlchloroethane exposure 
from the possible suggestive effect of the safety signs, and didn't comment 
upon the lack of the safety sign effect in the summer.
Clinically, he found hypertension in six of the women and positive 
urobilinogen in two; In addition, he reported what he described as 
autonomic dystrophy In two, circulatory dystrophy In one, and psychasthenia 
in one. [61]
An epidemiologic matched pair study by Kramer et al [64] measured 
numerous physiologic parameters of workers in two adjacent textile plants. 
Detailed blood chemistry and hematology studies were conducted for 151
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matched pairs of employees to compare the exposed and unexposed partners. 
All employees in the exposed group had 1,1,1-trichloroethane (and other 
solvent) exposures, in varying concentrations, for up to 6 years. The 
concentration range was 11-838 ppm, with a mean of 115 ppm 1,1,1- 
trichloroethane. Whether this period of exposure would result in toxic 
systoms is questionable, however. Since only healthy, active workers were 
selected, and the average length of exposure for the study population was 
less than 1 year at the stated TWA, no conclusions can be drawn about 
chronic effects. The control group had only minimal exposure to 
nonchlorinated solvents.
Pairs were matched with regard to age, race, sec, work shift, job 
description and socioeconomic status, and examined within a 10-week period. 
[64] During the study it was necessary to rematch subjects due to 
nonparticipation. Subject height, weight, blood pressure and pulse were 
obtained. Laboratory blood determinations included hematocrit, hemoglobin, 
red blood cell count (RBC), white blood cell count (WBC), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean 
corpuscular volume (MCV), alkaline phosphatase, SGOT, SGPT, gamma glutamyl 
transpeptidase, total bilirubin, urea nitrogen, LDH, uric acid, total 
protein, A/G ratio, albumin, calcium and phosphorus. Electrocardiograms 
also were taken. For quantitative variables, t tests and tests of 
homogeneity of variables were made. Multiple regression analysis was 
performed on paired differences with respect to environmental variables, 
and on the combined matched exposed and control populations with respect to 
demographic variables.
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Breathing zone samples were collected, except In a few locations 
where area sampling was more practical, on charcoal tubes and analyzed on a 
portable gas chromatograph equipped with a flame Ionization detector. 
Samples of expired air were analyzed immediately after collection by gas 
chromatography.
After dismissing some subjects' data on the basis of smoking habits, 
high blood pressure, of prior illness, the authors presented statistical 
findings but no individual data. [64] 1,1,1-Trichloroethane concentrations
in the breath ranged from "less than 5 ppm" to "greater than 30 ppm," with 
the majority, 127/151, between 5 and 29 ppm. Comparison of the health test 
data between exposed and control subjects revealed no statistically 
significant differences except SGPT and albumin. These differences were 
not discussed at length and the authors concluded that no health 
impairment was suffered by workers exposed at an average daily 
concentration of 115 ppm 1,1,1-trlchloroethane. The conclusion suffers 
statistically because many of the exposed groups were not exposed very long 
or at high level concentrations. The use of their biologic data in the 
computation of averages and ranges would preclude detection of any toxic 
effects occurring at the greatest concentrations and exposure times, thru 
"averaging down" by inclusion of data for much lower levels. Such pooling 
also increases error variances. For a comparison of the overall exposed 
and control means, the average differences and the standard deviation of 
the set of matched differences would have been more appropriate.
Seki and his colleagues [65] surveyed four Japanese printing 
factories where 1,1,1-trlchloroethane, the sole organic solvent in the 
entire process, was used to remove excess ink. Duration of
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workday/workweek and operational procedures were essentially uniform. 
Enclosure of vapor sources and installation of exhaust systems were, in the 
authors' opinion, mainly responsible for variation in vapor concentration. 
Subjects were men 23-53 years old and had been exposed to 1,1,1- 
trichloroethane vapor for at least 5 years. Laboratory tests, including 
peripheral hemograms, blood specific gravity and urinalysis for 
urobilinogen and protein, were not described, but the authors state 
performance by "conventional methods." A Japanese version of the Cornell 
Medical Index health questionnaire was answered by all subjects. A test of 
vibrational sense was performed as well as urinalysis for TCA and TCE, 
Decrease in urinary metabolite levels provided the basis for calculation of 
biologic half-life. The vapor concentration of 1,1,1-trichloroethane in 
the workroom air was determined by gas-liquid chromotography. A 
preliminary study revealed a fairly constant vapor concentration regardless 
of time and location of sampling. Data are presented in Tables III-ll, 
111-12, and 111-13.
TABLE III-ll
URINARY METABOLITE CONCENTRATION IN 























Adapted from Seki et al [65]
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TABLE III-12
RESULTS OF PHYSICAL EXAMINATIONS 
OF WORKERS EXPOSED TO 1,1,1-TRICHLOROETHANE











* Exclusions listed in Table 111-13 
Adapted from Seki et al [65]
TABLE III-13
EXCLUSIONS FROM HEALTHY CATEGORY 
BY CLASS OF DISORDER







Adapted from Seki et al [65]
The authors found, through regression analysis, a linear relationship 
between the vapor concentration of 1,1,1-trichloroethane and level of 
urinary metabolites (TCA and TCE), and for this reason they concluded the
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urinary metabolite level was a good index of 1,1,1-trichloroethane 
exposure. The biologic half-life of 1,1,1-trichloroethane was found to be 
8.7 + 1.8 hours.
In a detailed study of one worker, a steady increase in urinary 
metabolite concentrations toward the weekend as well as significant 
metabolite excretion on Sunday, suggested that 1,1,1-trichloroethane 
accummulated in the body. Total metabolite increase was primarily 
attributed to TCE. No dose-dependent difference in health, as reflected by 
the medical questionnaire, was found in any of the workers. The authors 
recommended, based on accummulation of 1,1,1-trichloroethane in the body, a 
subtraction from the maximum "no adverse effect" level for short-term 
exposures to establish a threshold limit value (TLV) for repeated 
exposures.
Animal Toxicity
(a) Acute Lethal Doses and Concentrations
Doses of 1,1,1-trichloroethane required to kill 50% of the animals 
(LD50’s), when administered orally, by intraperitoneal injection (ip) or by 
topical application to skin, have been estimated by several investigators. 
[36,66-71] In the original reports, the units of measurement were either 
millimoles/kg, g/kg, or ml/kg. In this document, doses are normally given 
as ml/kg; 1 ml/kg is 1.34 g/kg.
Determinations of the LD50 of 1,1,1-trichloroethane in an oil 
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Analytical grade Sprague-Dawley 
male rats
3.8 (3.3-4.2)
95% Confidence limits In parenthesis
Environmental temperature was reported in 1971 to affect the LD50 of 
an inhibited 1,1,1-trichloroethane preparation studied by Horiguchi and 
Horiuchi. [72] At an environmental temperature of 20 C, the ip LD50 dose
for NA2 mice was 3.7 ml/kg and at 30 C it was 2.6 ml/kg.
Oral doses of both inhibited and uninhibited 1,1,1-trichloroethane 
were administered by Torkelson et al [36] to rats, mice, rabbits, and
guinea pigs for determination of the LD50 for each species. Single doses
of undiluted 1,1,1-trichloroethane were administered. The determinations 
are listed in Table 111-15.
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TABLE III-15
LD50 AFTER ORAL ADMINISTRATION OF
1,1,1-TRICHLOROETHANE IN SOME LABORATORY ANIMALS
Characteristics of Animal LD50 (g/kg)
1,1,1-Trichloroethane Sex/Species Mean 95% Confidence 
Limits
2.4-3.0% dioxane 35 male rats 12.3 11.0-13.7
0.12-0.3% butanol 35 female rats 10.3 8.3-12.8
Trace of ethylene dichloride 16 female mice 11.2 --
I f 16 female rabbits 5.7 3.5-9.4
I f 16 male guinea pigs 9.5 3.5-13.3
Uninhibited 40 male rats 14.3 12.1-17.0
Not further defined 50 female rats 1 1 . 0 9.5-13.0
I f 40 female mice 9.7 --
11 40 female rabbits 10.5 9.7-11.3
I f 30 male guinea pigs 8.6 6.1-12.2
Adapted from Torkelson et al [36]
Both the inhibited and uninhibited 1,1,1-trichloroethanes were 
applied to the skin of rabbits and covered with bandages by Torkelson et al 
[36] to study the effects of 24-hour absorption. Eight rabbits were used 
with each material. Doses of 3.98 g/kg did not kill any animals; doses of
15.8 g/kg killed less than half the animals.
The concentrations of 1,1,1-trichloroethane required to kill 50% of 
rats (LC50's) exposed for up to 7 hours were studied by Adams et al [73] 
and reported in 1950. The 1,1,1-trichloroethane used in this investigation
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was a redistilled commercial product with a boiling point of 74.1 C. The 
total number of rats used was 326. The only impurity found by infrared 
analysis was 1,2-dichloroethane, in up to 1% of the liquid material. At
18,000 ppm, the exposure time required to kill one-half of the animals was 
3 hours with 95% confidence limits of 2.1-4.2 hours. The concentration 
required to kill one-half the animals (LC50) with 7 hours of exposure was 
14,250 ppm with 95% confidence limits of 12,950-15,675 ppm.
An inhibited 1,1,1-trichloroethane preparation was reported by 
Horiguchi and Horiuchi [74] in 1971 to have a 2-hour exposure LC50 for mice 
of 3,911 ppm.
(b) Central Nervous System Effects
1,1,1-Trichloroethane was administered to dogs and monkeys as an 
inhalation anesthetic by Krantz et al. [32] The amount of Inhaled 1,1,1- 
trichloroethane required to induce anesthesia was 0.34 + 0.09 ml/kg in 11 
dogs and 0.28 + 0.06 ml/kg in 10 monkeys. The period of induction was 
short and surgical anesthesia was uneventful. Fain reflexes were absent 
during surgical anesthesia and analgesia appeared to extend into the 
recovery period. Recovery from anesthesia of 20-30 minutes duration 
occurred in 2-5 minutes.
Microscopic studies of the brains and spinal cords of rats anesthe­
tized 1 hour/day on 9 consecutive days were reported by Krantz et al [32] 
to be without significant findings.
Increased electroencephalographic (EEG) activity, Indicative of 
increased vigilance in the opinion Truhaut et al, [75] was found in 
rabbits during 1 hour of artificial ventilation through a tracheal cannula 
with 6,250 ppm of 1,1,1-trichloroethane. At 16,850 ppm of 1,1,1-
58
trichloroethane, which killed half the animals during 2 hours of exposure, 
there was an initial slight increase in EEG activity. After 5-10 minutes 
of exposure, the EEG activity began to decrease, and the decrease continued 
to death or the end of exposure. [75,76]
Mice exposed at 13,500 ppm of 1,1,1-trichloroethane by Gehring [70] 
became anesthetized (immobilized) in 16.3 (15.4-17.2) minutes, and died
after 593 (578-615) minutes (95% condidence limits in parenthesis).
Signs of centra] nervous system responses of rats during exposure at 
different concentrations of 1,1,1-trichloroethane reported by Adams et al 
[73] are shown in Table 111-16.
TABLE 111-16
NEUROLOGIC RESPONSE OF RATS TO 
1,1,1-TRICHLOROETHANE
Concentration, ppm Response
18,000 Helplessness in 5 minutes; unconsciousness in 
1 hour
15,000 Unconsciousness after several hours
10,000 Decreased activity in 1-2 minutes; staggering, 
falling, inability to walk after 10 minutes; 
semiconsciousness after 3 hours
5,000 Definite but mild narcotic effect within 1 hour; 
decreased activity
Adapted from Adams et al [73]
Slight ataxia was observed by Adams et al [73] in a monkey after 1 
hour of exposure at 5,000 ppm of 1,1,1 ■ trichloroethane. After about 5 
hours of exposure, an occasional trembling of the hands and forearms was
observed.
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Varying degrees of anesthesia, ranging from ataxia to 
semiconsciousness, were observed by Torkelson et al [36] In rats exposed at
10,000 ppm of 1,1,1-trichloroethane for 1.0, 0.5, 0.2, or 0.1 hour/day, 70 
times in 90 days. The rats were reported to be more affected by the 
exposures at the beginning of each week than at the end.
Whether there were signs of central nervous system responses at 
exposures of less than 5,000 ppm 1,1,1-trichloroethane was not mentioned in 
the reports of Adams et al [73] or Torkelson et al. [36]
Running activity of an unspecified number of mice in rotary activity 
cages before, during, and after exposure to inhibited 1,1,1-trichloroethane 
was reported in 1971 by Horiguchi and Horiuchi. [74] The mice were exposed 
at 1,000 ppm of 1,1,1-trichloroethane 2 hours/day every other day for 3 
weeks. Activity was measured during three consecutive 2-hour periods on 9 
exposure days. The exposures occurred during the middle 2 hours. On the 
first and second days of exposure, activity was similar during the three 
periods of measurement. On all of the remaining days, there was greater 
activity during and after exposure than before the daily exposure. [74]
Rats and cats were exposed at 73 ppm of 1,1,1-trichloroethane 4 
hours/day for up to 4 months by Tsapko and Rappoport. [77] The threshold 
concentration of 1,1,1-trichloroethane necessary to alter conditioned 
reflex activity of rats in a single 4-hour exposure was reported to be 
180-900 ppm. In this chronic experiment, there were minor changes reported 
in the conditioned reflex activity of cats but not of rats. The 
differentiation reflexes were deranged in the cats.
Pathologic changes were not found in the brains of five rats examined 
microscopically by Tsapko and Rappoport [77] after 50 days of exposure, but
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venous stasis and perivascular edema in the brains and their membranes were 
found on examination of five other rats after 120 days of exposure. Other 
findings in the brains at this time were marginal and central chromatolysis 
in the nerve cells of the deep layers of the cerebral cortex, the 
subcortical area, and the caudate nucleus; signs of neurophagia in the 
subcortical area and in the caudate nucleus; and vacuolization of the 
cytoplasm of individual cells in the serrate nucleus of the cerebellum.
Fourteen days after exposure for 120 days, only residual signs of 
preexisting disturbances in the circulation and signs of dystrophy, were 
found in five other rats. [77]
(c) Cardiovascular and Respiratory Effects
Administration of 1,1,1-trichloroethane to two dogs to induce 
anesthesia without premed icat. ion was reported, in an abstract by Rennick et 
al [78] in 1949, to have resulted in sudden death. Further experiments 
with five dogs under barbital anesthesia showed that ventricular 
extrasystoles and ventricular tachycardia were regular occurrences when 
epinephrine was injected after administration of repeated small doses of
1,1,1-trichloroethane. Maximum sensitization of the heart occurred after 
administration of 0.25-0.40 ml/kg of 1,1,1-trichloroethane; greater 
amounts raised the threshold dose of epinephrine, partly because of severe 
hypotension. [78] Epinephrine itself, however, is known to induce 
ventricular extrasystoles and tachycardia, and the effects noted may have 
been due, at least in part, to epinephrine.
Krantz et al [32] reported electrocardiograms of six dogs and two 
monkeys maintained under deep anesthesia by 1,1,1-trichloroethane for 1 
hour. Electrocardiograms, obtained from each animal before it was
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anesthetized with 1,1,1-trichloroethane by a closed technique, were used 
for comparison. The heart rate was increased under anesthesia and the T- 
wave was either flattened or inverted.
Trochimowicz et al [40] did not find cardiac sensitization in a study 
of 41 dogs given 0.5% (v/v) 1,1,1-trichloroethane. An experimental group 
was subjected to myocardial infarction by placement of a copper wire within 
selected sites of the descending left coronary artery. Results 
demonstrated greater potential for sensitization (evidenced by changes in 
the EEG and SGOT levels) in the group that recovered from infarction as 
compared to the normal, healthy group.
Respiratory failure occurred in 11 dogs when an average of 0.60 
(range - 0.29-0.93) ml/kg of 1,1,1-trichloroethane had been administered 
and in 10 monkeys when an average of 0.59 (0.43-1.00) ml/kg had been 
administered. At the time of respiratory failure, the ECG patterns of six 
dogs and two monkeys showed depressed S-T segments and mild bradycardia, 
and the blood pressure was reduced to about one-half of its normal valuef 
Oxygen consumption in three deeply anesthetized monkeys decreased 16.7- 
54.3%. [32]
ECG changes reported by Griffiths et al [46] in 1972 occurred in 
three dogs several minutes after an abrupt drop in blood pressure when
1,1,1-trichloroethane was introduced into the trachea. Before the 
experiment the dogs were given sodium pentobarbital (20 mg/kg). 1,1,1- 
Trichloroethane was administered at an average concentration of about
125,000 ppm. Duration of exposure varied from 1.5-6.0 minutes and the 
total amount of 1,1,1-trichloroethane administered was 10 to 40 ml. 
Ventribular fibrillation, followed by cardiac arrest, occurred in one dog
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during its second 3-minute exposure; the first exposure had taken place 2 
weeks earlier.
Cardiac arrhythmias, myocardial depression, and tachycardia were 
reported by Belej et al [79] to have developed in three anesthetized Rhesus 
monkeys exposed for 5 minutes at 25,000 ppm of 1,1,1-trichloroethane, and 
again 10 minutes later when they were similarly exposed at 50,000 ppm. 




OF 1,1,1-TRICHLOROETHANE IN MONKEYS
Cardiovascular Exposure Concentration
Function
25,000 ppm 50*000 ppm
Control Response Control Response
Heart rate (beats/min) 153.3 167.3 155.0 186.7
Myocardial force (g) 45.9 37.9 34.4 24.3
Aortic blood pressure (mm Hg) 81.7 72.3 80.3 57.0
Left atrial pressure (mm Hg) 4.2 4.3 3.8 5.1
Pulmonary arterial pressure (mm Hg) 9.1 9.2 9.0 9.8
Adapted from Belej et al [79]
The pulse rate and blood pressure component of the physiograms 
constructed by Truhaut et al [75,76] was decreased by 5-10 minutes of
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exposure at 15,000-16,850 ppm of 1,1,1-trichloroethane in rabbits inhaling 
it through a tracheal cannula. At 6,250 ppm, there was a decrease in this 
component only during the first 10 minutes of exposure. 
Electroencephalograms either showed no change or increased activity at the 
time of the cardiac function changes. [75]
Cardiovascular function changes were associated with 1,1,1-
trichloroethane inhalation in nine anesthetized dogs (pentobarbital sodium 
35 mg/kg or chloralose 50 mg/kg, and 10% pentobarbital sodium) in
experiments reported by Herd et al [80] in 1974. Cardiovascular function 
measurements included arterial pressure, left ventricular pressure, aortal 
blood flow, and electrocardiograms. 1,1,1-Trichloroethane purified to 99.5 
vol% was administered at the desired concentrations with a positive 
pressure ventilation apparatus for no more than 5 minutes at a time. 
Recoveries from these brief exposures, judged by blood pressure and heart 
rate, required 10-45 minutes. Several experiments were conducted on each 
dog at 1-hour intervals. Concentrations of 1,1,1-trichloroethane used in 
the study were 8,000, 15,000, 20,000, and 25,000 ppm. [80]
A two-phase depression of blood pressure which was dependent on the
inhalation concentration of 1,1,1-trichloroethane was found. [80] In the 
first phase, there was a sharp decrease in total peripheral resistance, a 
parallel decline in systolic and diastolic blood pressure, and increased 
myocardial contractility and cardiac output. The cardiac responses were 
inhibited by pretreatment with propranolol hydrochloride and they were 
minimal when the dogs were anesthetized by pentobarbital. [80]
The second phase of blood pressure decline was independent of the 
anesthetic agent and was characterized by marked decreases in stroke
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volume, heart rate, and myocardial contractility. [80] Total peripheral 
resistance was not changed appreciably during this phase. The cardiac 
effects during this phase were inhibited by infusion of calcium ions. 
Injection of 1.2 mg of phenylephrine reversed the course of the blood 
pressure changes. [80]
Cardiac rhythm was studied by Reinhardt et al [81] in unanesthetized 
dogs during inhalation of 98.9% pure 1,1,1-trichloroethane at 2,500 (2,100- 
2,500), 5,000 (4,600-5,600), and 10,000 (9,700-11,600) ppm. In this study, 
reported in 1973, doses of epinephrine (8 Mg/kg in 1 ml normal saline) were 
injected into a cephalic vein. A control dose of epinephrine was given 
after 2 minutes of breathing air and a challenge dose of epinephrine was 
given 8 minutes later (after 5 minutes of breathing 1,1,1-trichloroethane). 
Criteria indicative of cardiac sensitization were multiple consecutive 
ventricular beats in excess of control observations and ventricular 
fibrillation. [81] At the lowest concentration, cardiac sensitization was 
not observed in 12 dogs. Cardiac sensitization occurred in 3 of 18 dogs 
exposed at 5,000 ppm of 1,1,1-trichloroethane and in all 12 dogs exposed at
10,000 ppm. Ventricular fibrillation occurred in one dog exposed at the 
highest concentration of 1,1,1-trichloroethane, but this reverted to 
multiple ventricular beats within a matter of seconds and eventually to a 
normal cardiac rhythm with recovery. [81]
Cardiotoxicity of 1,1,1-trichloroethane also has been studied in mice 
[82,83], and in rats, [32,80] yielding additional information on the toxic 
mechanism.
1,1,1-Trichloroethane was reported by Aviado and Belej [82] in 1974 
both to induce cardiac arrhythmias in mice and to sensitize the hearts of
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mice to epinephrine. The investigators anesthetized 239 mice with sodium 
pentobarbital (0.7 mg/10 g body weight) and exposed them at either 200,000 
or 400,000 ppm of 1,1,1-trichloroethane for 6 minutes. Epinephrine (6 
Mg/kg) was administered to 108 of the mice after the start of 1,1,1- 
trichloroethane inhalation. Second degree A-V blocks occurred in both 
groups of mice exposed at 400,000 ppm 1,1,1-trichloroethane but none 
occurred with 200,000 ppm. [82]
A study of the mechanism of 1,1,1-trichloroethane induced ventricular 
fibrillation in mice was reported in an abstract by Strosberg et al [83] in 
1973. Adrenalectomized mice and mice treated with a compound (P-286), 
which blocks the release of adrenal catecholamines, were not protected from
1.1.1-trichloroethane induced fibrillation. The mice, whether 
adrenalectomized or not, were protected by reserpine and particularly by 
the beter-blocker propranolol.
Isometric contractions were studied by Herd et al [80] in isolated 
papillary muscles from rat hearts, with and without 1,1,1-trichloroethane 
in the aeration mixture. 1,1,1-Trichloroethane had no effect on the time 
taken to develop peak tension or on the duration of the contractile cycle, 
but the time taken to develop the maximum rate of tension generation 
decreased approximately 10% during the exposure. The rate of tension 
generation and the rate of return of developed tension returned to their 
normal values more rapidly when calcium ions were added to the Krebs-Ringer 
solution after exposure to 1,1,1-trichloroethane.
Hepatic blood flow was studied in 1967 by Rice et al [84] in 
isolated, perfused rat livers. The rats were given an ip injection of
1.1.1-trichloroethane (2 ml/kg) 24 hours before the livers were removed and
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prepared for the measurements. Under these conditions, hepatic blood flow 
did not differ from the controls. A subcapsular inflammatory reaction, but 
no necrosis of the parenchymal cells, was found on examination of the 
livers after the hemodymic measurements were made. In the same experiment 
carbon tetrachloride did increase resistance to blood flow.
The oxygen uptake of cardiac ventricular slices from rats deeply 
anesthetized with 1,1,1-trichloroethane for 1 hour was found by Krantz et 
al [32] to be reduced from control values by one-third.
Pathologic studies of exposed dogs were reported by Griffiths et al 
[46] following two or three exposures 2-4 weeks apart. The dogs were 
killed by a lethal inhalation of 1,1,1-trichloroethane. The predominant 
autopsy finding was gross congestion in all tissues. Microscopic findings 
were slight heart cell necrosis and slight fatty infiltration of the liver. 
[46]
Venous hyperemia was found by Tsapko and Rappoport [77] in the liver, 
kidneys, heart and lungs of five rats examined after 50 days of daily 4- 
hour exposures to 1,1,1-trichloroethane at 73 ppm. Small foci of swelling 
were also found in the heart muscle. These conditions were more pronounced 
in five rats examined after 120 exposures.
Studies by Krantz et al [32] of blood clotting time in anesthetized 
animals and in vitro hemolytic action of 1,1,1-trichloroethane showed no 
effects.
(d) Effects on the Skin, Mucous Membranes, and Respiratory Tract
Gross or microscopic changes in the lungs which may have been 
attributable to exposure were not found by Prendergast et al [85] in 25 
rats, 15 guinea pigs, 3 rabbits, 2 dogs, or 3 monkeys exposed 8 hours/day,
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5 days/week, for 30 exposures at 2,200 ppm of 1,1,1-trichloroethane con­
taining 8% inhibitors and having a boiling range of 73.3-78.1 C.
Lung irritation was found by Torkelson et al [36] in two groups of 
five female guinea pigs exposed to inhibited 1,1,1-trichloroethane at
2,000 ppm for 12 or 30 minutes, 5 days/week, for 69 exposures in 99 days. 
Lung irritation was not found in two other similar groups exposed for 3 or
6 minutes/day.
Lung irritation was also found by Torkelson et al [36] in two other 
groups of five female guinea pigs exposed at 1,000 ppm 69 times in 98 days 
for 3 hours or 72 minutes daily. Lung irritation was not found in two 
other groups exposed for 18 or 36 minutes/day.
Congestion of the lungs was found by Horiguchi and Horiuchi [74] in 
mice exposed on alternate days to inhibited 1,1,1-trichloroethane at 1,000 
ppm for 2 hours for 9 days.
With continuous, ie 24 hours/day, 7 days/week, exposure to a 1,1,1-
trichloroethane preparation at 370 ppm for 90 days, Prendergast et al [85]
found gray nodules on the lower lobe of the left lung of 1 of 15 rats and
nonspecific inflammatory changes In the lungs of all species tested.
Varying degrees of lung congestion and pneumonitis were found in all 
species exposed continuously at 135 ppm for 90 days. [85]
No pathologic changes were observed in lungs of a female monkey 
subjected to 53 7-hour exposures at 3,000 ppm in 74 days. [73] Severe lung 
infections In rats dying following exposures at 5,000-18,000 ppm were 
found, and may reflect preexisting disease.
Moderately pronounced venous hyperemia in the lungs, emphysematous 
enlargement of individual groups of alveoli, and swelling of the bronchial
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epithelium was tound by Tsapko and Rappoport [77] in five rats exposed A 
hours daily for 50 days to 1,1,1-trichloroethane at 73 ppm. After 120 days 
of exposure, the emphysematous condition was much more pronounced, the 
interalveolar walls were thin and in some places they had broken down. The 
vascular walls were thickened and swollen, and around many of them there 
were accumulations of lymphoid and histiocyte cell elements and isolated 
plasma cells. The mucous membrane of the bronchi was swollen, and there 
were small amounts of mucus and detached epithelial cells in the lumen. 
The peribronchial lymphatic nodules were hyperplastic. [77] In this 
chronic study, even though conditioned reflex activity was not disrupted in 
the rats, structural changes in cortical and subcortical areas were noted. 
The authors did not report microscopic studies of cat brains in which 
changes in differential reflexes were found with chronic exposure. In the 
absence of other information, and because of the nature of the conditioned 
reflexes they were studying and the methods they used, it is difficult to 
assess the significance of the behavioral aspects of this study.
Chemosis and hyperemia of the conjunctivas of rabbits after in­
stillation of 1,1,1-trichloroethane (5% in corn oil) were found by Krantz 
et al [32] to be similar to those produced by chloroform administered 
similarly and simultaneously in the other eye.
A single undiluted application of either uninhibited or inhibited
1,1,1-trichloroethane to the eyes of rabbits was reported by Torkelson et 
al [36] to cause slight conjunctival irritation but essentially no corneal 
damage.
Only a slight reddening and scaliness of the skin were reported by 
Torkelson et al [36] to develop when a pad of absorbent cotton saturated
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with either inhibited or uninhibited 1,1,1-trichloroethane was bandaged to 
the shaved belly of a rabbit 10 times in 12 days. Healing was prompt when 
application ceased. When applied to the abraded skin, neither inhibited 
nor uninhibited 1,1,1-trichloroethane significantly altered the healing 
process. [36]
(e) Hepatic and Renal Effects
Effects on liver and kidney function and structure after acute 
Intoxication by 1,1,1-trichloroethane have been studied extensively. 
[32,66,67,69-71,73,86]
Liver function of male albino Princeton strain mice was evaluated in 
a report by Plaa et al [66] by 30-minute sulfobromophthalein (BSP) 
retention and sleeping time following sodium pentobarbital ip injection (45 
mg/kg). A commercial grade 1,1,1-trichloroethane preparation was 
administered subcutaneously, diluted in peanut oil (0.1 ml), at doses of 
12, 10, 8, and 4 ml/kg. Pentobarbital sleeping time in 270 control mice 
was 1.5 + 4.1 minutes (sic). Mice that slept more than 10 minutes when
pentobarbital was administered 24 hours after 1,1,1-trichloroethane were 
considered to have slept significantly longer than control mice. BSP 
retention was determined only in mice with significantly elevated sleeping 
times. BSP retention of 1.5 mg% was considered significantly greater than 
control values (0.46 + 0.50 mg%). Table 111-18 summarizes significant 
differences from sleeping time of controls.
Significant BSP retention was found in only 7 of the 18 mice with 
increased sleeping, at doses of 8 and 9 ml/kg.
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TABLE 111-18









12 83 14-172 10/10
10 92 10-160 8/9
8 19 17-21 2/9
(N = no. of mice tested; n = no. with significant response)
Adapted from Plaa et al [66]
Liver and kidney function studies following ip administration of 
analytical grade 1,1,1-trichloroethane to male Swiss-Webster mice was 
reported by Klaassen and Plaa [67] in 1966. The various doses of 1,1,1-
trichloroethane were administered in corn oil (0.01 ml/g). Liver function
was studied 24 hours after administration by 30-minute BSP retention and 
SGPT determinations. Kidney function was studied at the same time by
phenolsulfonphthalein (PSP) excretion and by protein and glucose analyses 
of the urine. From determinations on control animals, the upper limit of 
normality was determined for BSP retention (2.1 mg%), SGPT (50 units), and 
PSP excretion (22% of administered dose). From the series of 1,1,1-tri- 
chloroethane doses administered, the dose which would cause one-half of the 
treated animals to fall above the limit (ED50) was determined for each 
function test. The ED50 for BSP retention was 2.75 (95% confidence limits 
of 2.5-3.1) ml/kg, and for SGPT, 2.5 (95% confidence limits of 2.0-3.1)
ml/kg. None of the kidney function tests were abnormal. [67]
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Microscopic findings in the livers consisted of enlargement of the 
hepatocytes, cellular infiltration and vacuolation. Slight necrosis was 
found when mice were given near lethal doses. [67] No microscopic changes 
were found in the kidneys.
Swelling of the proximal convoluted renal tubules was reported in 
1965 by Plaa and Larson [86] in all five male Swiss mice studied after an 
ip dose of 2.5 ml/kg of 1,1,1-trichloroethane (otherwise not described) in 
olive oil (0.1 ml/10 g). No necrotic changes were found. Protein in 
excess of normal (100 mg%) was found in the urine of one of nine mice given 
2.5 ml/kg, in none of three administered 5 ml/kg. Glucose levels were 
normal in the urine of mice at both dose levels. [86]
The ED50 ip dose (corn oil, 0.01 ml/g) of 99.5% pure 1,1,1-tri­
chloroethane , eliciting a significant elevation (above 54 units) of SGPT 
activity in female Swiss-Webster mice, was reported by Gehring [70] to be
16.8 (95% confidence limits of 15.2-18.5) ml/kg. With similar mice, he
[70] reported that with inhalation at 13,500 ppm, half the mice died in 
595 (95% confidence limits of 578-615) minutes.
Analytical grade 1,1,1-trichloroethane administered ip at 2.8 ml/kg 
(corn oil, 1 ml/100 g) to male Sprague-Dawley rats by Klaassen and Plaa,
[71] caused no changes from control values in hepatic triglycerides, 
hepatic glucose 6-phosphatase, or degree of liver lipoperoxidation. They 
did find a significant increase, in vitro during lipoperoxidation, with an 
intermediate amount of 1,1,1-trichloroethane added to the incubation medium 
of rat liver slices. Lesser amounts of 1,1,1-trichloroethane had no effect 
on lipoperoxidation of the incubated liver slices and greater amounts were 
inhibitive.
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Liver and kidney findings reported by Adams et al [73] in rats 
subjected to various inhalation exposures to redistilled 1,1,1— 
trichloroethane are listed in Table 111-19,
TABLE III-19 
EFFECTS OF 1,1,1-TRICHLOROETHANE IN RATS
Exposure data Findings
18,000 ppm/2 hours Increased kidney weights; no 
significant pathologic changes
18,000 ppm/0.3 hours No pathologic findings
12,000 ppm/7 hours Increased liver weights, numerous 
small clear vacuoles (fat) through­
out cytoplasm of hepatic cells, con­
siderable congestion and hemorrhagic 
necrosis in central areas; slight 
increase in kidney weights; no 
pathologic findings
8,000 ppm/7 hours Fatty changes in the liver; no 
necrosis
8,000 ppm/5 hours No pathologic findings
Adapted from Adams et al [73]
Male and female mongrel dogs were given ip doses of 2.5 or 3.5 ml/kg 
of 1,1,1-trichloroethane in corn oil by Klaassen and Plaa [69] to determine 
the LD50 (3.1 ml/kg). Similar animals were given ip doses of 0.75 and 1,05 
ml/kg for studies of SGPT activity and 30-minute PSP excretion 24 hours 
after injection. Fifty units of SGPT were considered as the upper limit 
of normality; the ED50 dose of 1,1,1-trichloroethane at 24 hours was 0.87 
ml/kg. PSP excretion was not affected by the treatment. Moderate 
neutrophilic infiltrations in the sinusoids and portal areas were found in
the livers of the dogs surviving the LD50 study. Slight subcapsular liver 
necrosis was found in dogs from the ED50 study. [69]
Liver function was studied in three dogs by Krantz et al [32] before 
and after 1 hour of anesthesia with 1,1,1-trichloroethane. No changes in 
retention of BSP were found immediately, or 24 or 72 hours after the 
anesthesias. They [32] did find evidence of midzonal liver necrosis in one 
rat anesthetized for 1 hour/day on 9 consecutive days, but not in two 
other similarly exposed rats or in other rats anesthetized for 1 hour/day 
on 3 or 6 consecutive days.
Chronic administration of 1,1,1-trichloroethane has also been studied 
for effects on the liver and kidneys by other investigators. 
[36,73,74,77,84,85,87]
Increases in microsomal and cell-sap protein were found by Platt and 
Cockrill [87] in five rats given seven daily oral doses of 1.25 ml/kg
1,1,1-trichloroethane in liquid paraffin. Activities of two liver 
enzymes, NADPH2-cytochrome C reductase and glutamic dehydrogenase, were 
greater in the treated than in the control rats. The activities of seven 
other liver enzymes studied in the treated rats did not differ from control 
values. These seven enzymes were aminopyrine demethylase, NADH2-cytochrome 
C reductase, glucose-6-phosphatase and four dehydrogenases (lactic, 
glutamic, 6-phosphogluconate, and glucose-6-phosphate). Body and liver to 
body weight ratios were not changed from control values by the treatment. 
[87]
Congestion of the livers and inflammation around bile ducts were 
found by Horiguchi and Horiuchi [74] in NA2 male mice following nine 2-hour 
exposures to inhibited 1,1,1-trichloroethane at 1,000 ppm on alternate days 
over 3 weeks.
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increased liver weights were reported by Torkelson et al [36] in 5 
male rats exposed 70 times in 99 days to inhibited 1,1,1-trichloroethane at
10.000 ppm 1 hour/day, 5 days/week. Liver weights did not increase in 
other rats exposed for 0.5, 0.2 or 0.05 hours/day in the same experiment.
increased liver weights were found in female guinea pigs exposed 69 
times in the same experiment at 2,000 ppm, for 0.5 or 0.2 hours/day, and in 
others exposed 69 times at 1,000 ppm, for 3.0 or 1.2 hours/day. Exposures 
of shorter daily duration at 2,000 or 1,000 ppm did not result in increased 
liver weights. In the guinea pigs with increased liver weights, fatty 
changes were found in the livers.
No iivei. or kidney effects were reported by Torkelson et al [36] in 
126-130 exposures of rats, guinea pigs, rabbits or monkeys to inhibited
1,1,1-trichloroethane at 500 ppm. The exposures were 7 hours/day, 5 
days/week.
Fatty degeneration of the liver was reported by Adams et al [73] for 
guinea pigs, but not rats or rabbits, exposed 31 times in 44 days for 7 
hours/day, to redistilled 1,1,1-trichloroethane at 5,000 ppm. Fatty 
degeneration was also found in livers of guinea pigs exposed 20 times for 7 
hours/day at 3,000 ppm. No liver or kidney effects were reported for rats 
or monkeys repeatedly exposed (about 50 times) 7 hours/day, 5 days/week at
3.000 ppm. Liver or kidney effects were not reported for guinea pigs 
similarly exposed at 1,500 ppm over 2 months or at 650 ppm over 3 months.
No evidence of liver or kidney injury was reported by Prendergast et 
al [851 among animals exposed to inhibited 1,1,1-trichloroethane at 2,200 
ppm for 8 hours/day, 5 days/week for 6 weeks or at 370 or 135 ppm 
continuously for 90 days. At each exposure concentration, 15 rats, 15
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guinea pigs, 3 rabbits, 2 dogs and 3 monkeys were exposed.
A continuous exposure experiment lasting 14 weeks was reported in 
1974 by MacEwen and Vernot [88]. Exposure concentrations of 1,1,1- 
trichloroethane for which the purity was not stated were 250 and 1,000 ppm. 
At each concentration, 180 mice, 40 rats, 8 dogs and 4 monkeys were 
exposed. A similar group of animals was housed in the same type of 
exposure chambers for control studies. Ten mice were removed weekly from 
each group for gross examination, liver fat stains and liver triglyceride 
determinations.
Liver weights relative to body weights and liver triglyceride 
concentrations were significantly different from controls in all groups of 
mice examined after the 1,000 ppm exposure. These measurements were only 
slightly, or not at all altered in mice from the 250 ppm exposure. In mice 
examined 2 and 4 weeks after removal from exposure, relative liver weights 
and liver triglyceride concentrations were not significantly different from 
controls. Continuous exposure of mice at 1,000 ppm produced a significant 
increase in microglobular fat droplets in centrilobular hepatocytes. A 
slight increase was seen also at 250 ppm. There was no evidence by light 
microscopy of hepatocyte necrosis, inflammation, or fibrosis in any of the 
mouse livers examined. Focal hepatocyte necrosis, observed by electron 
microscopy, was greatest at the 12th week of exposure where it was present 
in 40% of the mice exposed at 1,000 ppm. This necrosis was associated with 
an acute inflammatory infiltrate and hypertrophy of Kupffer cells. [88]
Liver to body weight ratios were also significantly increased in rats 
exposed to 1,1,1-trichloroethane at 1,000 ppm, but at 250 ppm they were 
similar to controls. [88] Cytoplasmic alterations found by electron
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microscopy were most severe in centrilobular hepatocytes of the 1,000 ppm 
group and were mild to minimal in the 250 ppm group. These alterations 
consisted of vesiculation of the rough endoplasmic reticulum with loss of 
attached polyribosomes, increased smooth endoplasmic reticulum, microbodies 
and triglyceride droplets. Some cells had swollen cisternae of the
endoplasmic reticulum. [88]
The authors [88] also observed chronic respiratory disease, in 12 of 
40 control rats, in 28 of 40 exposed at 250 ppm, and in 7 of 40 exposed at 
1000 ppm. It appears that the respiratory disease was intercurrent rather 
than related to exposure.
No lesions in dogs or monkeys were ascribed to the exposure by the 
investigators. [88] McNutt et al, [41] however, found significant changes
in the livers of mice exposed at 1000 ppm 1,1,1-trichloroethane
continuously for 18 weeks and minor changes in mice exposed at 250 ppm. 
Changes in the 1000 ppm group included triglyceride accummulation, necrosis 
of hepatocytes, and cytoplasmic alterations of centrilobular hepatocytes. 
Cytoplasmic alterations were described as "mild to minimal" in the 250 ppm 
group.
Moderately pronounced venous hyperemia and swelling of individual
groups of cells was found by Tsapko and Rappoport [77] in rats examined 
after 50 days of daily 4-hour exposures to 1,1,1-trichloroethane at 73 ppm. 
In the rats examined after 120 days of exposure, these effects were more 
prominent, and protein dystrophy of the liver parenchymal cells was found. 
[77]
No adverse effects were reported by Eben and Kimmerle [89] in rats 
exposed at 220 and 440 ppm of 1,1,1-trichloroethane. Two groups of 20
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rats each were exposed for 4 hours, at 220 and 440 ppm during the acute 
experiment, and another group of 20 rats at 200 ppm 1,1,1-trichloroethane 
for 14 weeks, 8 hours/day, 5 days/week. Analysis demonstrated no 
significant changes In the standard hematology (Hgb, RBC, WBC, HCT, MCV and 
differential white count) and chemistry tests, SGOT, SGPT, sorbltal 
dehydrogenase, total bilirubin, urea, creatinine and glucose. On 
microscopic examination, no pathologic changes were found.
Quast et el [90] reported chronic Inhalation by rats In a 1975 
Interim report. Two groups of rats, each consisting of 96 males and 96 
females, were exposed at 875 and 1,750 ppm 1,1,1-trichloroethane, 
respectively, for 6 hrs/day, 5 days/wk for 52 weeks. The 1,1,1- 
trichloroethane formulation was analyzed for composition by gas 
chromatography and introduced Into a 3.7 cu m stainless steel chamber. The 
vapor concentration of 1,1,1-trichloroethane in the chamber was calculated 
from the ratio of material delivery rate and total chamber air flow rate. 
The concentration was verified at regular Intervals by infrared 
spectrophotometry.
Food and water were withheld during the exposure period. A control 
group of 192 male and 192 female rats was not subjected to lower exposures 
but was deprived of food and water on the same schedule as the experimental 
group. The portion of the diurnal cycle during which the animals were 
expozed was not stated. The investigators measured body weight, RBC 
count, Hgb concentration, packed cell volume, differential white count, and 
urinalysis for pH, specific gravity, sugar and albumin concentrations, 
presence of Ketone bodies, and bilirubin. After the experimental period, 
animals were observed until moribund or dead. Representative specimens of
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all major organs and glands were taken for microscopic examination. 
Behavioral signs indicative of CNS depression, such as hyperactivity, were 
sought. The authors reported no signs or indices attributable to 1,1,1- 
trichloroethane exposure. Several "spontaneous lesions" were found, but on 
comparison of frequencies between control and experimental groups were not 
associated with exposure. The portion of the diurnal cycle during which 
the animals were exposed was not stated. These findings were reported 
after 24 months and 18-23% of the males and 32-37% of the females were 
still alive at that time.
(f) Absorption, Excretion, Metabolism
Only limited information on absorption of 1,1,1-trichloroethane was 
found. Concentrations of 1,1,1-trichloroethane were measured by MacEwen 
and Vernot [88] in the blood of dogs and monkeys during 14 weeks of 
continuous exposure at 250 and 1,000 ppm. Table 111-20 lists the 
concentrations found.
Excretion by rats of 1,1,1-trichloroethane labeled with carbon 14 at 
the 1 position was reported by Hake et al [91] in 1960. The doses 
administered to three rats were 727, 642 and 705 g/kg (approximately 0.5 
ml/kg). For two rats in which it could be measured, an average of 97.6% of 
the administered dose was excreted unchanged in the exhaled air during 25 
hours, and in three rats an average of 0.85% (0.55, 0.86, and 1.14%) of the 
administered radioactivity was found in the urine.
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TABLE III-20
CONCENTRATION OF 1,1,1-TRICHLOROETHANE 
IN BLOOD OF DOGS AND MONKEYS, pg/g
Week Dogs Monkeys
250 ppm 1,000 ppm 250 ppm 1,000 ppm
3 11 75 4 33
5 16 46 14 48
9 9 38 3 17
13 17 75 4 30
Adapted from MacEwen and Vernot [88]
Concentrations of 1,1,1-trichloroethane were studied by Boettner and 
Muranko [92] in the breath of rats after removal from exposures at various 
concentrations and durations. With 3-hour exposures, concentrations of 
100, 200, 500 and 1,000 ppm of 1,1,1-trichloroethane were used. At 350 
ppm, exposure times were 1, 2, 5, 10 and 20 hours. Breath samples were 
collected at 1, 2, 4 and 8 hours after removal from exposure and analyzed 
by gas chromatography. The logarithm of the concentrations found in the 
breath at 1 and 8 hours after removal from the 3-hour exposures was plotted 
against the logaritham of exposure concentrations and linear relationships 
were found. The exposures at 350 ppm demonstrated an approach to 
equilibrium at 5 hours of exposure. [92]
Metabolites of labeled 1,1,1-trichloroethane identified by Hake et al 
[91] were carbon dioxide in the exhaled air (0.5% of the administered dose) 
and the glucuronide of 2,2,2 tetrachloroethanol in the urine. From 10 to
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25% of the activity in the urine was removed with toluene and was
volatilized by air drying. From 25 to 30% of the activity remaining in the
urine was also volatilized by air drying. The investigators [91] did not
find chlorinated acetic acids in the urine.
Urine of male and female Wistar rats was analyzed by Ikeda and 
Ohtsuji [93] for total trichloro compounds (TTC), trichloroacetic acid 
(TCA), and trichloroethanol (TCE) following 8 hours of exposure to 1,1,1- 
trichloroethane at 200 ppm. Urine was collected for 48 hours from the 
beginning of the exposure and analyzed colorimetrically using the Fujiwara 
reaction. The optical extinction after oxidation of the urine sample was 
attributed to TTC; that without oxidation to TCA, as well as the difference 
between the two, was attributed to TCE. Average 48-hour excretions (mg/kg 
body weight) from eight rats were: TTC 3.6 + 1.0; TCA 0.5 + 0.2; and TCA
3.1 + 1.0. Similar data were obtained with seven rats after ip injections 
of 1, 1,1-trichloroethane (6.9/ml/kg). Urine collected [93] for two
consecutive 48-hour periods after injection yielded the data in Table HI- 
21.
The "behavior" of 1,1,1-trichloroethane and its metabolites was 
investigated in the expired air, blood and urine of male Wistar rats by 
Eben and Kimnerle. [89] To quantitate concentrations of 1,1,1- 
trichloroethane and its metabolites, a gas chromatograph, equipped with an 
Ni-63 electron capture detector, was used. The major metabolites studied 
were TCE and TCA in the urine, 24 hours after exposure, for 3-4 days in the 
acute group, and 16 hours after exposure, daily, in the subchronic group. 
Chloral hydrate concentrations were also determined in the blood and 1,1,1- 




1,1,l-TRICHLOROETHANE IN RATS 
AFTER IP INJECTION
Collection Urinary Metabolites, mg/kg body weight (mean +SD)




4.0 + 1.5 
0.3 + 0.1 
0.3 + 0.1
0.5 + 0.2 
0.3 +0 . 1  
not measurable
3.5 + 0.4 
not measurable 
0.3 + 0 . 1
Adapted from Ikeda and Ohtsujl [93]
All animals in the acute experiment (220 and 440 ppm) excreted most 
of the TCE in the urine within 24 hours. Both TCA and TCE concentrations 
in the urine reflected a dose-dependent increase. 1,1,1-trichloroethane 
concentrations in the breath were also found to be dose-dependent, but 
decreased exponentially with time, after exposure.
In the subacute experiment, at 200 ppm, TCE concentrations in the 
urine increased continuously, reaching a maximum between the 55th and 65th 
days, and then decreased. Within the first few days, TCA concentrations 
rose to about 20 mg, then remained constant. 1,1,1-Trichloroethane and 
TCE concentrations in the blood were almost constant throughout the 
exposure period, and chloral hydrate was not detected. 1,1,1- 
Trichloroethane was not detected in the following tissue: adipose, brain,
hepatic, renal, cardiac or splenic.
Enzymatic dechlorination of 1,1,1-trichloroethane by rat liver 
microsomes In vitro was found to be minimal (less than 0.5% of Cl 36 
removed) by Van Dyke and Wineman. [94] Exposure of rats for 5 days, 7 
hours/day, to 500 ppm of 1,1,1-trichloroethane, had no effect on the
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dttchlurinating system, and dechlorination of 1,1,1-trichloroethane was not 
enhanced by exposure to the enzyme inducer, methoxyflurane.
Herd and Martin [95] investigated the effects of 1,1,1- 
tricliloroethane on mitochondrial metabolism. Biochemical characteristics 
of metabolism were studied by polarography; calcium uptake, respiratory 
rates and mitochondrial ATP activity were measured in albino rat liver and 
heart:, mitochondria. The investigators found a marked decline in ADP 
respiration with pyridine nucleotide linked substrates, an unaffected rate 
of succinate-linked ADP respiration, and an alteration of the passive 
permeability characteristics of the mitochondria to calcium and hydrogen 
ions. It was concluded that the results gave an explanation for 1,1,1- 
trichloroethane-induced depression of myocardial respiration. [95]
(g) Drug Interactions and Potentiation of 1,1,1-Trichloroethane 
Toxicity
1,1 ,l-'i’richloroethane was found by Van Dyke and Rikans [96] to 
stimulate aniline hydroxylase activity when added to the incubation medium 
of rat liver microsomes. In the same experiment, it had no effect on 
aminopyrine demethylase.
Metabolism of hexobarbital, meprobamate, and zoxazolamine, based on 
loss of righting reflex, was studied by Fuller et al [97] in male rats and 
mice, 24 hours after removal from 24 hours of continuous exposures to 
reagent gra r 1J ,1-trichloroethane at 3,000 ppm. The sleeping times 
induced by all three drugs were also reduced in rats and mice exposed to
1,1,1-trichloroethane. This indicates that 1,1,1-trichloroethane
stimulates the activity of hepatic microsomal enzymes used to metabolize 
these drugs.
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Other studies were conducted with hexobarbital to determine the 
mechanism by which 1,1,1-trichloroethane reduced the sleeping time. [97] 
To functionally block the hypophysis, rats were treated with morphine 
sulfate (20 mg/kg ip) for 4 days before exposure. This treatment did not 
alter the effect of 1,1,1-trichloroethane on hexobarbital sleeping time. 
In another experiment, adrenalectomized rats retained the 1,1,1-tri- 
chloroethane effect on hexobarbital sleeping time. [97]
Other groups of rats were treated with either cycloheximide or 
actinomycin D to block protein synthesis before they were exposed to 1,1,1- 
trichloroethane. [97] Both these drugs blocked the effect of 1,1,1- 
trichloroethane inhalation on hexobarbital sleeping time by preventing 
reduction of hexobarbital narcosis and an increase in hexobarbital 
metabolism.
In vitro studies showed that both hexobarbital and zoxazolamlne 
metabolism by rat livers were increased by exposure of the donor rat to
1,1,1-trichloroethane. Aminopyrine demethylase, NA.DPH cytochrome C 
reductase activity, and cytochrome P-450 activity were also increased by 
exposure. [97]
Sleeping time induced by ip administration of hexobarbital sodium (80 
mg/kg) in random-bred male and female Swiss albino mice was reported, in 
1970 by Lai and Shah, [98] to be decreased if the mice were exposed to 
reagent grade 1,1,1-trichloroethane. Most of the experiments were 
conducted with only male mice. Groups of males were exposed for 24 
consecutive hours to approximately 600, 1,500, 3,000 and 6,000 ppm and
sleeping time was determined 24 hours after exposure. Maximum reduction in 
sleeping time (50-60%) occurred after exposures at 3,000-6,000 ppm. Higher
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exposure concentrations were less effective.
Other experiments were conducted at the 3,000 ppm exposure level. 
When 24 hours of total exposure time were completed in three to six 
exposure periods, each separated by 18-21 hours, a cumulative effect was 
shown by progressive decreases in sleeping time. [98]
The cause of the decreased hexobarbital sleeping times following
1,1,1-trichloroethane exposures was studied. [98] It was found that 
neither barbital nor chloral hydrate induced sleeping times were affected 
by exposure to 1,1,1-trichloroethane. Oxidation of hexobarbital by 9,000 G 
supernatant fractions from livers of exposed mice was increased. Reduction 
of p-nitro-benzoic acid by the same liver fractions was not affected by 
exposure of the mice to 1,1,1-trichloroethane.
Treatment of mice with atropine, chlorpromazine or tolazoline 
immediately before and after 12 hours of exposure to 1,1,1-trichloroethane, 
did not block the effect of exposure on hexobarbital sleeping time. [98]
Administration of two doses of phénobarbital (50 mg/kg ip) by Cornish 
et al [99] 1 and 2 days before injection of reagent grade 1,1,1-
trichloroethane at doses of 0.3, 0.5, 1.0 and 2.0 ml/kg, did not enhance 
the hepatoxicity of 1,1,1-trichloroethane, evaluated by SG0T 
determinations. Similar increases in SGOT levels were found in control (no 
phénobarbital treatment) and treated animals at each 1,1,1-trichloroethane 
dose level. The SGOT levels were significantly increased by 1,1,1- 
trichloroethane with or without phénobarbital pretreatment.
Enhancement of 1,1,1-trichloroethane hepatotoxicity by phénobarbital 
was reported in 1973 by Carlson. [100] In this experiment, the male rats 
were pretreated with phénobarbital (50 mg/kg/day) for 4 days before an
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exposure for 2 hours to 1,1,1-trichloroethane at 11,600 ppm. This exposure 
without pretreatment, and phenobarbital without exposure, had no effect on 
relative liver weights, liver glucose-*6-phosphatase, or the serum enzymes 
SGPT and SGOT. The combination of pretreatment and exposure to 1,1,1- 
trichloroethane increased liver weights and serum enzyme activities, and 
decreased the liver glucose-6-phosphatase activity. Pretreatment of rats 
with 3-methylcholanthrene (40 mg/kg/day) for 2 days, before a 2-hour 
exposure to 1,1,1-trichloroethane at 13,000 ppm, did not cause any of these 
measurements to change from control values. [100]
Ingestion of ethanol was reported by Klaassen and Plaa [67] in 1966 
to increase the hepatotoxicity of analytical grade 1,1,1-trichloroethane. 
Ethanol (60%) was administered by gavage (stomach tube) at doses of 5 g/kg. 
In one experiment, a dose of ethanol was given on each of 3 days before ip 
administration of 1,1,1-trichloroethane in corn oil (0.01 ml/g) at doses of 
2.5-2.75 ml/kg. In another experiment, a single dose of ethanol was given 
12 hours before the 1,1,1-trichloroethane. In both experiments, BSP 
retention was significantly higher in the ethanol pretreated rats than in 
control rats given only 1,1,1-trichloroethane. SGPT activity was not 
affected in this experiment by 1,1,1-trichloroethane at a dose of 2.5 ml/kg 
with or without alcohol pretreatment, and kidney function as measured by 
PSP excretion was similarly not affected by 1,1,1-trichloroethane doses of
2.0 ml/kg. [67] SGPT activity was also not different from controls in dogs 
given 1,1,1-trichloroethane doses of 0.85 ml/kg, with or without ethanol 
pretreatment, by Klaassen and Plaa. [69]
Exposures of rats to redistilled reagent grade 1,1,1-trichloroethane 
for 2 hours at 10,000 or 15,000 ppm or for 6 hours at 5,000 or 10,000 ppm
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did not increase serum enzyme levels whether or not there had been ethanol 
pretreatment. [101] The serum enzymes studied in this 1966 report by 
Cornish and Adefuin [101] were SGOT, SGPT, and isocitric dehydrogenase. 
The ethanol (50%) was administered by stomach tube at 5 g/kg, 16-18 hours 
before the vapor exposures.
Isopropyl alcohol or acetone administered by gavage to male Swiss- 
Webster mice 18 hours before ip injection of 1,1,1-trichloroethane did not 
alter the response of SGPT activity to the administered 1,1,1-trichloro­
ethane. [102] The doses of 1,1,1-trichloroethane used in this experiment, 
by Traiger and Plaa [102] in 1974, were 1.0, 2.0 and 2.5 ml/kg. The latter 
dose caused increases in SGPT activity, but the increases were not affected 
by isopropyl alcohol or acetone pretreatment.
(h) Teratogenicity, Carcinogenicity, Mutagenicity
Sprague-Dawley rats and Swiss-Webster mice were exposed to 1,1,1-tri- 
chloroethane 7 hours/day on days 6-15 of gestation in an experiment 
reported by Schwetz et al in 1975 . [103] A commercial grade 1,1,1-
trichloroethane preparation [16] containing 5.5% inhibitors and impurities 
was used. The exposure concentration of 1,1,1-trichloroethane was about 
875 ppm, and the exposure concentration of the inhibitors and impurities 
was about 50 ppm. The numbers of bred animals subjected to this exposure 
were not explicitly stated in the report. The findings of the study are 
presented in Tables XII-3 to XII-5. An increase in liver weight was 
reported to be the only significant maternal, fetal or embryonal toxic 
effect in rats at 875 ppm. There were no significant findings reported in 
mice.
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Although the authors [103] concluded that there were not teratogenic 
effects in either rats or mice, certain soft tissue and skeletal 
abnormalities occurred in litters of exposed rats and mice that did not 
occur in litters of control mothers. These abnormalities in mice included 
one litter with short tail, and one with cleft palate. In rats, two 
litters were found with supernumerary vertebra. In concluding that the 
abnormalities were not statistically significant, the authors compared the 
exposed to the control group, but in comparing the appearances of 
abnormalities in the 1,1,1-trichloroethane exposed group, with no 
appearances during exposure to other chemicals, the findings take on added 
significance. The experiment needs to be repeated to confirm that these 
are not significant effects of 1,1,1-trichloroethane.
Other studies with 1,1,1-trichloroethane involving reproduction and 
studies of mutagenicity were not found by a search of the literature.
A study of 1,1,1-trichloroethane exposure in rats [90] revealed two 
tumors in each group studied; controls, exposed males and exposed females. 
The tumors are only described as hyperplastic proliferations of liver 
cells, and they were dismissed by the authors due to appearance in the 
control group. Another tumor, appearing in one female rat exposed at 1,750 
ppm, was variously diagnosed, by different pathologists, as a 
hemangiosarcoma, undifferentiated hepatic cell carcinoma or hepatoblastoma 
with areas of sarcoma. A second study involving carcinogenesis is 
currently underway at the National Cancer Institute.
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Correlation of Exposure and Effect
Summaries of inhalation exposures and effects are presented in 
Tables XII-6 to XII-10. The most significant findings concerning the 
effects of 1,1,1-trichloroethane in man and animals are the depression of 
the CNS, cardisvoscular toxicity and hepatic toxicity. Irritation of the 
lungs and mucous membranes also has been reported. Information on 
experimental exposures of more than 6 months duration, or at 1,1,1- 
trichlorethane concentrations below about 75 ppm, was not found in the 
literature. Both experimental studies and occupational experiences 
indicate that 1,1,1-trichloroethane is irritating to the skin and mucous 
membranes and that the nervous system, cardiovascular system, and the liver 
are affected by exposures.
(a) Central Nervous System Effects
The first reported biologic study of 1,1,1-trichloroethane, by Tauber 
[2] in 1880, established that it had anesthetic properties. Clinical 
trials in 1958-1960 established that it was not very effective as a 
surgical anesthetic, and its use for this purpose was discontinued. [32— 
34] The anesthetic properties of 1,1,1-trichloroethane have had 
occupational significance, [36,49] and will continue to be of significance 
to work practices and requirements for respiratory protective devices.
Concentrations of 1,1,1-trichloroethane required to induce anesthesia 
under working conditions have not been determined. [36,49] The clinical 
studies are difficult to extrapolate to occupational situations because the 
patients were usually given sedatives before administration of anesthetic 
gas, and nitrous oxide was used in the 1,1,1-trichloroethane carrier gas. 
[33,34] Under the conditions of the clinical trials, light plane 1 anes­
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thesia developed within 2 minutes when 1,1,1-trichloroethane was 
administered at 10,000-26,000 ppm and could be maintained by 6,000-22,500 
ppm. [33]
Subjects became unable to stand when exposed experimentally to 1,1,1- 
trichloroethane for 15 minutes, with the concentration rising from 0 to
2,650 ppm. [35] Loss of ability to stand also has been experienced in 
occupational exposures [51]; however, the concentrations of 1,1,1- 
trichloroethane were not reported. Both these reports demonstrate the need 
for adherence to good work practices, and the use of proper ventilation and 
protective equipment when working with 1,1,1-trichloroethane.
Other central nervous system effects which could impair judgment and 
increase accident risk have been found with human exposure conditions 
which would not be anesthetic. [35,36,38]
Lightheadedness and impaired coordination and equilibrium have been 
experienced by subjects exposed at 900-1000 ppm for 20 minutes or more. 
[35,36] Other tests have shown impaired perceptual speed, reaction times, 
and manual dexterity during 1 hour of exposure to 1,1,1-trichloroethane at 
350 ppm but not at 250 ppm. [38] Similar responses have been found with 
occupational exposure to 1,1,1-trichloroethane with at least one reported 
case of sufficient intoxication to cause a fall. [51]
Animal experiments have shown central nervous system responses and 
behavioral changes with exposure to 1,1,1-trichloroethane. [74,75,77] 
Increased EEG activity was found in rabbits during 1 hour of 1,1,1- 
trichloroethane inhalation at 6,250 ppm. [75] Increased running activity 
was found in mice exposed at 1,000 ppm 2 hours/day on alternate days. [74] 
In this experiment the activity did not alter until the third exposure.
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Pathologic vascular changes were found in the brains of rats after 50 
exposures. [77] After 120 exposures, pathologic changes in the nerve cells 
were found. Whether these anatomic changes reflect adverse effects of
1.1.1-ttichloroethane or are histologic artifacts, is not clear since data 
from control rats are not presented.
(b) Cardiovascular Effects
Daring anesthesia, a drop in blood pressure was observed in most 
patients, and ECG changes in some of them. [33-35] The changes found by
ECG analysis included premature ventricular contractions, depressed S-T 
segments, and one case of cardiac arrest. [33] The cause of the cardiac
arrest was unknown.
Sudden death was reported in 1949 to have occurred in unanesthetized 
dogs inhaling 1,1,1-trichloroethane, and in subsequent experiments with 
anesthetized dogs it was demonstrated that 1,1,1-trichloroethane sensitizes 
the heart to epinephrine. [78] Experiments by other investigators 
[46,81,82] have shown that exposure to 1,1,1-trichloroethane sensitizes the 
hearts of dogs, monkeys, and mice. Sensitization occurred in unanes­
thetized dogs with 5 minutes of exposure at 5,000 ppm, but not at 2,500 
ppm. [81]
Sudden death has occurred in humans from both use and misuse of
1.1.1-trichloroethane. [45,80] At least some of the 11 reported 
occupational fatalities may have been sudden deaths. [14,36,47,50] The 
occupational cases described by Kleinfeld and Feiner [48] had many
similarities to cases of sudden death from inhalation of 1,1,1—
trichloroethane described by Bass. [45]
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Changes in cardiovascular function found in dogs exposed to 1,1,1- 
trichloroethane at 8,000 ppm for no more than 5 minutes included an abrupt 
drop in total peripheral resistance with compensatory cardiac responses. 
[80] Within seconds, the compensatory cardiac responses were dissipated 
and stroke volume, heart rate, and myocardial contractility decreased. 
[80] A decrease in heart rate and blood pressure was found in rabbits 
during the first 10 minutes of exposure at 6,250 ppm. [75] Studies of this 
kind have not been reported at lower concentrations of 1,1,1- 
trichloroethane, but similar results have been found at higher concentra­
tions in dogs, [46,80] rabbits, [75] and monkeys. [79]
Studies with animal tissues have shown decreased oxygen consumption 
of heart muscle excised from rats anesthetized with 1,1,1-trichloroethane. 
[32] Another In vitro study showed that addition of 1,1,1-trichloroethane 
to the aeration mixture affected the contractile mechanics of isolated 
papillary muscles from rat hearts. [80]
Autopsy findings in animals exposed to 1,1,1-trichloroethane 
reflected the cardiovascular effects mentioned above. The predominant 
findings in dogs autopsied after two to three exposures in a study of 
cardiac rhythm, were slight heart cell necrosis and gross congestion in all 
tissues. [46] Congestion has been a common finding in animal tissues at 
autopsy after administration of 1,1,1-trichloroethane. [73,74,77,84]
Hypertension was found in six of nine women occupationally exposed to
1,1,1-trichloroethane for several months. [61] Neither blood pressure nor 
ECG changes were found in human subjects experimentally exposed to 1,1,1- 
trichloroethane at 0 to 2,650 ppm during 15 minutes, [35] or about 1,000 
ppm for 70 to 75 minutes, or 400 to 600 ppm for 7.5 hours. [36] No
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reports of other cases have found hypertension.
Autopsy findings in human fatalities resulting from exposure to
1.1.1-trichloroethane are indicative of a state of decreased peripheral 
resistance and cardiac insufficiency. [44,49,50] Fractional analysis of 
LDH in a patient who died 5 days after inhaling 1,1,1-trichloroethane 
showed the heart was the major source of the increased serum concentration 
of this enzyme. [46] Heart cell necrosis and liver fatty metamorphosis 
were also found on autopsy. [46]
(c) Liver and Kidney Effects
Slight increases in serum transaminase (unspecified) were found in
two of five patients on the days following surgery under 1,1,1-
trichloroethane anesthesia. [33]
Positive urinary urobilinogen was found in two of seven subjects 7 
hours after an exposure of 15 minutes to 1,1,1-trichloroethane at 0 to
2,650 ppm. A few red blood cells were found in the urine of five of the 
subjects. [35]
Elevated urinary urobilinogen was also found in one subject following 
a 20-minute exposure at 900 ppm, and some evidence of possible kidney 
injury was found in six subjects after exposure at 500 ppm for 78 minutes. 
Serum enzymes were not elevated. [35]
Evidence of kidney injury (red blood cells and protein in the urine) 
and elevated serum bilirubin were also found in a man following ingestion 
of 1,1,1-trichloroethane. [35]
Autopsy findings in a woman with a history of chronically sniffing
1.1.1-trichloroethane were limited to the respiratory system, stomach, and 
brain. [44]
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Elevated urinary urobilinogen was found In one worker after he had 
worked with 1,1,1-trichloroethane for 1 hour in a closed room, [51] and in 
two of nine women after they had worked with 1,1,1-trichloroethane for 
several months.
These reports [33,35,42,51] indicate a potential for both kidney 
injury and liver injury by 1,1,1-trlchloroethane in exposed workers. 
Animal experiments generally do not confirm kidney Injury. 
[66,67,69,71,73,74,85-87] The tests for liver and kidney function that 
have been used are not the same in animals and man and In neither animals 
nor man have the tests most sensitive to 1,1,1-trichloroethane effects been 
widely used. Stewart et al [35] reported microscopic hematuria in men 
experimentally exposed at 500 ppm or higher concentrations. Whether this 
reflects effects of the dioxane inhibitor, an incidental and unrelated 
effect, or a toxic effect of 1,1,1-trichloroethane, is not clear. Research 
to clearify this is needed.
Accumulation of triglycerides In the liver has been found in rats 
only with prolonged exposures at 1,000 ppm or more. [36,73,84] Necrotic 
changes have not generally been found but focal hepatocyte necrosis was 
found by electron microscopy in mice exposed continuously for 90 days at
1,000 ppm. [88] Mild to minimal changes were also found by electron 
microscopy in the livers of rats exposed at 250 ppm continuously for 90 
days. The necrotic changes were associated with an acute inflammatory 
infiltration and hypertrophy of Kupffer cells. [88]
Congestion of the livers and inflammation around biliary ducts were 
found in mice following nine 2-hour exposures on alternate days to 1,1,1- 
trlchloroethane at 1,000 ppm. [74]
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Swelling of individual cells and moderately pronounced venous 
hyperemia was found in the livers of rats exposed 4 hours daily, 50 or 120 
times, to 1,1,1-trichloroethane at 73 ppm. [77]
(d) Effects on Skin and Mucous Membranes
1,1,1-Trichloroethane is irritating to the skin and mucous membranes.
[32,36,44,49,50,61,73,74,77,85,88]
Congestion of bronchial vessels and passive congestion throughout the 
lungs were found at autopsy of a woman who had chronically sniffed 1,1,1- 
trichloroethane. [44] Autopsy findings in another case where chronic
inhalation of 1,1,1-trichloroethane may have been involved were congestion, 
edema, dilated vessels and small hemorrhages in the lungs. [44] Lung
congestion and edema were found on autopsy of seven workers who were found 
dead at their site of work with 1,1,1-trichloroethane. [49,50]
Lung irritation was found by Torkelson et al [36] in guinea pigs 
repeatedly exposed to 1,1,1-trichloroethane at 1,000 ppm or more.
Congestion of the lungs was found in mice exposed 2 hours/day, on 9
alternate days, at 1,000 ppm of 1,1,1-trichloroethane.
Chronic respiratory disease was found in rats exposed continuously at
1,000 ppm or 250 ppm for 91 days, [88] but it is not clear that endemic 
respiratory disease was not present prior to the exposures. Lung 
congestion and pneumonitis were found in all tested species exposed 
continuously at 135 ppm for 90 days. [85]
Transient irritation of the conjunctiva or the upper respiratory
tract and a burning sensation of the tongue were experienced by women 
exposed at concentrations of 1,1,1-trichloroethane reported to be 10 to 40 
ppm. [61] However, excretion of TCA by these workers indicated exposures 
of 500 ppm or above»
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Skin irritation has also been reported with experimental exposures to 
liquid 1,1,1-trichloroethane [53] and from occupational use. [36,61] In 
addition to skin irritation, liquid 1,1,1-trichloroethane can be absorbed 
to a moderate degree through the skin.
96
IV. ENVIRONMENTAL DATA AND BIOLOGIC EVALUATION
Environmental Concentrations and Engineering Controls
There is little information available about the concentrations of
1,1,1-trichloroethane to which workers have been routinely exposed.
Concentrations of 1,1,1-trichloroethane developed in cleaning 
electrical equipment were reported by Burkatskaya et al [104] in 1973. The 
sampling and analytical method were not described. The greasy parts were 
sprayed with or dipped into the solvent. Parts were sprayed for 4-5 
minutes and dried with a jet of air for 2-3 minutes. The room had an 
exhaust fan and a general two-way exhaust that provided 35-40 air changes 
(time interval not given).
Concentrations of 1,1,1-trichloroethane in the shop area during the 
spraying period were 27-70 ppm. These concentrations declined rapidly when 
the spraying and drying process was completed and, after 30 minutes, the 
room air concentration was not measureable.
Concentrations found in different parts of the room when the dipping 
tanks opened were 25-55 ppm. When the parts were taken from the bath, 
about 250 ppm of 1,1,1-trichloroethane were found in the workroom air. 
[104]
An average breathing zone concentration of 410 ppm 1,1,1- 
trichloroethane was found in a degreasing operation study reported by 
Hervin and Reifschneider [105] in 1973. A 3 x 3 x 3 foot metal hood vented 
to the outside air was provided for operations involving the use of 1,1,1- 
trichloroethane. The bottom of the hood was a basin which contained 5 
gallons of solution. The basin was covered when not in use. The operation
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involved dipping the metal parts in the solution and then standing them 
upright for visual inspection. The operator then shook the parts and 
handed them to the packer who placed them in a wooden box. This operation 
normally was performed intermittently for a few hours each day.
Eight breathing zone and general area samples were collected with 
charcoal tubes during the survey and analyzed by gas chromatography. The 
operations were noted for about 2 hours by the investigators. [105]
Concentrations of 1,1,1-trichloroethane in the workroom of a printing 
plant were studied by Tada. [60] The samples were collected from various 
parts of the room on the third to fifth day of the week and the 1,1,1-tri­
chloroethane concentrations were determined by the alkali-pyridine- 
benzidine method. The survey showed that the workers were exposed to
1,1,1-trichloroethane at 37 ppm on the average for 7 hours/day.
Colorimetric indicator tubes (designed for methyl bromide) were ised 
by Weitbrecht [61] to estimate air concentrations of 1,1,1-trichloroethane 
in a room where it was used by nine women for washing brass frames in open 
containers. The average concentrations found by this method were 10 ppm in 
the general room air and 20 ppm at the worksite. The average exposure 
concentrations of two of the women were estimated at 40 ppm by another non­
specific colorimetric indicator method.
Kay et al [106] reported on atmospheric sampling in the vicinity of 
vapor degreasing operations in 21 factories. Workers wore personal
samplers to measure their average exposure over most of a working day and 
other atmospheric samples were taken at selected points around the
degreasing tanks. Some of the factories used 1,1,1-trlchloroethane and
others used trlchloroethylene. Of 71 workers using trichloroethylene, 18
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were exposed in excess of the TLV (100 ppm) throughout their working day. 
During the survey, concentrations of 1,1,1-trichloroethane were "well below 
toxic levels" (apparently meaning 350 ppm) during normal vapor degreasing.
In this same study, [106] methods of operation and ventilation were 
highlighted as important safeguards. The authors reported samples taken 
near vapor degreasing plants at 21 factories in England. They found that 
lip exhaust ventilation was provided at three-fourths of the open top tanks 
surveyed. Extraction rates varied (tank to tank) from 0 to > 100 cu 
ft/min. Lips slots were commonly found to be closed, by dropage of heavy 
objects or deposits of dirt. Conditions were found to be poorest at tanks 
without lip exhausts, and over half of the operators were receiving
concentrations above the TLV. This was aggrevated in some conditions by
poor general ventilation. Also, downward drafts caused solvent vapor to be 
blown out of the tanks and into the workers' breathing zone. The authors 
suggested that this effect could be limited by the use of covers and 
screens at the tank. The authors [106] found that manual unloading of 
tanks as well as preparation of work for the tanks, caused a sharp increase 
of 1,1,1-trichloroethane in the workers' breathing zones.
The following recommendations were made: (1) Degreasing tanks should
be sited in well ventilated areas giving particular attention to tanks in 
confined areas, (2) vapor degreasing tanks should be provided with
efficient lip exhaust systems (35 cu ft/min was suggested as an adequate
extraction rate) and covered by protective screens to prevent escape of
1,1,1-trichloroethane vapor, (3) work should be arranged so that it can be 
contained in the freeboard zone of the tank during the removal of excess 
solvent and stacked to ensure complete drainage of the degreasing solvent,
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(4) operations which require high temperature, such as welding, should not 
be carried out in areas where 1,1,1-trichloroethane may be present, due to 
breakdown to toxic products. [106]
Recent sampling by Kramer et al, [64] as part of a matched pair study 
of two textile plants, found that workers were exposed to an average daily 
concentration of 115 ppm 1,1,1-trichloroethane. During cleaning operations 
at noon, this level rose to about 350 ppm. Air samples were analyzed by 
gas chromatography.
1,1,1-Trichloroethane exposures during vapor degreasing were reported 
by Skory et al [107] as average concentrations and average peak 
concentrations. Exposures found during different phases of the work were: 
idling degreaser, 76 ppm (average peak concentration 187 ppm); racking and 
loading, 73 ppm (average peak concentration 164 ppm); cleaning parts, 95 
ppm (average peak concentration 182 ppm); unloading parts, 131 ppm (average 
peak concentration 268 ppm).
To minimize exposure to 1,1,1-trichlorethane during these operations, 
the authors suggested that parts should be withdrawn slowly from the 
degreaser so as not to pull solvent out, heating input and condensing 
capacity should be properly balanced, the nozzle of the sprayer should be 
kept below the vapor-air interface during spraying applications, air flow 
in the degreasing area should be controlled so drafts do not sweep across 
the top of the vapor degreaser or toward the operator, and lip exhausts 
should be properly operated. [107]
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Environmental Sampling and Analytical Methods 
(a) Collection Methods
Most analytical methods are dependent upon the effectiveness and 
reproducibility of the uptake of 1,1,1-trichloroethane by different 
collection media. Air samples are usually collected and transported t:o a 
laboratory, then desorbed or chemically treated, and finally analyzed 
quantitatively.
Silica gel, which has been used as a collection medium, [108-110] is 
a polar adsorbent and shows pronounced selectivity in adsorbing polar 
molecules, particularly water. [Ill] A laboratory study with 1-inch silica 
gel tubes indicated that the silica gel could become saturated with water 
and lose its collection efficiency when sampling 3 liters of air. [Ill]
Activated charcoal has been used as a collection medium followed by 
analysis by gas chromatography. [112] Charcoal is nonpolar and will 
generally adsorb organic vapors in preference to water vapor resulting in 
less interference from atmospheric moisture than with silica gel. [Ill]
Williams and Umstead [113] reported the use of porous polymer beads 
as a collection medium. With this method, the same column was used for 
sample collection and gas chromatographic analysis. This method 
consolidates collection and analysis into one operation, but only one 
analysis can be made on each sample. This method has not been developed 
for field use.
When solid collection media are used, it is necessary to desorb the 
collected contaminant from the medium. Desorbtion from charcoal was 
studied by Otterson and Guy [114] who recommended the use of different 
desorbing agents depending upon the comparative gas chromatograph retention
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times for the desorber and the contaminant. Carbon disulfide vas
determined to be the best desorbent for 1,1,1-trichloroethane collected in 
charcoal tubes. [114]
Liquids have been used to collect chlorinated hydrocarbons from 
contaminated atmospheres. Midget itnpingers containing m-xylene or
tetrachloroethylene have been used for collection in conjunction with gas 
chromatographic analysis, [114,115] and bubble bottles containing a
pyridine solution have been used for collection in conjunction with 
colorimetric analysis. [60] The successful use of lmplngers for 
collection of breathing zone samples requires careful handling of glassware 
during collection and shipment of samples to the laboratory to avoid 
spillage.
Other investigators have collected grab samples of contaminated
atmospheres directly in a variety of containers ranging from plastic bags 
to hypodermic syringes. [55,59,114]
(b) Analysis
Several methods have been used to quantify 1,1,1-trichloroethane in 
air samples. The analytical methods can be divided into two broad 
categories: (1) methods based on 1,1,1-trichloroethane chemical reactions,
and (2) methods based on its physicochemical characteristics.
The three chemical methods that have been used extensively are: (1)
dechlorination of collected vapor samples with strong alkalis followed by 
titration of the chloride ion (alkaline hydrolysis) [60,116]; (2)
Colorimetric measurement of the reaction products of tetrachloroethane and 
pyridine heated in alkali solution (Fujiwara reaction) [60,117]; and (3) 
direct reading colorimetric indicators. [55,61,118]
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The dechlorination method (alkaline hydrolysis) requires collection 
of the 1,1,1-trichloroethane contaminated atmosphere by a suitable 
collection medium followed by alkaline hydrolysis in isopropyl alcohol, and 
titration of the liberated chloride with silver nitrate. [116] The 
percentage of chlorine hydrolyzed is determined by comparison between 
samples and known controls. A disadvantage of this method is that chlorine 
is not easily removed from 1,1,1-trichloroethane and the amount removed 
depends on the duration of the dechlorination process. Another 
disadvantage is that it is not specific for 1,1,1-trichloroethane.
In the colorimetric analytical method based on the Fujiwara reaction, 
a stream of air containing 1,1,1-trichloroethane is passed through a bottle 
containing pyridine. [60] Potassium hydroxide is then added to a portion 
of the sample, and this mixture is heated in a boiling water bath and 
cooled during a fixed time period. A portion of the potassium hyroxide 
solution, to serve as a blank, is similarly heated and cooled. Absorption 
coefficients of the pyridine layer are determined with a spectrophotometer. 
This method requires less time than the dechlorination method, but the 
problem of specificity with mixtures of chlorinated hydrocarbons remains.
The third chemical method utilizes direct reading detector tubes. 
[60,61,118] These are glass tubes packed with chemicals that change color 
when a measured and controlled flow of air containing 1,1,1-trichloroethane 
passes through the chemical. Depending on the type of detector tube, the 
air may be drawn directly through the tube and compared with a calibration 
chart, or the air may be drawn into a pyrolyzer accessory prior to the 
detection tube. [118] In either case, the analysis is not specific for
1,1,1-trichloroethane since liberated halide ions produce the stain and any
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halogen or halogenated compounds will Interfere. Federal regulations on 
detector tubes provide that measurements with colorimetric indicator tubes 
shall be correct +25% of the values read (42 CFR 84.50).
Photodetection (halide meters), [119] infrared spectrometry, [120] 
and gas chromatography [115] are among the analytical methods that are 
based on the physicochemical properties of 1,1,1-trichloroethane.
Halide meters are made to detect the increased brightness of an arc 
across metal electrodes when they are enveloped by an atmosphere contam­
inated with halogens and halogenated compounds. These instruments are 
sensitive to all halogens and halogenated compounds and consequently they 
are not specific for 1,1,1-trichloroethane. Halide meters are suitable for 
continuous monitoring if 1,1,1-trichloroethane is the only halogenated 
contaminant present in the sampled air. [119]
An infrared spectrophotometer in conjunction with a suitable recorder 
can be used to document instantaneous concentrations or to record 
continuously. With this method, concentrations are measured directly and 
it is not necessary to collect individual samples or to transport them to a 
laboratory for analysis. Infrared spectrophotometry has been used for 
continuous monitoring of industrial operations for chlorinated 
hydrocarbons. [120] The atmosphere of relevant working stations must be 
sampled and must correspond to the breathing zone of the workers at the 
working stations. Infrared analysis is subject to interferences from other 
air contamiants and these interferences are not easily detected or 
resolved without substantial knowledge of infrared spectrophotometry.
Gas chromatography provides a quantitative analytical method which 
can be specific for different chlorinated hydrocarbons. [112] Every
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compound has a specific retention time in a given chromatography column, 
but several compounds in a mixture may have similar retention times. [121] 
This problem can be overcome by altering the stationary phase of the 
chromatography column or by changing the column temperature or other 
analytical parameters. Altering conditions usually will change the 
retention times and separate the components.
A mass spectrometer can be used subsequent to gas chromatography to 
identify the substance present in a gas chromatographic peak more 
positively. Linked gas chromatograph-mass spectrometer instruments perform 
this identification automatically. A charcoal capillary tube has been used 
to trap and transfer the material associated with a gas chromatographic 
peak to a mass spectrometer for qualitative identification when only 
unlinked units are available. [122]
A comparative study of a colorimetric method, a gas chromatographic 
method, and colorimetric detection tubes for analysis of 1,1,1-
trichloroethane was reported in 1970 by Fukabori. [55] The data are 
presented in Table XII-11. They suggest that the detector tubes give 
higher values than the other two methods used.
(c) Conclusions and Recommendations
(1) Compliance Method 
Based on this review of air sampling and analytical methods, it is 
recommended that 1,1,1-trichloroethane in air samples be collected with
activated coconut shell charcoal, desorbed with carbon disulfide, and 
analyzed by gas chromatography. Although the indirect system of
measurement which requires collection and desorption prior to analysis is a 
disadvantage, this sampling and analytic method has the following 
attributes:
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(A) Charcoal tubes are easy to prepare, ship, and
store.
(B) Estimation of exposure with personal samplers is
easily achieved.
(C) Desorption with carbon disulfide is efficient 
and reproducible. However, unusual care is required in the handling of 
carbon disulfide, to prevent Inhalation and skin contact, and ignition by 
sources such as steam pipes.
(D) 1,1,1-Trichloroethane can be identified in 
combination with many other compounds.
(E) At the sample volumes recommended, Interference 
by moisture is minimal.
(F) Sampling tubes and personal pumps are 
commercially available.
(2) Monitoring Methods 
Exposure to 1,1,1-trichloroethane associated with its continuous and 
constant use can be monitored by infrared spectrophotometry, portable gas 
chromatography or, if it is the only halogenated hydrocarbon in the 
workroom air, halide meters can be used. Air from representative work­
sites can be drawn directly into the infrared spectrophotometer or halide 
meter by a multiprobe sampling apparatus. A time-location study of the 
workroom at the different probe locations can be used to estimate TWA 
exposures to 1,1,1-trichloroethane.
Direct reading colorimetric tubes (gas detection tubes) can be used 
as an inexpensive way to monitor 1,1,1-trichloroethane concentrations. The 
tubes must be used as instructed by the manufacturer. They are not
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suitable for determining compliance with the standard, as variability is 
larger here than with chemical and GC methods.
Biologic Evaluation of Exposure
Three studies were reported of occupational exposure evaluation by 
analysis of breath for 1,1,1-trichloroethane or urine for trichlorinated 
compounds. [59-61]
Prost et al [59] collected alveolar air samples at the end of the 
work, day from 12 workers involved in a degreasing operation. The investi­
gators [59] considered that their study was adequate to make formal con­
clusions. They we^e able to differentiate a group of workers with higher 
exposure from another group with lower exposure.
Trichloroacetic acid concentrations in the urine of 15 workers were 
determined in a printing plant where the average daily exposure to 1,1,1- 
trichloroethane was 35 ppm. The average concentration of TCA found in the 
urine on the 3 days were 3.0-3.7 mg/liter.
Weitbrecht [61] found TCA concentrations of 20-60 mg/liter in the 
urine of seven women with 1,1,1-trichloroethane exposures estimated at 10- 
20 ppm, In this study, the atmospheric measurements were questionable and 
also the women were subjected to exposure through the skin.
Prost et al [59] also studied TCA excretion by workers and concluded 
it was not as reliable for evaluation of exposure as analysis of breath for
1,1,1-trichloroethane.
Experimental studies have shown considerable variation in results of 
breath analyses among investigators. [35,55,56] The concentrations in the 
breath depend upon past exposure history, exposure concentrations, exposure
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times, time since last exposure, physical activity during and after 
exposure, and Individual factors. [35,39,52,54-58]
Although considerable data have been collected, they have not been 
synthesized into useable form to be able to quantitatively evaluate 
exposure to 1,1,1-trlchloroethane by either breath or urine analysis.
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V. DEVELOPMENT OF STANDARD
Basis for Previous Standards
The first Threshold Limit Value (TLV) for 1,1,1-trichoroethane was 
published by the American Conference of Governmental Industrial Hygienists 
(ACGIH) in 1953. [123] The value set was a time-weighted average TWA of
500 ppm. The basis for this standard was not reported but most likely it 
was the work of Adams et al, [73] published in 1950. In 1959, Elkins [116] 
suggested a maximum allowable concentration (MAC) of 250 ppm, and cited the 
paper by Adams et al. [73]
The ACGIH published its first documentation for the TLV of 500 ppm 
for 1,1,1-trichloroethane in 1962. [124] This value was based on the
studies of Torkelson et al [36] and Stewart et il. [35] The ACGIH report 
concluded that to prevent lightheadedness, the 500 ppm limit should no!: be
exceeded for "appreciable periods."
A reduction of the TLV to 350 ppm was recommended by the ACGIH in 
1963 on basis of odor, complaints of other forms of irritation, and concerr 
for undue exposure to chlorinated hydrocarbons. [125,126]
The American Industrial Hygiene Association (AIHA) published 
Emergency Exposure Limits for 1,1,1-trichloroethane in 1964. [127] These
limits were 2,500 ppm for 5 minutes, 2,000 ppm for 15 and 30 minutes, and
1,000 ppm for 60 minutes. Exposures for the stated times at these 
concentrations "will cause definite anesthetic effects and incoordination 
but no organic injury is expected and recovery should occur within minutes 
after a subject is withdrawn from exposure." [127] The data from which the 
emergency limits were derived came from studies on the anesthetic
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trichloroethane [3,31-35] and the reports of Stewart et al, [35] Torkelson 
et al, [36] Stewart, [47] Rowe et al, [58] Plaa et al, [66] Adams et al, 
[73] and Rennick et al. [78]
The American National Standard Acceptable Concentrations of Methyl 
Chloroform (1,1,1-trichloroethane) (ANSI Z37.26-1970), [8] published In
1970, gave an acceptable TWA of 400 ppm for protection of health, assuming 
an 8-hour workday, an acceptable celling concentration of 500 ppm If the 
TWA was below 400 ppm, and a maximum peak above the celling of 800 ppm for 
not more than 5 minutes and not more than once In 2 hours. This standard 
was based on the reports of Stewart et al, [35] Torkelson et al, [36] 
Stewart, [47] Stewart and Dodd, [53] Adams et al, [73] Rennick et al, [78] 
and Prendergast et al. [85]
"Permissible Levels of Toxic Substances In the Working Environment" 
for many countries was published by the International Labour Office in 








Finland 2,700 500 8 hours continuous exposure
Germany (Fed Rep) 1,080 200 MAC
Japan 1,900 350 None stated
Yugoslavia 1,080 200 None stated
Rumania 1,000 185 None stated
Adapted from reference 128
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The documentation of the TLV of 350 ppm, originally given in 1966, 
[126] was updated in 1971. [129] Additional references cited in this
documentation were Irish, [14] Stewart et al, [39] Stewart, [47] Hatfield 
and Maykowski, [50] Rowe et al, [58] and Hake et al. [91]
The German Research Society MAK Commission published the criteria for 
its MAC standard for 1,1,1-trichloroethane in 1972. [130] The standard was 
200 ppm (1,080 mg/cu m) and it was reported to be an average, presumably a 
TWA for an 8-hour workday. This standard was based on experimental studies 
[35-37,39] of humans where subnarcotic effects were observed which could 
reduce a person's ability to work after repeated exposures lasting several 
hours. The studies cited included Stewart et al, [35,39] Torkelson et al, 
[36] and Salvini et al. [37]
The USSR MAC is 3.66 ppm (20.0 mg/cu m). [104]
The present US federal standard was adopted from "Threshold Limit 
Values of Airborne Contaminants for 1968." [131] It is an 8-hour time- 
weighted average of 350 ppm (1,910 mg/cu m) (29 CFR 1910.1000).
Basis for Recommended Environmental Standard
The recommended environmental action limit is based upon CNS 
responses to acute exposures [37, 38, 39] in man, cardiovascular and
respiratory effects associated with chronic exposures [85, 88] in several 
species, the similarity of pathologic changes in man and several animal 
species, and the absence of reported effects in man at concentrations below 
the proposed limit. [65, 64]
Impairment of the CNS, to the extent that escape would be impossible, 
has occurred experimentally in human subjects when the exposure
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concentration of 1,1,1-trichloroethane was increased from 0-2,650 ppm 
during 15 minutes. [35] Impaired coordination and balance have also been 
demonstrated in experimental exposures of human subjects to 1,1,1- 
trichloroethane at 900-1,000 ppm for 20 minutes or more. [35, 36]
Exposure at 250 ppm for 30 minutes followed immediately by exposure 
at 350 ppm for another 30 minutes resulted in impaired perceptual speed, 
reaction times, and manual dexterity. [38] These later findings [38] did 
not develop during the first 30 minutes of exposure at 250 ppm but exposure 
at this concentration for a longer period of time was not made. The study 
was also not conducted with repetitive exposures, and the effects of 
breathing the vapor through a mouthpiece and the use of menthol to disguise 
the odor of 1,1,1-trichloroethane were not assessed. The experiment with 
mice [74] indicated accumulative effects on the CNS of 1,1,1- 
trichloroethane exposure.
With exposures at 500 ppm, 7 hours/day for 5 days, CNS effects such 
as sleeplessness, lightheadedness, headache and an abnormal Romberg test 
were reported. [39]
Based on a case report of a fall resulting in injury associated with
1,1,1-trichloroethane exposure [51] and the experimental evidence that 
nervous system responses that might be manifested as accident proneness can 
occur with exposures at 450 ppm, [37] it is recommended that a ceiling 
exposure be established below this concentration.
1,1,1-Trichloroethane has been shown to have a direct effect on the 
cardiovascular system. [32, 46, 75, 76, 79, 80] The first response that 
has been detected upon administration of 1,1,1-trichloroethane was 
decreased peripheral resistance to blood flow. [80] The blood pressure
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fell within seconds and continued to fall as the heart lost its contractile 
strength. [79, 80] These effects have been found experimentally with 
concentrations of 8,000 ppm or more during exposures of no more than 5 
minutes.
Heart muscle from rats which had been anesthetized for 1 hour with
1.1.1-trichloroethane had impaired oxygen consumption, [32] and heart 
muscle from unexposed rats developed impaired contractility when exposed to
1.1.1-trichloroethane in the aeration mixture. [80] Fractional analysis of 
LDH from a patient poisoned with 1,1,1-trichloroethane showed that the 
heart was the major source of the increased amounts of this enzyme in the 
patient's blood. [46]
Autopsy findings of gross congestion and pulmonary edema in workers 
overcome by 1,1,1-trichloroethane exposures [49, 50] are evidence of
cardiovascular effects of the type observed experimentally, [79, 80] or 
clinically. [46] Neither blood pressure changes nor ECG changes were 
found in humans experimentally exposed to 1,1,1-trichloroethane at 
concentrations of 2,650 ppm or less. [35, 36] In other experimental human 
exposures, blood pressure and ECG changes were not reported. [37, 38, 39] 
There were no significant ECG findings in the four reported cases of acute 
occupational exposures [51] or the one reported case of 1,1,1- 
trichloroethance ingestion. [42]
Changes that may be attributable to cardiovascular insufficiency have 
been reported in chronic animal experiments. [74, 77] Congestion of the 
liver and lungs was found in mice after nine 2-hour/day exposures on 
alternate days to 1,1,1-trichloroethane at 1,000 ppm, [74] but these 
authors did not adequately describe their control techniques. A more
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recent study, repeating this work, has found neither congestion of the 
lungs nor liver, nor traces of inflammation around the biliary duct area. 
[132] Nonspecific inflammatory changes have been reported in several
species exposed at 370 ppm continuously for 90 days. [85]
Human exposures at an average TWA concentration of 115 ppm 1,1,1- 
trichloroethane have been reported by Kramer et al [64] in workers exposed 
for 8 hours/day, 5 days/week for up to 5 years. Upon laboratory testing 
(hematology, blood chemistry, urinalysis and ECG) as well as medical
Interviews, no adverse effects were reported.
Exposures of humans at 4 to 53 ppm in four Japanese printing plants 
have been reported by Seki et al. [65] The investigators reported tests of 
vibrational sense, routine laboratory examinations in hematology and 
urinalysis, and medical interviews. No adverse effects were reported at 
these concentrations.
No adverse health effects were reported in the study by Kramer et al 
[64] when workers were exposed at 1-175 ppm 1,1,1-trichloroethane. Some of 
these workers had, for 1-2 years, previously been exposed at concentrations 
as high as 838 ppm, and if there had been any effects at the time, recovery 
had occurred because the subjects were reported to be healthy when the 
study began. To some extent, animal studies support these observations in 
exposed workers. Significant findings were not demonstrated in rats, mice, 
dogs and monkeys exposed at 250 ppm continuously for 90 days [84] and only 
minimal findings at 370 ppm continuously for 90 days. [85] In another 
study, minimal effects were reported in hepatic function of mice exposed 
continuously for 14 weeks at 250 ppm. [41] Other Investigators have not 
reported any significant effects at similar levels in man and animals. 
[35,36,38,132]
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Respiratory irritation has been reported in man and several other 
species. At 400 ppm eye, nose and throat irritation have been experienced 
by subjects during exposure to 1,1,1-trichloroethane. [35,37] Varying 
degrees of lung congestion were found in all species exposed continuously 
for 90 days to 1,1,1-trichloroethane at 135 ppm. [85] The authors stated, 
however, in view of pneumonitis in the surviving animals and in the control 
group, that no positive conclusions could be drawn connecting the 1,1,1- 
trichloroethane exposure to the effects. Irritation of the upper 
respiratory tract was reported among women during occupational exposure to
1,1,1-trichloroethane. [61] No other studies of respiratory disease
associated with chronic occupational exposure to 1,1,1-trichloroethane have 
been reported. The recommended ceiling limit should protect workers from 
acute irritation effects, but it is not known if it will protect them from 
chronic respiratory effects.
From the data presented above, it is evident that a ceiling should be 
placed on occupational exposure to 1,1,1-trichloroethane. Evidence of CNS 
response at 450 ppm [37] and minimal to no response at 250 to 350 ppm [38]
leads to the conclusion that 350 ppm is a reasonable ceiling concentration.
This ceiling will assure a safe TWA as excursions above the action level 
will not lead to the chronic effects described in humans and animals.
Although information on workers exposed to 1,1,1-trichloroethane for over 6 
years is sui.-e, workers who had experienced TWA's of 217 ppm for up to 6 
years showed no adverse effects, and thus it is unnecessary to recommend a 
TWA limit below 350 ppm to prevent chronic effects. To provide some 
assurance that the environmental limit is not exceeded, an action level of 
200 ppm is recommended.
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It is recognized that many workers handle small amounts of 1,1,1- 
trichloroethane or work in situations where, regardless of the amounts 
used, there is only negligible contact with the substance. Under these 
conditions, it should not be necessary to comply with all the provisions of 
this recommended standard. However, concern for worker health requires 
that protective measures be instituted below the enforcable limit to ensure 
that exposures stay below that limit. Therefore, environmental monitoring 
and recordkeeping is recommended for those work situations which involve 
exposure above the recommended action level of 200 ppm determined as a TWA 
for a 10 hour-day, 40 hour-week, to delineate work areas that do not 
require control of inhalation hazards. The environmental action level has 
been chosen on the basis of professional judgment rather than on 
quantitative data that delineate nonhazardous areas from areas in which a 
hazard definitely exists.
In view of Individual variation in human response to noxious 
substances, as well as the variation in worker exposure to 1,1,1- 
trichloroethane, NIOSH recommends comprehensive preplacement and annual 
examinations be made available to all workers exposed to 1,1,1- 
trichloroethane. In certain cases, a given individual may exhibit symptoms 
warranting a more frequent examination schedule. Recognition of the 
selective hazard to the nervous, hepatic and cardiovascular systems leads 
to emphasis of these factors for any physical examination.
For the medical program to be effective, it is important that the 
worker recognize the signs and symptoms as well as hazards of working with
1,1,1-trichloroethane. At the onset of specific symptoms attributable to 
exposure, the physician should be consulted. Thus, NIOSH recommends that
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employees be informed of health hazards and that warning signs be posted in 
appropriate locations in plants where 1,1,1-trichloroethane is 
manufactured, used or stored. Further information should be transmitted 
through a continuing educational program instituted by the employer.
During day-to-day work, where the occurrence of spills, spray., and 
splashes, as well as the generation of high concentrations of 1,2,1- 
trichloroethane in accidental and emergency situations, is likely to occur, 
appropriate control measures need to be taken. To prevent the escape of 
hazardous quantities of 1,1,1-trichloroethane, various engineering control 
procedures are recommended to contain the chemical and ensure safe working 
habits in the vicinity of its use, manufacture and storage. These work 
practices include handling, storage, ventilation, maintenance of equipment, 
personal hygiene and emergency procedures. Due to the hazard of a bui du.p 
of 1,1,1-trichloroethane concentration above the environmental ceiling in 
small work areas, special instructions are given for working in confined 
spaces.
To monitor the concentration of 1,1,1-trichloroethane, it is 
necessary to periodically sample the employees’ breathing zone air. NIOSH 
has reviewed the literature on sampling and analytical methods in chapter 
IV and has recommended the sampling and analytical method presented in 
Appendices I and II.
Although it is known that many potentially harmful substances used in 
industry enter the maternal bloodstream and are capable of crossing the 
placenta, there is insufficient evidence at this time to exclude women of 
childbearing age from working in areas where 1,1,1-trichloroethane is 
manufactured, stored, or used. Data are available from only one study in
117
rats and mice, and although cleft palate, supernumerary vertebra, and split 
sternebra occurred, the lack of new data, ie number of animals per litter, 
and confirmation from other studies, precludes a firm statement of 
teratogenicity. The incidence of these abnormalities in large samples of 
these strains of rats and mice is not known. The observation of these 
abnormalities in this small sample experiment is not sufficient to warrant 
special restriction of women of child bearing age. Based on the 
insufficiency of the experiment, it is not recommended that pregnant 
females be advised of any potential hazard unless a repetition of the 
experiment provides confirmation of the results.
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VI. WORK PRACTICES
Information concerning work practices for 1,1,1-trichloroethane can 
be found in the Manufacturing Chemists Association Safety Data Sheet SD-90. 
[15] Information on work practices for some specific uses is also 
available. [106,133]
(a) Transport, Handling, and Use
1,1,1-Trichloroethane may be stored in mild steel containers or, if 
there is excess moisture in the ambient air, in stainless steel or resin- 
lined containers. It can be decomposed to toxic and corrosive compounds 
including phosgene and hydrochloric acid by contact of liquid or vapor with 
open flame or red-hot surface, so it should be appropriately stored and 
handled to prevent such contact. [134,135] Damaged drums or other storage 
or transporting containers should not be welded until thoroughly purged 
with steam, flushed with water, and air dried. [136]
All piping and valves at the loading or unloading station should be 
of material resistant to 1,1,1-trichloroethane and should be carefully 
inspected prior to connection to the transport vehicle and periodically 
during the operation. Personal protective clothing must be provided during 
both inspection and connection. Information on imperviousness of some 
materials to 1,1,1-trichloroethane is available. [137] Eye wash and safety 
shower installations should be readily available in the immediate area. 
Signs indicating the location of safety showers and eye wash facilities 
should be prominently displayed throughout the work area. Unloading areas 
must be posted "DANGER: LOADING OR UNLOADING 1,1,1-TRICHLOROETHANE."
119
Due to the toxicity of 1,1,1-trichloroethane, processes in which it 
is used in large quantities should be carried out in closed systems. Well 
designed hoods and ventilation systems should be used to maintain exposures 
at or below concentrations specified by this recommended standard. Further 
protective measures include the use of personal protective equipment and 
clothing and purging of equipment prior to and during servicing and 
maintenance.
Safety showers are desirable and eye wash facilities are necessary 
in areas where 1,1,1-trichloroethane is handled. In locations where such 
facilities are not available, a container of water for emergency use must 
be kept with the first aid supplies.
(b) Equipment Maintenance
All equipment used for handling 1,1,1-trichloroethane must be emptied 
and purged prior to entry or disassembly. Steaming followed by washing 
with water is recommended for purging tanks and other containers which have 
held 1,1,1-trichloroethane. Pipe lines should be disconnected and capped. 
Under conditions where it is necessary to enter highly contaminated areas 
or otherwise work with 1,1,1-trichloroethane contaminated equipment, 
maintenance personnel must use either a self-contained breathing apparatus 
of the pressure demand mode, with an impervious protective suit, or a 
combination supplied air suit with auxiliary self-contained air supply. 
Ventilation should be continued during this time by blowing or drawing 
fresh air through the system. Safety precautions for emergency rescue 
require that all maintenance personnel be informed of the toxic properties 
of 1,1,1-trichloroethane and be instructed on the necessity of wearing 
personal protective equipment. Constant observation of anyone entering a
tank should be maintained in case rescue work is necessary.
(c) Emergencies
Spills must be anticipated. Storage tanks should be diked to contain 
the contents of the tank. Drum storage areas must also be diked to contain 
the volume of 1,1,1-trichloroethane present in the drums to prevent release 
to other areas. Areas where major spills are likely to occur should be 
constructed so that they may be closed until properly protected personnel 
can ventilate, enter, and clear the area. Warning signs must be posted so 
that unauthorized personnel will not enter the area. Normal work should 
not be continued until the concentration of 1,1,1-trichloroethane has been 
reduced to the recommended workplace environmental limit. Any combustion 
operations must be stopped until the spill is cleared. Disposal of 1,1,1- 
trichloroethane must be performed in compliance with local, state, and 
federal waste disposal regulations. Consideration should be given to 
pumping the diked spill to another tank. In addition, it is advisable to 
have facilities for transfer of the contents of a leaking tank to another 
suitable tank.
Areas in which small spills have occurred should be evacuated and 
well-ventilated. Small, portable fans may be used in confined areas where 
local exhaust ventilation is not feasible. Workers should not return to 
any work area if the odor of 1,1,1-trichloroethane is still perceptible 
without the concentration being determined first.
(d) Respiratory Protection
For adequate respiratory protection against the many conditions which 
may be encountered in individual operations, many types of respirators have 
been developed and approved. Each has a particular application and
121
limitations from the viewpoint of protection, as well as advantages and 
disadvantages from the viewpoint of operational procedures and maintenance. 
Detailed information on the selection and use of respirators can be
obtained from the Respiratory Protection Devices Manual [138] published by 
the AIHA and the ACGIH in 1963. The American National Standards Practices 
for Resporatory Protection, ANSI Z88.2-1969, [139] also classifies,
describes, and gives the limitations of respirators.
There are three categories of respirators: atmosphere-supplying
respirators, air-purifying respirators, and combination atmosphere- 
supplying and air-purifying respirators.
One factor that affects the overall performance of demand-type
(negative pressure) respirators is the variability of the face seal. 
Facepiece leakage is the major limitation of half-mask and quarter-mask 
facepieces operated with a negative pressure.
For uniform regulations covering the many face sizes and shapes of 
the US population, NIOSH recommends that the half-mask or quarter-mask 
facepieces operated with a negative pressure not be used for protection 
above 10 times the TWA environmental limit, although the majority of
wearers can obtain protection in atmospheres of higher 1,1,1- 
trichloroethane concentrations. On the same basis, NIOSH recommends that 
the full facepiece, operated with negative pressure, may be used up to 50 
times the TWA concentration limit. As eye irritation has been reported at 
concentrations of 500 ppm 1,1,1-trichloroethane, it is recommended that 
full facepiece respirators be used above this level. Due to the adequate 
warning nature of 1,1,1-trichloroethane, air-purifying respirators, such as 
the chemical cartridge type, may be used at concentrations less than 500
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ppm. When significant and nonreversible health effects may occur, at 1,000 
ppm and .-bove, ee if-contained breathing apparatus or supplied-air 
r e s p i r a w i t h  a full facepiece must be used,
Tii-’ maximum use concentration guides do not take into account the 
service Lite of the filters or absorbent canisters which also affect the 
performance of air--purifying respirators. The approval tests (under 30 CFR 
11) for these two devices specify only carbon tetrachloride for the service 
life test. Based or, recent tests by Nelson and Harder, [140] who tested 
standard respirator cartridges against many types of industrial organic 
solvents, it is now possible to estimate the service life of approved 
organic vapor canisters or cartridges against 1,1,1-trichloroethane. With 
a test concentration of 1,000 ppm of 1,1,1-trichloroethane, they reported 
that the standard organic vapor cartridge has a service life of 59 minutes 
before a breakthrough 100 ppm of 1,1,1-trichloroethane. Under the same 
test conditions, a service life of 90 minutes for carbon tetrachloride was 
obtained. The standard industrial size gas mask canister is tested against
20,000 ppm of carbon tetrachloride and it must have a service life of 12 
minutes before a breakthrough of 5 ppm. Since it has been shown that 
charcoal can absorb 1.5 times as much carbon tetrachloride as 1,1,1- 
trichloroethane, it can be estimated that the service life for an 
industrial size canister is 150 minutes in an atmosphere of 1,000 ppm
1,1,1-trichloroethane.
NIOSH periodically issues a list of approved or certified respiratory 
protective devices. All devices approved by the Bureau of Mines are listed 
Information Circular 8559 and supplements. All types of devices 
sertified by the Testing and Certification Laboratory of NIOSH are listed
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in separate publications. These are available from the Testing and 




The evidence from epidemiologic studies is somewhat contradictory. 
Several studies [36,47,50,62,64] reported no adverse effects in man at 
concentrations of 100-800 ppm of 1,1,1-trichloroethane. Unfortunately, 
individual data is lacking in some, and experimental details are lacking in 
all of these studies.
Interpretation is further complicated by other studies [61,63] which 
report symptoms attributable to "substances used in the work environment,'1 
not necessarily 1,1,1-trichloroethane, at 10-250 ppm. These studies suffer 
from (1) exposure to vapors in addition to those of 1,1,1-trichloroethane
(2) inadequate characterization of exposure concentrations and (3) 
intervening variables such as skin exposure and psychological effects. 
Therefore, carefully controlled, cross-sectional studies, which report 
individual data, adequately characterize the environment and control for 
exposure to airborne contaminants other than 1,1,1-trichloroethane, should 
be conducted.
Chronic Animal Studies
Although a number of animal studies have indicated chronic changes in 
the heart, [77] nervous reflex activity, [7 7] respiratory function,
[77,85,88] and hepatic anatomy [41,77,88] resulting from "long term" 
exposure to 1,1,1-trichloroethane, most of these studies have used 
continuous exposures, which are not typical of the occupational setting.
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Therefore, studies Investigating the chronic effects of long term exposure 
to 1,1,1-trichloroethane should be conducted that utilize exposure 
schedules similar to those observed in industry, ie, an 8 to 10-hour day, 5 
days per week.
Mutagenicity. Teratogenicity. Carcinogenicity
As only one study was available on teratogenicity [103], further 
studies are needed concerning the influence of 1,1,1-trichloroethane upon 
the mother and fetus. While it has not been determined if 1,1,1- 
trichloroethane is teratogenic, mutagenic, or carcinogenic in man, and it 
is not known what the tolerated dose of 1,1,1-trichloroethane is In the 
embryo or fetus, there is little doubt that many detrimental substances in 
the maternal bloodstream can readily reach the embryo or fetus via the 
placenta. As 1,1,1-trichloroethane concentrations in the occupational 
environment will lead to small but measurable concentrations of this 
substance in the bloodstream, additional information is needed.
A study by Dow Chemical Company in rats was Inconclusive, as 
spontaneous neoplastic lesions occurred in both control and experimental 
groups. [90] A carcinogenesis study, as yet incomplete, by the National 
Cancer Institute may provide more data.
Synergistic Effects
From a review of the literature, it is evident that research must be 
initiated to answer important questions concerned with exposure to 1,1,1- 
trichloroethane and that a concerted effort must be directed toward
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determining the possible additive, synergystic, or inhibitory effects of
1,1,1-trichloroethane, in combination with other hydrocarbons and organic 
solvents, on dose-response relationships.
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FOR COLLECTION OF 1,1,1-TRICHLOROETHANE
General Requirements
(a) Air samples representative of the breathing zones of workers 
should be collected to characterize the exposure from each job or specific 
operation in each work area.
(b) Samples collected should be representative of exposure of
individual workers.
(c) Suggested records:
(1) The date and time of sample collection.
(2) Sampling rate and duration.
(3) Total sample volume.
(4) Location of sampling.
(5) Temperature, pressure, and relative humidity at time of
sampling.
(6) Other pertinent information.
Sampling
(a) Samples should be collected as near as practicable to the
faces of workers without interfering with freedom of movement.
(b) Samples should be collected to permit determination of TWA
workday and ceiling exposures for every job involving exposure to 1,1,1- 
trichloroethane in sufficient numbers to express the variability of the 
exposures for the work situation.
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(c) Apparatus for Charcoal Tube Sampling
(1) Pump, battery-operated, complete with clip for attach­
ment to the worker.
(2) Charcoal tubes: glass tube with both ends flame-
sealed, 7 cm long with a 6-iuni O.D., and a 4-mm I.D., containing two 
sections of 20/40 mesh activated coconut-shell charcoal, fired at 600 C, 
separated by a 2-mm portion of urethane foam. The first is the adsorbing 
section and contains 100 mg of charcoal from coconut shells. The second, 
or reserve section, contains 50 mg. A 3-mm portion of urethane foam is 
placed between the outlet of the tube and the reserve section. A plug of 
silated glass wool is placed in front of the adsorbing section. The 
pressure drop across the tube when in use must be less than 1 inch of 
mercury at a flowrate of 1 liter/min.
(d) Calibration of Sampling Instruments
(1) Air sampling instruments should be calibrated with a
representative charcoal tube in line, over a normal range of flowrates (25— 
1000 ml/min). Calibration curves must be established for each sampling 
pump and be used in adjusting the pump prior to and during each field use. 
Airflow through the pump should be within +5% the desired rate. New 
calibration curves should be established for each sampling pump after 
making any repairs or modifications to the sampling system.
(2) The volumetric flowrate through the sampling system
should be spot-checked and the proper adjustments made before and during 
each study to ensure obtaining accurate airflow data.
141
(1) Immediately before sampling, break both ends of the 
tube to provide openings at least one-half the internal diameter of the 
tube (2 mm).
(2) The smaller section of charcoal Is used as a reserve 
and should be positioned nearest the sampling pump.
(3) The charcoal tube should be placed in a vertical posi­
tion during sampling, to prevent channeling which would result in sample 
loss.
(4) Tubing may be used to connect the back of the tube to 
the pump, but air being sampled should not be passed through rubber or 
plastic hose or tubing before entering the charcoal tube.
(5) The sample can be taken at flowrates of 25-1000 ml/min,
depending on the pump. Total sample volumes of less than 35 liters are 
recommended, eg, a sample could be collected at 200 ml/min for 15 minutes 
to give a total sample of 3 liters, or at 25 ml/min for 24 hours to give a 
total sample volume of 36 liters. However, for determining the action
level, it is also recommended that each sample be collected in 4 hours or
less.
(6) The charcoal tubes should be capped with inert plastic
caps immediately after sampling. Under no circumstances should rubber caps 
be used.
(7) One charcoal tube, to serve as an analytical blank,
should be handled in the same manner as the sample tube (break, seal, and
transport) except that no air is passed through this tube.
(e) Collection and Handling of Samples
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X. APPENDIX II - ANALYTICAL PROCEDURES FOR DETERMINATION 
OF 1,1,l-TRICHLOROETHANE
Principle of the Method
(a) A known volume of air is drawn through a charcoal tube to trap
the 1,1,1-trichloroethane vapor.
(b) The 1,1,1-trichloroethane is desorbed from the charcoal with
carbon disulfide.
(c) An aliquot of the desorbed sample is injected into a gas
chromatograph.
(d) The area of the resulting peak is determined and compared with
areas obtained from the injection of standards.
Range and Sensitivity
(a) The lower limit for detection of 1,1,1-trichloroethane on a
gas chromatograph with a flame ionization detector is 300 ng/sample.
(b) The upper limit value for 1,1,1-trichloroethane is 36.0
mg/sample. This is the estimated amount of 1,1,1-trichloroethane which the
front section will hold before this compound breaks through to the reserve 
section of charcoal. If a particular atmosphere is suspected of containing 
a high concentration of 1,1,1-trichloroethane, it is recommended that a 
smaller volume of air be sampled.
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Interferences
(a) 1,1,1-Trichloroethane will not be trapped when the amount of 
water In the air is so great that condensation occurs in the charcoal 
sampling tube.
(b) Any compound which has the same retention time as 1,1,1- 
trichloroethane with the chromatographic conditions described in this 
method could interfere. Such interferences may be eliminated by altering 
operating conditions of the gas chromatograph using a different column 
packing or using a selective detector.
Advantages of the Method
(a) This method provides one basic procedure for determining many 
different organic compounds.
(b) The sampling device is small, portable, and involves no 
liquids.
(c) The analysis of the tubes can be accomplished rapidly.
Disadvantages of the Method
(a) The amount of sample which can be taken is limited by the 
weight of 1,1,1-trichloroethane which the tube will hold before 
overloading.
(b) When the sample value obtained for the reserve section of 
charcoal exceeds 25% of that found on the front section, the possibility of 
appreciable sample loss exists.
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(c) Other organic compounds in high concentrations may displace
1,1,1-trichloroethane from the charcoal.
Apparatus
(a) Gas chromatograph equipped with a flame ionization detector.
(b) Stainless steel column (20 ft x 1/8 in) with 10% free fatty 
acid polymer (FFAP) stationary phase on 80/100 mesh chromosorb (or 
equivalent), acid washed and treated with dimethyldichlorosilane.
(c) A recorder and some method for determining peak area.
(d) Glass stoppered microtubes of 2.5-ml capacity or 2-ml vials 
that can be sealed with inert caps.
(e) Microsyringe of 10-^1 capacity, and convenient sizes for 
making standards.
(f) Pipets, 0.5-ml delivery pipets or 1.0-ml pipets graduated in
0.1-ml increments.
(g) Volumetric flasks of 10-ml capacity or convenient sizes for 
making standard solutions.
Reagents
(a) "Spectroquality" carbon disulfide.
(b) 1,1,1-Trichloroethane, preferably "chromatoquality" grade.
(c) Bureau of Mines Grade A helium or nitrogen.
(d) Prepurified hydrogen.
(e) Filtered compressed air.
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Analysis of Samples
(a) All equipment used In the analysis should be washed In
detergent followed by appropriate tap and distilled water rinses.
(b) Preparation: Each charcoal tube Is scored with a file In
front of the first section of charcoal and broken open. The glass wool is
removed and discarded. The charcoal in the first (larger) section is 
transferred to a small stoppered vial. The separating foam is removed and
discarded; the second section is transferred to another similar test tube.
These two sections are analyzed separately. Prior to analysis, 0.5 ml of 
carbon disulfide is pipetted (not by mouth) into each test tube to desorb
1,1,1-trichloroethane from the charcoal. A desorbtlon time of 30 minutes, 
with occasional stirring, is recommended.
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES WHEN USING CARBON
DISFULIDE BECAUSE OF ITS HIGH TOXICITY AND FIRE AND EXPLOSION
HAZARDS. IT CAN BE IGNITED BY HOT STEAM PIPES. ALL WORK WITH
CARBON DISULFIDE MUST BE PERFORMED UNDER AN EXHAUST HOOD.
(c) Typical chromatographic operating conditions:
(1) 50 ml/min (70 psig) helium carrier gas flow.
(2) 65 ml/mln (24 psig) hydrogen gas flow to detector.
(3) 500 ml/min (50 psig) airflow to detector.
(4) 200 C injector temperature.
(5) 200 C manifold temperature (detector).
(6) 60 C isothermal oven or column temperature.
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(d) Injection: The first step in the analysis is the injection of 
the sample into the gas chromatograph. To eliminate difficulties arising 
from blowback or distillation within the syringe needle, the solvent flush 
injection technique is employed. The 10-jul syringe is first flushed with 
carbon disulfide several times to wet the barrel and plunger. Three 
microliters of carbon disulfide are drawn into the syringe to increase the 
accuracy and reproducibility of the injected sample volume. The needle is 
removed from the carbon disulfide solvent, and the plunger is pulled back 
about 0.2 nl to separate the solvent flush from the sample with a pocket of 
air to be used as a marker. The needle is then immersed in the sample, and 
a 5-/il portion is withdrawn, taking into consideration the volume of the 
needle, since the sample in the needle will be completely injected. After 
the needle is removed from the sample and prior to injection, the plunger 
is pulled back a short distance to minimize evaporation of the sample from 
the tip of the needle. Duplicate injections of each sample and standard 
should be made. No more than a 3% difference in area is to be expected.
(e) Measurement of area: The area of the sample peak is 
determined and preliminary sample results are read from a standard curve 
prepared as discussed below.
Determination of Desorption Efficiency
It is necessary to determine the percentage of 1,1,1-trichloroethane 
on the charcoal that is removed in the desorption process. This desorption 
efficiency is determined once for a given compound provided the same batch 
of charcoal is always used.
Activated charcoal, equivalent to the amount in the first section of
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the sampling tube (100 mg), is measured into a 2-inch long tube, with an
I.D. of 4 mm, flame-sealed at one end. This charcoal must be from the same 
batch as that used in obtaining the samples and can be obtained from unused 
charcoal tubes. The open end is capped with inert plastic. A known amount 
of the compound is injected directly into the activated charcoal with a 
microliter syringe, and the tube is capped with inert plastic.
At least five tubes are prepared in this manner and allowed to stand 
at least overnight to ensure complete adsorption of 1,1,1-trichloroethane 
onto the charcoal. These five tubes will be referred to as the "desorption 
samples." A parallel blank tube should be treated in the same manner 
except that no 1,1,1-trichloroethane is added to it. The desorption 
samples and blanks are desorbed and analyzed in exactly the same manner as 
previously described.
Two or three desorption standards are prepared for analysis by 
Injecting the same volume of 1,1,1-trichloroethane into 0.5 ml of carbon 
disulfide with the same syringe used in the preparation of the desorption 
samples. These are analyzed with the desorption samples.
The desorption efficiency equals the difference between the average 
peak area of the desorption samples and the peak area of the blank divided 
by the average peak area of the desorption standards, or
desorption efficiency ■ area of sample - area of blank
area of standard
Calibration and Standards
It is convenient to prepare standards in terms of mg 1,1,1-
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trichloroethane/0.5 ml of carbon disulfide because samples are desorbed in 
this amount of carbon disulfide. To minimize error due to the volatility 
of carbon disulfide, 20 times the weight can be injected into 10 ml of car­
bon disulfide. For example, to prepare a 0.3 mg/0.5 ml standard, 6.0 mg of
1,1,1-trichloroethane is injected into exactly 10 ml of carbon disulfide in 
a glass-stoppered flask. The density of 1,1,1-trichloroethane (1.2528 
g/ml) is used to convert 6.0 mg into microliters for easy measurement with 
a microliter syringe. A series of standards is prepared, varying in 
concentration over the range of interest and analyzed under the same gas 
chromatographic conditions and during the same time period as the unknown 
samples. Curves are established by plotting concentration versus average 
peak area.
Calculations
(a) The weight in mg corresponding to the peak area is read from 
the standard curve. No volume corrections are needed, because the standard 
curve is based on mg l,l,l-trichloroethane/0.5 ml carbon disulfide, and the 
volume of sample injected is identical to the volume of the standards in­
jected.
(b) Separately determine the weights of 1,1,1-trichloroethane on 
the front and reserve sections of the charcoal tube.
(c) Corrections must be made to the 1,1,1-trichloroethane weights 
determined on both the front and reserve sections for the weights of the 
respective sections of the blank charcoal tube.
(1) Subtract the weight of 1,1,1-trichloroethane found on 
the front section of the blank charcoal tube from the weight of 1,1,1-
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trlchloroethane found on the front section of the sample charcoal tube to
give a corrected front section weight.
(2) Subtract the weight of 1,1,1-trlchloroethane found on 
the reserve section of the blank charcoal tube from the weight of 1,1,1- 
trichloroethane found on the reserve section of the sample charcoal tube to 
give a corrected reserve section weight.
(3) Add the corrected amounts of 1,1,1-trlchloroethane 
present on the front and reserve sections of the sample tube to determine 
the total measured 1,1,1-trlchloroethane in the sample.
(4) Divide this total weight by the determined desorption 
efficiency to obtain M, the total mg per sample.
(d) Convert the liters of air sampled (V) to volume (V') at
standard conditions of 25 C and 760 mm Hg, as follows:
V' - 298VP - 0.392VP
760(T+273) (T+273)
Where:
V' - volume of sampled air in liters at 25 C and 760 mm Hg
V - measured volume of sampled air in liters
P ■ barometric pressure in mm Hg, measured at time of 
sampling
T - temperature of air In degree Celsius, measured at 
time of sampling
(e) The concentration of 1,1,1-trlchloroethane in the sampled air 
can be expressed in various ways using M, the weight of 1,1,1- 
trichloroethane obtained in (c)(4), and V', the standardized sample volume, 
obtained in (d), as follows:
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(1) mg/liter « M/V'
(2) mg/cu m - ¿£g/liter - 1,000 M/V*
(3) ppm = 247 M/V'
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XI. APPENDIX III 
MATERIAL SAFETY DATA SHEET
General Instructions for preparing a Material Safety Data Sheet 
(MSDS) are presented in this chapter. The examples used in the text are 
for illustrative purposes and are not intended to apply to any specific 
compound or product. Applicable information about a specific product or 
material shall be supplied in the appropriate block of the MSDS.
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read 
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the guidelines in 
Chapter V, Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company Identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of 
Section I* The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a
single component product must have the name of the material repeated in
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, ie, "100 ppm LC50 rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flammable or reactive data
competitor's trade name need not be listed.
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could be flash point, shock sensitivity, or other brief data indicating
nature of the hazard.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point In degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury
(mmHg); vapor density of gas or vapor (air ■ 1); solubility in water, In
parts/hundred parts of water by weight; specific gravity (water ■ 1);
percent volatiles (Indicate if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This Information is 
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate
identification of substances stored in Improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flash point and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a time-weighted average 
(TWA) concentration, as a permissible exposure, or by some other indication 
of an acceptable limit. Other data are acceptable, such as lowest LD50 if 
multiple components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, irritation, and cracking.
Readily absorbed through the skin with severe systemic effects.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed workers.
(e) Section V. Health Hazard Information
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The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall Include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect workers assigned to cleanup 
detail. Specific neutralizing chemicals or procedures should be described 
In detail. Disposal methods should be explicit including proper labeling 
of containers holding residues and ultimate disposal methods such as 
"sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal anti-pollution ordinances" are proper but not 
sufficient. Specific procedures should be Identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Tes," "No," or "If Necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. Specify 
respirators as to type and NIOSH or US Bureau of Mines approval class, ie, 
"Supplied air," "Organic vapor canister," "Suitable for dusts not more 
toxic than lead,” etc. Protective equipment must be specified as to type 
and materials of construction.
(£) Section VI. Reactivity Data
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"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to workers 
potentially exposed to the hazardous material. The MSDS can be used as a 
training aid and basis for discussion during safety meetings and training 
of new employees. It should assist management by directing attention to 
the need for specific control engineering, work practices, and protective 
measures to ensure safe handling and use of the material. It will aid the 
safety and health staff in planning a safe and healthful work environment 
and in suggesting appropriate emergency procedures and sources of help in 
the event of harmful exposure of employees.
(i) Section IX. Special Precautions
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PHYSICAL PROPERTIES OF 1,1,I-TRICHLOROETHANE






Molecular formula CH3 CC1 3
Formula weight 133.41
Bolling point 74.0 C (165.2 F) (760 mm Hg)
Melting point -32.62 C (-26.7 F)
Vapor density 4.6 (air ■ 1)
Specific gravity 1.339 (20 C), (water ■ 
1.000 at 4 C)
Solubility 0.44g/100g water at 25 C; 
soluble in ethyl ether, 
ethyl alcohol
Density of saturated air 1.6 (air - 1)
Concentration of saturated air 16.7% by volume at 25 C
Flammable (explosive) limits 10-15% in air with hot wire 
ignition
Flash point None
Autoignition temperature 500 C (932 F)








PHYSICAL PROPERTIES OF 1,1,l-TRICHLOROETHANE
Conversion factors, 1 mg/liter = 1 g/cu m = 183 ppm
(25C 760 mm Hg) 1 ppm = 5.46 mg/cu ra = 5.46 /ug/liter
Adapted from references 1,5,6,8,12-15
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CONCENTRATIONS OF 1,1,1-TRICHLOROETHANE 
IN BLOOD OF EXPOSED SUBJECTS
TABLE XII-2
Arterial Venous No. of
Blood, ppm Blood, ppm Subjects
Mean SD Mean SD
250 ppm
rest 36.5 ft-lbs/sec 3.0 + 0.2 1.4 + 0.2 12
exercise, 4.5 + 0.2 3.1 + 0.4 9
73.0 ft-lbs/sec 5.2 + 0.1 3.5 + 0.8 4
exercise
109.5 ft-lbs/sec 5.5 + 0.3 4.4 + 0.4 4
350 ppm
rest 5.0 + 0.5 3.0 + 0.6 5
exercise
36.5 ft-lbs/sec 7.2 + 0.4 4.0 + 6.6 5
250 ppm
rest 1.9 2.5* 0.5 1.2* 3
rest -4- 4Z CO2 3.0 - 3.9* 0.9 - 1.3* 3
exercise + 4Z C02 3.2 4.5* 1.4 2.3* 3
* Range is presented by authors when n<3. 
Adapted from Astrand et al [54]
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TABLE XII-3
EFFECTS OF 1,1,1-TRICHLOROETHANE EXPOSURE* AT 875 ppm 
ON REPRODUCTION DATA OF RATS AND MICE
Rats Mice
Control Exposed Control Exposed
Number of litters 30 23 26 13
Corpora lutea/dam 15 + 2 14 + 2 — —
Implantation sites/ 
litter 13 + 2 11 + 4 14 + 2 14 + 2
Live fetuses/litter 12 + 3 10 + 4 12 + 2 12 + 2
%, resorptions/ 
implantation sites 4 (16/378) 7 (19/255) 10 (39/369) 8 (14/175)
%, litters with 
resorptions 40 (12/30) 56 (13/23) 69 (18/26) 77 (10/13)
Litters totally 
resorbed 0/30 0/23 0/26 1/13
Resorptions/litters 
with resorptions 1.3 (16/12) 1.5 (19/13) 2.2 (39/18) 4.3 (26/6)
Sex ratio, M:F 54:46 53:47 54:46 47:53
Fetal body weight, g 5.42 + 0.45 5.86 + 0.32 1.30 + 0.08 1.27 + 0.13
Fetal crown-rump 
length, mm 43.5 + 1.4 44.0 + 0.7 26.2 + 0.8 25.6 + 1.0
* Also Includes 50 ppm impurities and inhibitors 
Adapted from Schwetz et al [103]
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TABLE XII-4
FETAL ANOMALIES FOUND IN MICE AFTER MATERNAL






Short tail (0) 8 (1)
Runts (wt. less than means X - 3 S.D.) 38 (10) 31 (4)
SOFT TISSUE
Cleft palate (0) 8 (1)
Subcutaneous edema 27 (7) 38 (5)
SKELETAL
Delayed ossification - skull bones 69 (18) 62 (8)
Lumbar ribs or spurs 31 (8) 38 (5)
Delayed ossification - sternebrae 4 (1) 23 (3)
Split sternebrae (0) 15 (2)
Extra sternebrae (0) 8 (1)
Malaligned sternebrae (0) 15 (2)
Number of litters examined 26 13
Adapted from Schwetz et al [103]
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TABLE XI1-5
FETAL ANOMALIES FOUND IN RATS AFTER MATERNAL
EXPOSURE TO 1,1,1-TRICHLOROETHANE AT 875 ppm
Control Exposed
SOFT TISSUE % No. % No.
Dilated renal pelvis (0) 4 (1)
Subcutaneous edema 17 (5) 17 (4)
SKELETAL
Delayed ossification - skull bones 33 (10) 30 (7)
Lumbar ribs or spurs 13 (4) 22 (5)
Delayed ossification - sternebrae 30 (9) 16 (3)
Split sternebrae (0) 4 (1)
Supernumerary vertebra (one, thoracic) (0) 4 (2)
Number of litters examined 30 23
Adapted from Schwetz et al [103]
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TABLE XII-6














Torkelson et al 
[36]

























Induction of anesthesia 
usually within 2 minutes 





2 of 7 exposed subjects 
unable to stand; feeling 




Positive Romberg test 
ECG’s normal
Impaired coordination and 
equilibrium








paired Romberg tests; eye 
nose and throat irrita­
tion; no evidence of 
liver or kidney injury
Balance and coordination 
not affected
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TABLE XII-6 (CONTINUED) 
INHALATION EXPOSURES AND EFFECTS IN HUMANS
Reference Exposure Species and Effects
Salvini et al 450 ppm Decreased perceptive
[37] 8 hours capabilities under stress 
conditions; eye, nose and 
throat irritation
Gamberale and 350 ppm Perceptual speed, reaction
Hultengren [38] 2 hours times, and manual dexterity 
impaired
250 ppm Perceptual speed, reaction
2 hours times, and manual dexterity 
not impaired
Blnaschl 250 ppm Unspecified symptoms
[63] Occupational
Kramer et al [64] 115 ppm No significant distrubrances
Occupational of hematology or blood 
chemistry
Weitbrecht Occupational exposure Conjunctival and respira­
[61] with skin exposure tory irritation; headache;
several months tiredness; insomnia; gas­
trointestinal complaints ; 
positive urobilinogen; 




INHALATION EXPOSURES AND CENTRAL NERVOUS
SYSTEM EFFECTS IN ANIMALS
Reference Exposure Species and Effects
Adams et al 
[73]
18,000 ppm, 5 minutes 
3 hours 
3 hours 





Truhaut et al 
[75]
16,850 ppm, 5 minutes 
More than 5 minutes
Rabbits, increased EEG 
activity
Decreased EEG activity
Gehring [70] 13,500 ppm, 16 minutes Mice, anesthesia
Adams et al 
[73]
10,000 ppm, 1-2 minutes 
10 minutes 
3 hours
Rats, decreased activity 
Rats, helpless 
Rats, semiconscious
Truhaut et al 
[76]
6,250 ppm, 1 hour Rabbits, sustained increase 
in EEG activity
Adams et al 
[73]
5,000 ppm, 1 hour 
1 hour 
5 hours
Rats, mild narcotic effect 
Monkey, slight ataxia 




1,000 ppm, 2 hours/day 
9 exposures on alternate 
days




180-900 ppm, 4 hours
73 ppm, 4 hours/day 
up to 120 days 
50 days 
120 days
Rats and cats, threshold 




Rats, more extreme patho­




INHALATION EXPOSURES AND CARDIOVASCULAR
EFFECTS IN ANIMALS





Dogs, abrupt drop in blood 
pressure; ventricular 
fibrillation in 1 dog on 
second exposure; gross con­
gestion in all tissues; 
heart cell necrosis
Belej et al 
[79]
25,000 ppm, 5 minutes Rhesus monkeys, cardiac 
arrythmias; myocardial 
depression; tachycardia
Herd et al 
[80]
8,000 ppm, 5 minutes Dogs, sharp decrease in 
peripheral resistance 
followed by decreased 
stroke volume, heart rate 
and myocardial- 
contractillty
Truhaut et al 
[75]




5,000 ppm, 5 minutes 
2,500 ppm, 5 minutes
Dogs, cardiac sensitiza­
tion to epinephrine 




73 ppm, 4 hours/day 
50 days 
120 days
Rats, venous hyperemia 
and small foci of swelling 
in heart muscle, more 
severe at 120 days
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TABLE XI1-9
INHALATION EXPOSURES AND PULMONARY EFFECTS IN ANIMALS
Reference Exposure Data Species and Effects
Torkelson 
et al [36]
2.000 ppm, 12 minutes/day
5 days/week 
69 exposures
1.000 ppm, 72 mlnutes/day
5 days/week 
69 exposures
Guinea pigs, lung 
irritation




1,000 ppm, 2 hours/day












250 ppm, continuously 
for 90 days




135 ppm, continuous 
for 90 days
Several species, varying 




73 ppm, 4 hours/day 
50 or 120 days
Rats, emphysematous 






INHALATION EXPOSURES AND LIVER AND KIDNEY EFFECTS IN ANIMALS
Reference Exposure Species and Effects
Adams et al 
[73]
18,000 ppm, 2 hours
12,000 ppm, 7 hours
8,000 ppm, 7 hours
Rats, increased kidney 
weights
Rats, increased liver 
weights, fatty liver 
changes, congestion and 
hemorrhagic necrosis; 
increased kidney weights






10.000 ppm, 1 hour/day 
5 days/week/70 times
0.5, 0.2, 0.05 hours/day 
5 days/week/70 times
3.000 ppm, 7 hours/day 
5 days/week
20 exposures
1,500 ppm, 7 hours/day 
5 days/week for 2 mo
Rats, increased liver 
weights and fatty changes
Rats, liver weights 
not increased
Guinea pigs, fatty 
degeneration of the 
liver; no kidney or 
liver effects in rats 
or monkeys
Rats and monkeys, 
no kidney or liver no 
effects
650 ppm, 7 hours/day 
5 days/week for 3 
months
Guinea pigs, no 
kidney or liver 
effects




2,200 ppm, 8 hours/day 
5 days/week for 6 weeks
2.000 ppm, 12 minutes/ 
day, 5 days/week
69 exposures
2.000 and 1,000 ppm 
< 0.2 hours/day
69 exposures
Rats, guinea pigs, 
rabbits, dogs, monkeys, 
no evidence of kidney 
or liver injury
Guinea pigs, increased 
liver weights with 
fatty changes




INHALATION EXPOSURES AND LIVER AND RIDNEY EFFECTS IN ANIMALS








500 ppm, 7 hours/day 
5 days/week, 126-130 
exposures
1.000 ppm, 2 hours/day 
9 exposures on 
alternate days
1.000 ppm, continuously 
for 90 days
Rats, guinea pigs, 
rabbits, and monkeys, 
no liver or kidney 
effects
Mice, liver congestion, 
inflammation around 
biliary ducts
Mice, increased liver 
weights; Increased liver 
triglycerides ; focal 
hépatocyte necrosis; acute 
inflammatory Infiltrate 
and hypertrophy of Kupffer 
cells
Rats, increased liver 
weights; vésiculation of 
the endoplasmic reticulum 
of hepatocytes with loss 
of polyribosomes; Increased 
smooth endoplasmic 
reticulum




INHALATION EXPOSURES AND LIVER AND KIDNEY EFFECTS IN ANIMALS
Reference Exposure Species and Effects
MacEwen and Vernot 
[88] continued
250 ppm, continuously 
for 100 days
Rats, above changes 
mild to minimal; mice, 
no change in liver 
weight nor in 
triglycerides; monkeys 
and dogs, no lesions 
observed
Prendergrast et al 
[85]
135 ppm, continuously 
for 90 days
Rats, guinea pigs, 
rabbits, dogs, monkeys, 
no evidence of liver or 
kidney injury
McNutt et al [41] 1000 ppm, continuously 
for 14 weeks
Mice, significant changes j 
centrilobular hepatocytes; 
moderate triglyceride 
accumulation; necrosis of 
hepatocytes
250 ppm, continuously 
for 14 weeks
Mice, mild to minimal 





73 ppm, 4 hours/day 
50 days
120 days
Rats, venous hyperemia 
and swelling of individual 
groups of cells 
Rats, above findings 
exaggerated; protein 




COMPARISON OF THREE ANALYTICAL METHODS 
FOR DETERMINING 1,1,1-TRICHLOROETHANE 
CONCENTRATIONS
Sampling 1,1,1-Trichloroethane, ppm
time, minutes Colorimetry Gas chromatography Detector tube
Exp. 1 0 117.5 (90.0)* 175
15 137.5 - 220
30 227.5 140.6 220
45 222.5 - 350
60 192.5 236.3 220
75 165.0 - 280
90 210.0 236.3 250
105 237.5 - 340
120 247.5 162.9
Average 195.2 194.0 256.9
Exp. 2 0 277.5 (187.6)* 300
15 297.5 - 500
30 297.5 258.3 350
45 415.0 - 550
60 387.5 302.2 420
75 - - 300
90 500.0 374.7 650
105 362.5 - 580
120 471.9 320.1
Average 376.2 313.8 456.2
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TABLE XII-11 (CONTINUED)
COMPARISON OF THREE ANALYTICAL METHODS 
FOR DETERMINING 1,1,1-TRICHLORQETHANE 
CONCENTRATIONS
Sampling 1,1,1-Trichloroethane, ppm
time, minutes Colorimetry Gas chromatography Detector tube
Exp. 3 0 485.0 (339.0)* 650
15 445.0 - 580
30 695.0 551.2 650
45 605.0 - 620
60 520.0 495.0 620
75 542.5 - 550
90 662.5 601.1 600
105 605.0 - 790
120 465.0 545.0
Average 558.3 548.0 632.5
Exp. 4 0 760.0 (372.3)* 780
15 792.5 - 810
30 830.0 538.7 760
45 870.0 - 730
60 830.0 603.8 800
75 870.0 - 810
90 792.5 619.8 720
105 870.0 - 750
120 870.0 603.8 “
Average 831.6 591.4 770.0
* Numbers in parenthesis are not 
Adapted from Fukabori [55]








Toxic Effects Basis for Total No. No. of
Reported Medical Evaluation of Subjects Subjects
Reporting
Symptoms



























tion (eye, ear, 










Visi-trol [141] 5.5-77 Dermatitis** Medical interview 25
1,1,1-TRICHLOROETHANE EXPOSURE CONCENTRATIONS
TABLE XII-12 (CONTINUED)


























acid determinations 13 0
Injection molding 
[144]
<1 No adverse 
effects
Medical interview 8 0
Exposure for several hours daily, not a TWA
** Not attributed to 1,1,1-trichloroethane by author of report 
Adapted from NIOSH Health Hazard Evaluation Reports [141-146]
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